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Abstract  
 
Background  
Fragility fractures constitute a major public health problem associated with considerable and 
growing individual, societal and economic burden. One of the main modifiable factors that 
determine fracture risk is bone strength that depends on bone size, morphology and material 
properties. As with many other chronic diseases, the approach currently used to explain the 
etiology of suboptimal bone strength is built on the premise that there is important tracking of 
this characteristic throughout the life course, modulated by gene-environment interactions. 
Body size is recognized as one of the major determinants of bone fragility and strong cross-
sectional relations between body size and composition and bone properties have been clearly 
established since pediatric ages. However, important issues regarding longitudinal effects of 
early life growth on childhood mineralization remain to be clarified. Namely, there is still no clear 
understanding of the impact of maternal gestational weight gain (GWG) on offspring bone 
physical properties. Additionally, it is unknown whether knowledge of children’s growth 
trajectories since birth improves the statistical prediction of bone mineralization or turnover 
during the first decade of life. Finally, the potential for adiposity to specifically influence bone 
physical properties in children remains to be clarified. 
 
Objectives  
In the present work our objectives were: 
 
1. To quantify the associations between gestational weight gain and bone mineralization 
in offspring, testing early pregnancy body mass index as an effect modifier (Paper I) 
 
2. To characterize the impact of early life growth on bone mineralization in childhood by:  
 
a. Identifying sensitive periods for the effect of early growth on childhood bone mass 
(Paper II) 
 
b. Assessing whether different trajectories of weight gain since birth influence 
childhood bone mineralization (Paper III) 
 
3. To describe markers of bone turnover in generally healthy children and assess their 
correlations with anthropometric growth and bone mineralization (Paper IV) 
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4. To test the potential for adiposity to specifically influence bone mass in children, using 
common causes as a benchmark (Paper V) 
 
Methods 
We used data from the Generation XXI, the first Portuguese birth cohort study assembled in 
Porto. All women who delivered live-born children with gestational age above 23 weeks in one 
of the five public units in the metropolitan area of Porto between April 2005 and August 2006, 
and whose residence was in the units’ catchment area were eligible for recruitment. Seventy 
percent of eligible mothers were invited and, of these, 91.4% accepted to participate. All 8647 
children enrolled at birth were invited to attend follow-up assessments at ages four (2009-2011) 
and seven (2012-2014) years (86.3% and 79.7% participation, respectively). 
At baseline, in the first 24 to 72 hours after delivery, trained interviewers were responsible for 
presenting the study and inviting mothers. Subsequent follow-up evaluations of the cohort took 
place at our research center. In face-to-face interviews at baseline and follow-up evaluations, 
information was collected using structured questionnaires concerning the child’s and mother’s 
health. Family medical history and data on demographic, socioeconomic and psychosocial 
circumstances, and lifestyles were also collected. A physical examination including 
anthropometric assessment was performed to children and mothers. Routine primary care data 
regarding the child’s development were periodically extracted from the Child’s Health Book. 
Velocities of growth in weight and length/height, across different age periods, were obtained 
through multilevel linear spline models. Weight trajectories since birth up to the age of 6 years 
were identified through normal mixture modeling for model-based clustering.  
In each evaluation, a child blood sample drawn from an antecubital vein, after overnight fasting, 
were collected and, at 7 years of age, a subsample of 400 participants was selected to measure 
the following bone metabolism markers: total alkaline phosphatase (tALP), osteocalcin (OC) 
and β-isomerized C-terminal telopeptides of type I collagen (β-CTx). 
In the 7 years-old follow-up evaluation a consecutive subsample of children who attended the 
face-to-face interview was invited to undergo a whole body dual-energy X-ray absorptiometry 
(DXA). Scanning was successfully performed in 2408 children (79.9% of the eligible sample 
and 27.8% of the entire cohort). Bone mineral content (BMC) and areal bone mineral density 
(aBMD) were obtained from DXA scan and a measure of size-corrected BMC (scBMC) was 
calculated.  
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Results 
Paper I  
 
In 2167 mother-child pairs, 35.8% of the mothers were overweight or obese [body mass index 
(BMI) ≥ 25 kg/m2] at the beginning of pregnancy. According to Institute of Medicine (IOM) 
recommendations for gestational weight gain, we found that 36.6% mothers gained excessive 
weight during pregnancy. We estimated heterogeneous associations between GWG and bone 
mineralization in the offspring at 7 years of age according to maternal BMI. Among 
under/normal weight mothers there was a positive association between GWG and offspring 
bone measures: per 5 kg of GWG, BMC: 0.07 standard deviation (SD) (95% confidence interval 
- 95% CI:, 0.01, 0.12); aBMD: 0.10 SD (95% CI: 0.05, 0.15), while in overweight/obese mothers 
no effect of GWG on bone was observed: BMC: 0.02 SD (95% CI: –0.04, 0.09); aBMD: 0.02 
SD (95% CI: –0.04, 0.08). When GWG was analyzed using IOM recommended categories, 
there were no differences in offspring mean bone properties between mothers gaining 
excessive and adequate weight during pregnancy, for both early pregnancy BMI groups.  
 
Paper II 
 
In 1853 children, all the five weight velocities (“early neonatal”: 0-10 days, “early infancy”: 10 
days-3 months, “late infancy”: 3-12 months, “early childhood”: 1-3 years, and “later childhood”: 
3-6 years) and four length/height velocities (“early infancy”: 0-3 months, “late infancy”: 3-12 
months, “early childhood”: 1-3 years, and “later childhood”: 3-6 years) were associated with 
increased bone mass and height at 7 years. Strongest associations were observed for growth 
in early childhood [(per 1 SD increase in weight velocity height-adjusted BMC z-score increased 
by 0.27 (95% CI: 0.22, 0.32) in girls and 0.24 (95% CI: 0.19, 0.29) in boys; per 1 SD increase 
in length/height velocity height-adjusted BMC z-score increased by 0.12 (95% CI: 0.07, 0.17) 
in girls and 0.11 (95% CI: 0.06, 0.16) in boys]. Estimates remained positive, albeit attenuated, 
after adjusting for preceding velocities of growth. 
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Paper III 
 
In 1889 7-year-old children, 66.2% had a trajectory of growth characterized by “normal weight 
gain”, 8.4% had a “weight gain during infancy” trajectory, 14.6% had a “weight gain during 
childhood” trajectory and 10.9% had a “persistent weight gain” trajectory. Compared with the 
“normal weight gain” group, bone measures were greater in all the remaining trajectories. 
Children who followed a “persistent weight gain” trajectory since birth had clearly increased 
bone mass and density in comparison to “normal weight gain” children (girls [BMC: 674.0 vs. 
559.8 g, aBMD: 0.677 vs. 0.588 g/cm2, scBMC: 640.7 vs. 577.4 g], boys [BMC: 689.4 vs. 580.8 
g, aBMD: 0.682 vs. 0.611 g/cm2, scBMC: 633.0 vs. 595.6 g]). After adjustment for current 
weight, girls with a “weight gain during childhood” trajectory had greater bone measures than 
those with a “normal weight gain” trajectory (BMC: 601.4 vs. 589.2 g, aBMD: 0.618 vs. 0.609 
g/cm2). 
 
Paper IV 
 
In 395 children, reference intervals (2.5th- 97.5th percentile) for serum tALP was 159 - 439 U/l; 
for β-CTx was 470 - 1690 ng/l and for OC was 52.5 - 137.7 µg/l in girls and 50.0 - 129.9 µg/l in 
boys. We found a moderate correlation between serum concentrations of bone-specific 
metabolism markers OC and β-CTx, likely representing the dynamic nature of bone turnover. 
Concentration of tALP increased slightly with height (Pearson partial correlations (rpartial) 
controlled for sex=0.26, 95% CI: 0.17, 0.35), was higher in overweight than in healthy weight 
children, and in children who gained weight above average during infancy. No correlations were 
found between OC or β-CTx and growth. In girls, OC was slightly correlated with measures of 
total body less head BMC (rpartial=0.22, 95% CI: 0.08, 0.35), subtotal aBMD (rpartial=0.20, 95% 
CI: 0.06, 0.33) and lumbar spine aBMD (rpartial=0.23, 95% CI: 0.09, 0.36). tALP and β-CTx were 
not correlated with any of the DXA-derived bone measures. Therefore, bone formation and 
resorption markers seemed to have limited usefulness to describe overall anthropometric 
growth and bone mineralization status in generally healthy children. 
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Paper V 
 
Using association between socioeconomic position (SEP) and fat mass as a benchmark, in a 
subsample of 2408 children, we found that among 10 SEP indicators associated with fat mass 
only educational level and occupational level of caregivers was associated with BMC: 
[educational level of the main (less than higher vs. higher education, standardized linear 
regression coefficient: 0.15, 95% CI: 0.07, 0.24) and secondary (0.13, 95% CI: 0.03, 0.22) 
caregivers; occupations of the main (blue and lower white vs. upper white collar: 0.12, 95% CI: 
0.03, 0.20) and secondary (0.10, 95% CI: 0.01, 0.18) caregivers]. A similar pattern to that 
observed for BMC was found for lean mass and height. In summary, assuming that traits that 
are causally related share causes to a measurable extent, the observation that fat mass and 
BMC did not share socioeconomic causes, may mean that fat mass has a small specific effect 
on BMC in childhood beyond its contribution to body size.  
 
Conclusions 
In the present study, we found no beneficial effect of excessive maternal GWG on childhood 
bone mineralization. Therefore, adherence to current recommendations for pregnancy weight 
gain may contribute to optimize child’s skeletal health. Regarding early life growth, our findings 
suggested that second and third years of life might represent a sensitive period for the effect 
of growth in height and weight on childhood bone mass, partly through their effect on concurrent 
body size. Additionally, the shape of the overall trajectory of weight gain since birth up to 6 
years was associated with DXA-derived bone measures, but not with bone turnover, at 7 years 
of age. Markers of bone turnover were also not particularly related to bone mineralization 
suggesting their limited usefulness in generally healthy children. Finally, we found that fat and 
bone mass did not share socioeconomic causes, from which we concluded that adiposity is 
likely to have a small specific effect on bone mass in childhood beyond its contribution to body 
size.  
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Resumo  
 
Introdução  
As fraturas de fragilidade estão associadas a elevada morbilidade e mortalidade e constituem 
um importante problema de saúde pública associado a custos substanciais para os doentes e 
para a sociedade. Um dos principais fatores modificáveis que determinam o risco de fratura é 
a resistência óssea que depende do tamanho, morfologia e propriedades materiais do osso. 
Como em muitas outras doenças crónicas, a abordagem teórica atualmente utilizada para 
explicar a etiologia do desenvolvimento de pior resistência óssea, e subsequente risco de 
fratura, baseia-se na premissa de que a qualidade óssea é em grande parte conservada desde 
as primeiras décadas de vida, e modulada por interações gene-ambiente. A corpulência é 
reconhecida como um dos principais determinantes da fragilidade óssea, e têm sido 
encontradas fortes relações transversais entre o tamanho e composição corporal e as 
propriedades do osso desde idades pediátricas. No entanto, permanecem por esclarecer 
algumas questões importantes sobre os efeitos longitudinais do crescimento no início da vida 
na mineralização óssea das crianças. Nomeadamente, não é claro o efeito do ganho de peso 
gestacional (GPG) da mãe nas propriedades físicas do osso da criança. Além disso, 
desconhece-se em que medida o conhecimento das trajetórias de crescimento desde o 
nascimento melhora a predição estatística das medidas de mineralização ou do turnover ósseo 
durante a primeira década de vida. Finalmente, permanece por esclarecer o potencial 
especifico da adiposidade para influenciar as propriedades físicas do osso em crianças. 
 
Objetivos 
Os objetivos do presente trabalho foram: 
 
1. Quantificar as associações entre o ganho de peso gestacional e a mineralização óssea 
da criança, testando o índice de massa corporal no início da gravidez como modificador 
de efeito (Artigo I) 
 
2. Caracterizar o impacto do crescimento no início da vida na mineralização óssea na 
infância através da: 
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a. Identificação de períodos sensíveis para o efeito do crescimento no início da 
vida na mineralização óssea na infância (Artigo II) 
 
b. Determinação do efeito de diferentes trajetórias de ganho de peso desde o 
nascimento na mineralização óssea na infância (Artigo III) 
 
3. Descrever marcadores de remodelação óssea em crianças globalmente saudáveis e 
determinar as suas correlações com o crescimento antropométrico e a mineralização 
óssea (Artigo IV) 
 
4. Testar o potencial específico da adiposidade para influenciar a massa óssea em 
crianças, usando causas comuns como um benchmark (Artigo V) 
 
Métodos  
Foram utilizados dados do estudo Geração XXI, a primeira coorte de nascimentos portuguesa 
realizado no Porto. Foram consideradas elegíveis para o estudo, todas as mulheres que 
tiveram partos originando nados-vivos com idade gestacional superior a 23 semanas numa 
das cinco maternidades de nível III do Porto, entre abril de 2005 e agosto de 2006, e que 
residiam na área de referência das maternidades. Das mães elegíveis, 70% foram convidadas 
e, destas, 91,4% aceitaram participar. Todas as 8647 crianças incluídas no estudo ao 
nascimento foram convidadas a participar em reavaliações da coorte aos quatro (entre 2009 e 
2011) e sete (entre 2012 e 2014) anos (86,3% e 79,7% de participação, respetivamente). 
No recrutamento, que ocorreu nas primeiras 24 a 72 horas após o parto, entrevistadores 
treinados foram responsáveis por apresentar o estudo e convidar as mães. As reavaliações 
da coorte ocorreram no nosso departamento de investigação. Ao nascimento e nas 
reavaliações subsequentes foram realizadas entrevistas presenciais, utilizando questionários 
estruturados, com o objetivo de recolher informação sobre a saúde da criança da mãe. Foi 
também recolhida informação sobre a história familiar de doença, características 
demográficas, socioeconómicas e psicossociais, e estilos de vida. Foi também realizado um 
exame físico que incluía uma avaliação antropométrica da criança e da mãe. Foram extraídos 
do Boletim de Saúde Infantil, dados de rotina dos cuidados primários relativos ao crescimento 
e desenvolvimento da criança. As velocidades de crescimento em peso e comprimento/altura, 
em diferentes intervalos de idade, foram obtidas através de modelos lineares multinível usando 
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splines. As trajetórias de peso do nascimento até aos 6 anos de idade foram identificadas 
através de modelação de mistura normal para clustering baseado em modelos. 
Em cada avaliação, foi colhida uma amostra de sangue de uma veia antecubital da criança, 
após jejum noturno e, aos 7 anos de idade, foi selecionada uma subamostra de 400 
participantes para determinação dos seguintes marcadores de metabolismo ósseo: fosfátase 
alcalina total (tALP), osteocalcina (OC) e telopeptídeos β-isomerizados do C-terminal do 
colagénio tipo I (β -CTx). 
Na reavaliação da coorte aos 7 anos de idade, uma subamostra consecutiva de crianças que 
compareceu à entrevista presencial foi convidada a fazer um exame de absorciometria de raio-
X de dupla energia (DXA). O exame foi realizado com sucesso em 2408 crianças (79,9% da 
amostra elegível e 27,8% de toda a coorte). O conteúdo mineral ósseo (CMO) e a densidade 
mineral óssea areal (DMOa) foram obtidos a partir do exame DXA e calculou-se uma medida 
de BMC corrigida para a corpulência (DMOcc). 
 
Resultados  
Artigo I 
 
Em 2167 pares mãe-filho, 35,8% das mães apresentavam sobrepeso ou obesidade [índice de 
massa corporal (IMC) ≥ 25 kg/m2] no início da gravidez. Usando como referência as 
recomendações do Institute of Medicine (IOM) para ganho de peso gestacional, observou-se 
que 36,6% das mulheres tinham ganho peso excessivo durante a gravidez. Observaram-se 
relações heterogéneas entre GPG e mineralização óssea da criança aos 7 anos de acordo 
com o IMC da mãe. Nas mães com peso baixo/normal observou-se uma associação positiva 
entre GPG e as propriedades ósseas da criança: por 5 kg de GPG, CMO: 0.07 desvios-padrão 
(DP) (intervalo de confiança a 95% - IC 95%: 0,01; 0,12); DMOa: 0.10 DP (IC 95%: 0,05; 0,15), 
enquanto em mães com sobrepeso/obesidade não foi observado efeito do GPG no osso: CMO: 
0.02 DP (IC 95%: –0,04; 0,09); DMOa: 0.02 DP (IC 95%: –0,04; 0,08). Quando o GPG foi 
analisado usando as categorias de referência do IOM, não se observaram diferença nas 
médias das propriedades ósseas da criança, entre mães que tinham ganho peso excessivo e 
as que tinham ganho peso adequado durante a gravidez, para ambos os grupos de IMC no 
início da gravidez. 
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Artigo II 
 
Em 1853 crianças, observou-se que todas as velocidades de peso em 5 períodos de 
crescimento (entre 0 e 10 dias, entre 10 dias e 3 meses, entre 3 e 12 meses, entre 1 e 3 anos 
e entre 3 e 6 anos), bem como as velocidades de comprimento/altura em 4 períodos de 
crescimento (entre 0 e 3 meses, entre 3 e 12 meses, entre 1 e 3 anos e entre 3 e 6 anos), se 
associaram com o aumento da massa óssea e com a altura aos 7 anos de idade. As 
associações mais fortes foram observadas para o crescimento entre o 1º e 3º anos de vida 
[(um aumento de 1 DP na velocidade de peso relacionou-se com um aumento do z-score CMO 
ajustado para a altura de 0,27 (IC 95%: 0,22; 0,32) nas raparigas e de 0,24 (IC 95%: 0,19; 
0,29) nos rapazes; um aumento de 1 DP na velocidade de comprimento/altura relacionou-se 
com um aumento do z-score CMO ajustado para a altura de 0,12 (IC 95%: 0,07; 0,17) nas 
raparigas e 0,11 (IC 95%: 0,06; 0,16) nos rapazes]. 
 
Artigo III 
 
Em 1889 crianças de 7 anos de idade, 66,2% tinham uma trajetória de crescimento 
caracterizada por “ganho normal de peso”, 8,4% tinham “maior ganho de peso no início da 
infância”, 14,6% tinham “maior ganho de peso mais tarde na infância” e 10,9% teve uma 
trajetória de “ganho persistente de peso”. Em comparação com o grupo “ganho normal de 
peso”, as propriedades ósseas foram significativamente maiores em todos os outros grupos 
de crianças nas restantes trajetórias. As crianças com uma trajetória de crescimento 
caracterizada por "ganho persistente de peso" desde o nascimento apresentavam 
significativamente mais conteúdo e densidade mineral óssea do que as crianças com "ganho 
normal de peso" (raparigas [CMO: 674,0 vs. 559,8 g, DMOa: 0,677 vs. 0,588 g/cm2, CMOcc: 
640,7 vs. 577,4 g], rapazes [CMO: 689,4 vs. 580,8 g, DMOa: 0,682 vs. 0,611 g / cm2, CMOcc: 
633,0 vs. 595,6 g]). Após ajuste para o peso atual, as raparigas com uma trajetória “maior 
ganho de peso mais tarde na infância” apresentavam melhores propriedades ósseas do que 
aquelas com uma trajetória de “ganho normal de peso” (CMO: 601,4 vs. 589,2 g, DMOa: 0,618 
vs. 0,609 g/cm2). 
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Artigo IV 
 
Em 395 crianças, os intervalos de referência para os marcadores de metabolismo ósseo 
analisados foram (percentil 2,5 - 97,5) -  tALP sérico: 159 - 439 U/l; β-CTx: 470 - 1690 ng/l; 
OC: nas raparigas 52,5 - 137,7 μg/l e nos rapazes 50,0 - 129,9 μg/l. Identificou-se uma 
correlação moderada entre as concentrações séricas dos dois marcadores específicos do 
metabolismo ósseo, OC e β-CTx, provavelmente representando a natureza dinâmica do 
turnover ósseo. Observou-se que a concentração de tALP aumentava ligeiramente com a 
estatura da criança (rparcial (coeficiente de correlação parcial) tendo em conta o sexo=0,26, IC 
95%: 0,17; 0,35), era mais elevada em crianças com excesso de peso, relativamente a 
crianças de peso normal, e nas crianças com “maior ganho de peso no início da infância”. Não 
foram encontradas correlações entre OC ou β-CTx e variáveis de crescimento. Nas raparigas, 
a OC estava ligeiramente correlacionado com o CMO do corpo inteiro (rparcial=0,22, IC 95% CI: 
0,08; 0,35), DMOa do corpo inteiro (rparcial=0,20, IC 95% CI: 0,06; 0,33) e a DMOa da coluna 
lombar (rparcial=0,23, IC 95% CI: 0,09; 0,36). As concentrações séricas de tALP e β-CTx não 
estavam correlacionados com nenhuma das propriedades ósseas obtidas por DXA. Estes 
resultados sugerem que os marcadores de formação e reabsorção óssea em crianças na sua 
maioria saudáveis tem utilidade limitada para descrever quer o crescimento antropométrico 
quer a mineralização óssea. 
 
Artigo V 
 
Usando a associação entre a posição socioeconómica (PSE) e massa gorda como benchmark, 
observou-se que, numa subamostra de 2408 crianças, dos 10 indicadores de PSE associados 
à massa gorda, apenas a escolaridade e a ocupação dos cuidadores estavam associados ao 
CMO: coeficiente de regressão linear estandardizado e respetivos IC 95% para escolaridade 
do principal cuidador [menor que escolaridade superior vs. escolaridade superior, 0,15 (IC 
95%: 0,07; 0,24)]; escolaridade do cuidador secundário [0,13 (IC 95%: 0,03; 0,22]; ocupação 
do cuidador principal [ocupações de manuais vs. não manuais, 0,12 (IC 95%: 0.03; 0.20)]; 
ocupação do cuidador secundário [0,10 (IC 95%: 0,01; 0,18]. Foi encontrado um padrão 
semelhante ao observado para o CMO para massa magra e estatura. Em suma, supondo que 
variáveis que têm uma relação causal entre si também partilham determinantes, o facto de não 
se observarem as mesmas causas socioeconómicas para a massa gorda e CMO, pode 
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significar que a massa gorda tem um pequeno efeito específico sobre o CMO da criança além 
da sua contribuição para a corpulência. 
 
Conclusões 
No presente estudo, não se observou efeito benéfico do GPG excessivo da mãe na 
mineralização óssea da criança. Assim, a adesão às recomendações atuais para ganho de 
peso na gravidez pode contribuir para otimizar a saúde óssea da criança. Em relação ao 
crescimento no início da vida, os resultados sugeriram que o segundo e o terceiro anos de 
vida podem representar um período sensível para o efeito do crescimento em altura e em peso 
na massa óssea da criança, parcialmente através do efeito na corpulência atual. Além disso, 
a forma global da trajetória de ganho de peso desde o nascimento até aos 6 anos associou-
se às propriedades ósseas obtidas por DXA, mas não aos marcadores do turnover ósseo, aos 
7 anos de idade. Estes marcadores também não se mostraram estar particularmente 
relacionados com a mineralização óssea, o que pode sugerir que a sua utilidade é limitada 
quando se refere a crianças saudáveis. Finalmente, observou-se que a massa gorda e massa 
óssea não partilhavam causas socioeconómicas, pelo que se concluiu que a adiposidade tem 
provavelmente pouco efeito específico na massa óssea na infância, para além da sua 
contribuição para a corpulência.  
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1. Introduction 
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1.1. The burden of musculoskeletal disorders 
Musculoskeletal conditions comprise a group of more than 150 diseases and syndromes, being 
diverse with regards to pathophysiology, but linked anatomically, and by their association with 
pain and loss of physical function [1]. Historically, musculoskeletal disorders have been 
underestimated, mainly due to their low fatality rate and were viewed as irreversible conditions 
or simply part of the ageing process [2]. However, nowadays, it is recognized that this group of 
diseases has an enormous and growing impact on populations worldwide, being  the largest 
contributor to disability in high-income countries [3]. In the 2017 Global Burden of Disease 
Study, musculoskeletal disorders were the major contributor to the global number of years of 
life lost due to disability (YLDs), being responsible for 15.9% of the total YLDs, which reflected 
an increase of 66.0% in the number of YLDs since 1990 and of 20.0% since 2007 [4].  
Severe long-term pain, impaired mobility and function, and reduced quality of life and mental 
well-being, affecting the ability to work and actively participate in all aspects of life, are the most 
common consequences of musculoskeletal conditions [5]. Therefore, musculoskeletal 
conditions have a profound economic impact, both for the individual and society, through direct 
health expenditure and indirect costs related to loss of productivity [6].  
The prevalence and burden of musculoskeletal conditions are predicted to rise as the 
population grows and ages, and the prevalence of risk factors for noncommunicable diseases 
(such as obesity and sedentary lifestyles) increases, particularly in developing countries [7]. 
Among musculoskeletal conditions, osteoporosis, a skeletal disorder characterized by low bone 
mass, deterioration of the bone tissue microarchitecture and compromised bone strength, 
contributes largely to this burden by increasing the risk of low-trauma fracture [2]. Fragility 
fractures are associated with chronic pain, reduced mobility and disability, and an increasing 
degree of dependence, thus representing the most important outcome of bone fragility, and 
their prevention is an essential goal for the early promotion of bone health. 
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1.2. The population burden of fragility fractures 
In the general population, fracture incidence has a bimodal age distribution peaking during 
childhood and in the elderly population (Figure 1) [8,9]. This pattern of fracture incidence across 
the age spectrum results from the relative bone fragility observed in these two periods of life, 
due to skeletal immaturity (and partly also to increased trauma frequency and severity) in 
childhood and to the age-related structural deterioration of the skeleton in the elderly [10,11]. 
 
 
Figure 1. Annual fracture incidence (at all fracture sites) per 10 000 people, by age and sex, in the 
Australian general population 2006-2007 (reproduced from Pasco et al. [8]) 
 
In adulthood, fracture incidence increases with age as a function of age-related worsening of 
the intrinsic physical properties of bone tissue and due to a greater propensity to fall [12]. The 
incidence of falls increases with age because several sensory systems that control posture 
(vestibular, visual, and somatosensory) become compromised with advancing age. In addition, 
muscle mass, which prevents instability and corrects imbalance, declines 3 to 8% per decade 
from age 30 and on, and a greater declines is observed after age 65 [13,14]. 
As illustrated in Figure 2, different types of fragility fractures, with different impacts on the 
patients who suffer them, are likely to occur at different stages of life. Overall, as age advances, 
the prognosis of fracture worsens, due to a generally debilitated health status and to the 
presence of co-morbidities [15,16]. 
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Figure 2. Schematic representation of the morbidity associated with different fractures with age 
(adapted and reproduced from Bone Health and Osteoporosis: A Report of the Surgeon General [15]) 
 
Fragility fractures are defined as fractures that result from a low-energy trauma, such as a fall 
from a standing height or from stairs, steps or curbs, or from moderate trauma, other than a 
fall, such as a collision with an object during daily routine [17]. Alternatively, as fractures are 
particularly frequent in older ages, they can also be operationalized as those fractures that 
occur at a skeletal site with decreased bone strength and whose incidence increases after the 
age of 50 years [18]. The anatomical sites where most fractures due to skeletal fragility are 
likely to occur are, by order of the related disability burden, the hip, the lumbar spine and the 
distal forearm [18,19]. Since hip fractures are typically related with decreased bone strength, 
leading almost always to hospital admission and resulting in major temporary or even 
permanent functional disability, they have become the standard outcome for estimating the 
burden of bone fragility. These fractures also contribute for the largest proportion of the 
morbidity, mortality and costs attributable to fragility fractures [1,20].  
Besides the age effect observed in fracture trends, a gender effect in the susceptibility to 
fractures has been described, with women having an increased fracture risk compared to men. 
In different population settings, the lifetime risk of fracture was estimated to be two to four times 
higher in women than in men [21-25]. Differences in fracture risk between sexes are attributable 
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not only to higher areal bone mineral density (BMD) in men than in women, but also to 
increased bone size and bone geometry resulting in higher bone strength, and greater 
mechanical resistance of the male skeleton throughout life [21,26]. Also, relevant loss of bone 
mass occurs among postmenopausal women [26]. Nevertheless, even though the mortality 
rate after hip fracture is described to be higher in men than in women, the huge morbidity and 
financial burden of fragility fractures in the population arise mainly from fractures occurring in 
women [27].    
Worldwide, but particularly in high-income countries, age-related fragility fractures are frequent 
events. In 2000, there were an estimated 9.0 million fragility fractures occurring worldwide of 
which, 1.6 million were at the hip, 1.7 million at the forearm and 1.4 million were clinical vertebral 
fractures [28]. In Europe, where fragility fractures account for over one third of all those 
occurring worldwide, the number of new fractures, in 2010, was estimated to be 3.5 million and 
included 610,000 hip fractures [29]. More recently, a report from the International Osteoporosis 
Foundation (IOF) referred that, in 2017, there were an estimated 2.7 million fractures occurring 
in six European countries (France, Germany, Italy, Spain, Sweden, and United Kingdom) of 
which, 51% were major fragility fractures (hip, spine, humerus, or forearm fractures) [30]. 
A substantial variation in the estimates of incidence rates of fragility fractures by geographic 
region is supported by numerous country-specific and regional studies (Figure 3) [25,29,31,32]. 
Excluding countries providing very old or poor-quality estimates, age-standardized hip fracture 
rates vary around 10-fold between countries [31,32]. Median age-standardized hip fracture 
rates are the highest in Western populations (North America and Europe) followed by Oceania, 
Asia, Middle East, Oceania, Latin America and Africa [25]. Annual hip fracture incidence rates 
higher than 250/100,000 have been described in Denmark, Norway, Sweden and Austria, while 
the lowest rates (<150/100,000) were found in Nigeria, South Africa, Tunisia and Ecuador [31]. 
Nevertheless, some high-risk countries (e.g., Malta, Argentina, Singapore and Taiwan) seem 
to escape this pattern [31]. Within the same continent, rates also seem to vary markedly: in 
Europe, for example, Scandinavia presents some of the highest age-adjusted rates of hip 
fractures worldwide, almost seven-fold higher than in southern European countries [25,31]. 
Furthermore, hip fracture incidence rates seem to be lower in rural than in urban areas [33]. 
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Figure 3. Hip fracture rates for men and women combined in different countries of the world, 
categorized by risk. Where estimates are available, countries are color coded red (annual incidence 
>250/100,000), orange (150–250/100,000) or green (<150/100,000) (reproduced from Kanis et al.[31]) 
 
In addition to the large geographic variation in the incidence of hip fractures throughout the 
world, contrasting secular trends were described across different countries and regions [34-
36]. Temporal trends in the age- and sex-adjusted incidence of hip fractures worldwide reveal 
that, in high-income countries, after increases throughout the second half of the 20th century, 
incidence rates seem to have stabilized, or started to decline, over the last two decades [34]. 
Indeed, in Europe specifically, hip fracture incidence rates in different countries can be 
described within the same overall pattern of secular trend reversal, with significant intercountry 
variability in the timing of reversal and peak fracture rates, which suggests that European 
countries show variations of the same hip fracture epidemic (Figure 4) [37]. In developing 
populations, however, particularly in Latin America and Asia, there is evidence for a continuous 
rise in age-adjusted hip fracture rates [34,35]. Although time trends for fragility fractures at other 
anatomical sites are less well characterized, similar trends to those described for hip fractures 
have been suggested [35,36]. 
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Figure 4. Distribution of calendar year of trend reversal (boxplots on the left) and peak incidence rates 
(boxplots on the right) in country clusters and the geographical distribution of countries in each cluster 
(reproduced from Lucas et al. [37]) 
 
 
As the incidence of osteoporosis and associated fractures increases exponentially with 
advancing age [38], the burden of fragility fractures is expected to increase, particularly in 
developing countries [39]. Based on current demographic changes and if age-adjusted 
incidence rates for hip fractures remain stable, it is estimated that the global annual number of 
hip fractures may reach 6.3 million by 2050 [40]. Additionally, since fracture rates seem to be 
rising in many parts of the world, the projected number of hip fractures worldwide could be as 
high as 8.2 million by 2050, if a 1% per year rise in age-adjusted rates is assumed [40]. The 
percentage increase will be greater in men (310%) than in women (240%) [41]. In Europe, the 
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number of individuals with osteoporosis is projected to increase from 27.5 million in 2010 to 
33.9 million in 2025, which translates into an estimated annual number of 4.5 million incident 
fragility fractures [29]. Thus, fractures will continue to place a high financial burden on 
individuals, healthcare systems, and ultimately on the society.  
 
As a public health issue, hip fractures are associated with important short- and long-term 
morbidity, with a significant impact on quality of life, as well as increased mortality [42,43]. Hip 
fracture survivors experience worse mobility, health and quality of life, less independence in 
function, and higher rates of institutionalization than age matched control subjects. It has been 
estimated that, after a fragility fracture, 50% of previously independent people do not return to 
their pre-fracture level of autonomy, 30 to 50% of patients become totally dependent, and 10 
to 20% of patients are institutionalized within 6 to 12 months post-fracture [28,44]. 
The burden of disease due to incident hip fracture using disability-adjusted life-years (DALYs) 
was estimated to be 1.75 million DALYs lost globally, in 1990, due to hip fractures, which 
translates into an average loss of 0.1% of the total burden of disease [36,45]. Recently, using 
real-life data of a large cohort consortium of middle-aged and older individuals in Europe and 
the United States followed for up 13 years, the burden of disease due to hip fracture was 5964 
DALYs (27 per 1000 individuals), representing a loss of 2.7% in the healthy life expectancy in 
this population [46]. In comparative terms, fragility fractures account for more DALYs than most 
common cancers in Europe [28].  
Despite advances in the management of osteoporosis, fragility fractures, especially hip 
fractures, are associated with a higher mortality rate [43,47]. Around 20 to 40% of people die 
within the first year following a hip fracture event [34]. In comparison with general population 
mortality rates, hip fractures are associated with a two- to four-fold increased risk of mortality 
during the first year after the event, in women and men respectively [48]. 
 
Economically, mainly due to their high frequency and associated incapacity, fragility fractures 
pose a significant economic burden to the individual, to financial and health systems, and 
ultimately to societies. In a recent systematic review of studies from 27 countries reporting costs 
attributable to hip fractures, the average cost of the index hospitalization following a hip fracture 
was estimated to be USD 10,075. Additionally, the health and social care costs in the 
12 months following hip fractures were estimated to be USD 43,669 [49]. In fact, expenses of 
hospital care and rehabilitation during the first year following hip fractures exceed those of other 
highly prevalent pathologies of the elderly, such as acute coronary syndrome and ischemic 
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stroke [49]. Hence, in the United States, the annual estimated cost attributable to incident and 
prevalent fractures was more than USD 19 billion in 2005 and it is speculated that it will increase 
up to USD 25.3 billion by 2025 [50]. In Europe, the total monetary osteoporosis burden in 2010 
was estimated at EUR 37 billion annualy [29]. Costs attributable to the treatment of incident 
fractures accounted for 66% of this cost, while pharmacological prevention and long-term 
fracture care represented 5% and 29% of the total costs, respectively [29]. Furthermore, if the 
costs attributable to the quality-adjusted life years lost were included in the cost associated with 
fracture management, estimates would be EUR 98 billion and have been projected to increase 
around 25% between 2010 and 2025, up to EUR 121 billion by 2025 [29].  
 
1.3. Bone fragility and fractures 
Fractures depend upon both bone strength and propensity to trauma (Figure 5) [51]. From a 
mechanical perspective, fractures represent a structural failure of the bone, which occurs when 
the loads applied to the bone exceed its strength. The forces applied to the bone will depend 
on the specific activity, and will vary with the magnitude and direction of the loads applied to it. 
For example, during a fall, the loads applied to the proximal femur depend on the height and 
direction of the fall, the impact surface, the extent of the natural “trochanteric padding” i.e. of 
the soft tissue overlying the hip, and the ability of the individual to decrease the impact of the 
fall [51]. 
 
Figure 5. Etiology of age-related fractures (reproduced from Bouxsein [51]) 
 
 
Whole bone strength, i.e. the load-bearing capacity of a bone and its consequent ability to resist 
fracture, depends on the bone’s biomechanical properties. These include structural properties, 
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which are influenced by the amount of bone (i.e. size or mass) and the spatial distribution of 
bone tissue (i.e. shape and architecture) and material properties, which reflect the intrinsic 
biomechanical characteristics of bone tissue (apparent density and microstructural 
arrangement of trabeculae) [51] (Figure 6). Therefore, bone fragility is said to occur when the 
biomechanical properties of the organ as a whole are compromised, leading to increased 
fracture risk [52]. 
Maintenance of the shape, mass and size of the skeleton depends on the continuous process 
of remodeling. Bone remodeling is a process characterized by the coordinated actions of 
osteoclasts and osteoblasts, organized in bone multicellular units, following an activation-
resorption-formation sequence of events [53,54]. This process involves the removal of 
mineralized bone by osteoclasts, followed by the replacement with newly formed bone matrix 
(osteoid) by osteoblasts, which then undergoes mineralization to form new bone. Bone 
remodeling takes place in four different bone surfaces, namely, periosteal, endocortical, 
trabecular and intracortical (or Haversian). Within each envelope, osteoclastic bone resorption 
is tightly coupled with local osteoblastic bone formation, and the balance between these two 
processes allows bone to adapt structure to function in response to stress and other 
biomechanical forces. Also, bone remodeling is an integral part of the calcium homeostatic 
system, and provides a crucial mechanism for the removal of old bone and repair of 
microdamages in bone matrix [62]. Contrasting to bone modeling, that is the predominant 
process occurring in childhood, bone remodeling predominates in adulthood, and is thus 
essential for the maintenance of overall bone strength and for repairing damaged tissue 
throughout the life course [55]. 
 
Figure 6. Determinants of whole bone strength (reproduced from Bouxsein [51]) 
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1.4. Estimating bone fragility - Bone mass as a surrogate for bone 
strength 
According to the United States National Institutes of Health Consensus Development Panel on 
Osteoporosis Prevention, Diagnosis, and Therapy, from 2001, osteoporosis was defined as “a 
skeletal disorder characterized by compromised bone strength predisposing to an increased 
risk of fracture” [19]. As previously mentioned, whole bone strength depends on the 
combination of the amount of bone (i.e. size), the spatial distribution of the bone mass (i.e. 
shape), and the intrinsic properties of the materials that comprise the bone. Among these, 
emphasis has been placed on the mass component as it is easily quantifiable without the need 
for invasive testing and it is, to a certain extent, modifiable through interventions [15]. The 
importance of bone mass as a determinant of bone strength is reflected in fact in the World 
Health Organization (WHO) operational definition of osteoporosis [56]. This definition 
established four thresholds based on reference populations of healthy young women to be used 
in diagnosing osteoporosis and determining intervention; a BMD value higher than 1 standard 
deviation (SD) below the young adult female reference mean (T-score ≥ −1 SD) indicates 
normal bone density, while a BMD value between 1 and 2.5 SD below the reference mean (T-
score < −1 and > −2.5 SD) is indicative of Osteopenia, a BMD value 2.5 (SD) or more below 
the (T-score ≤ −2.5 SD) reflects Osteoporosis and a BMD value 2.5 SD or more below the 
reference mean in the presence of 1 or more fragility fractures indicates Severe osteoporosis 
(established osteoporosis). More recently, in 2008, dual-energy X-ray absorptiometry (DXA)-
derived BMD measurements at the femoral neck were recommended as the reference standard 
for the description of osteoporosis [57]. A normative database of femoral neck measurements 
obtained in women aged 20 to 29 years, as part of the NHANES III, should be used as the 
reference data [57]. 
The development of DXA in the mid-1980s, as a rapid and safe imaging modality, allowed for 
the measurement of bone mineral mass. DXA distinguishes bone mass from soft tissue, both 
for the total body and for specific regions, by the differential attenuation of the high and low 
energy X-rays of these tissues. This technique uses an X-ray source to produce a beam of two 
discrete energies, and while bone tissue, mainly constituted of phosphorus and calcium, 
attenuates high-energy photons, soft tissue composed by muscle, fat, skin and water 
attenuates low-energy photons. In addition to the estimation of the content of bone mass and 
projected bone area, DXA also provides a measure of bone quality, or BMD, that is computed 
as the ratio between bone mass and bone area [58].  
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Considering the high precision and accuracy of DXA, which make this technique the standard 
method to measure BMD in order to assess fracture risk, other advantages include very low 
radiation dose exposure to patients, availability, short scan times, ease of use and a relatively 
low cost [59]. DXA is also the method of choice to assess bone mass in children, however 
errors related to growth and maturity significantly diminish the accuracy of this method for bone 
quality measurement [60,61].  
The importance of the identification of osteoporosis is mainly chiefly with regard to associated 
fractures and their sequelae [20,62]. In prospective studies among adults, the risk of fragility 
fracture increases continuously as BMD declines by a factor of 1.5–3.0 for each SD decrease 
in BMD [62], and similar fracture risk increments in children and adolescents have been 
reported [63,64]. The ability of BMD to predict fracture is comparable to the use of blood 
pressure to predict stroke, and significantly better than serum cholesterol to predict myocardial 
infarction [56]. The relationship between BMD and fracture risk was confirmed in a meta-
analysis using approximately 39,000 participants from 12 cohort studies, where it was 
estimated that, per each SD decrease in BMD, the risk of fragility fracture increased by 1.55 
(95% CI: 1.47, 1.62) and the relative risk of hip fracture increased by 2.07 (95% CI: 1.91, 2.24) 
[65].  
However, there is increasing concern about the limitation of BMD to accurately predict bone 
strength and fracture risk, at the individual level, considering that the majority of fragility 
fractures occur in individuals with values of BMD above the threshold for osteoporosis 
diagnosis [66,67]. In fact, in comparison to individuals with osteoporosis, the higher number of 
individuals who have normal BMD, although individually at lower risk, contributes with a higher 
number of fractures to the total burden. For this reason, over the past years, efforts have been 
directed to identify clinical risk factors for the risk of fractures independently of BMD. From a 
series of meta-analyses using individual data from prospective population-based studies in 
Europe, North America, Asia and Australia, the determinants of fragility fractures identified were 
age, gender, body mass index, prior fragility fractures, parental history of hip fractures, long-
term use of oral glucocorticoids, rheumatoid arthritis and other secondary causes of 
osteoporosis, current smoking and increased alcohol intake [68-72]. This consideration has led 
to more pragmatic approaches toward the prediction of fracture risk combining BMD with 
clinical and epidemiological risk factors in absolute risk calculators, such as the Fracture Risk 
Assessment Tool, FRAX® developed by the WHO [38,73]. The use of clinical risk factors in 
addition to BMD measurement has been demonstrated to increase the accuracy of fragility 
fracture (hip or major fractures) risk assessment [74,75]. 
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1.5. The life course approach to bone health 
Key stages in people's lives have particular relevance for their health and the life course 
approach acknowledges the importance of these stages. The growing interest in the 
relationship between adverse circumstances across the life course leading to changes that 
impact on disease risk and early mortality have led to research that explains disease etiology 
within a life course framework [76]. 
Life course theory emerged in the second half of the twentieth century in order to answer to the 
question of how the interrelationship of social structures, time, place and history of individuals’ 
lives influence their own life and their successfulness [77]. Thereafter, emerging research has 
led to a convergence of evidence on the wide-ranging effects of early environment and the 
associated development for later health outcomes [78]. As the life course theory has evolved 
over time, four core principles have emerged from early empirical observations to provide a 
framework to guide research on the matter of problem identification and conceptual 
development. These principles are [77,79]: 
1. Historical time and place: the life course of individuals is embedded in and shaped by the 
historical times and places they experience over their lifetime; 
2. Timing in lives: the developmental impact of a succession of life transitions or events is 
contingent on when they occur in a person’s life;  
3. Linked lives: lives are lived interdependently, and social and historical influences are 
expressed through this network of shared relationships; 
4. Human agency: individuals construct their own life course through the choices and actions 
they take within the opportunities and constraints of history and social circumstances.  
The objective of a life course approach in epidemiology is to establish how biological, 
behavioral and psychosocial factors, as well as a countless number of interactions between 
them, operating at different stages of life and across generations, contribute to the development 
of adult health and disease over time [80]. Considering this approach, health outcomes in adult 
life may be seen as long-term effects of exposures acting from preconception through 
pregnancy, infancy, childhood and adolescence, through adulthood [76]. Life course 
epidemiology extends the developmental origins of adult disease perspective by focusing 
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attention on potentially sensitive periods throughout the life course [78]. Although the terms 
“critical period” and “sensitive period” are often used interchangeably, important distinctions 
exist between them. A critical period of development refers to a time window, when an exposure 
can have long-lasting adverse or protective effects on the structure or function of organs, 
tissues, or body systems, which are not modified by later experience and may eventually result 
in disease. Outside this window, this developmental mechanism for mediating exposure and 
disease risk is no longer available, i.e. an exposure in a critical period results in permanent and 
irreversible damage or disease. Additionally, there may also be sensitive developmental 
periods when exposures exert stronger effects on development than they would during other 
periods. It means that there is a greater scope for modification or even reversion of those 
changes outside the time window, than there is in a critical period [76]. Overall, both critical and 
sensitive periods refer to qualitatively different exposure-time interactions [81]. To understand 
how exposures may differentially act in critical and/or sensitive periods, a life course approach 
requires some understanding of physiological trajectories of normal biological systems. Most 
interest has focused on changing exposures, particularly developmental variables, such as 
height and weight, which change rapidly throughout life and may have specific periods when 
endogenous changes, triggered or modified by environmental factors, play a role and may have 
lifelong consequences on endocrine systems [78]. 
Adopting a life course approach presents major challenges for both the design and analysis of 
epidemiological studies [76]. In this context, using data sets that are suited for life course 
analyses, with repeated measures of exposure and/or outcomes, such as those obtained from 
population-based birth cohorts, are the most powerful way to examine dynamic processes and 
determine if any critical or sensitive periods exist [82]. For this purpose, birth cohort studies 
established some decades ago have been fundamental to provide relevant evidence about 
health and functions across the life course, and between generations that link to adult outcomes 
[78]. Birth cohort studies allow stating the temporal ordering of exposure variables and their 
inter-relationships, both directly and through intermediate variables, with the outcome measure. 
They allow for the operationalization of early life course exposures and conceptualization of 
their inter-relationships across the life course, and also to test possible pathways with potential 
intermediate or confounding factors [76]. Because different periods across the life course 
influence phases of biological development, stability or decline, longitudinal studies since birth 
clearly remain one of the most powerful ways to test life course models. More ambitiously, 
cohorts from different time periods can provide insights into whether exposure-disease 
30 
 
associations differ across time and how these are manifested in disease trends that are 
observed over time at the population level [82]. 
Not surprisingly, the life course theory started being used to study chronic disease distribution 
and its determinants, resulting in the development of a life course approach to chronic disease 
epidemiology [81]. This relies on a multidisciplinary framework for understanding how early- 
and later-life biological, behavioral and psychosocial exposures operate across an individual’s 
life course, as well as across generations, to influence the development of chronic diseases 
[76]. Further, a life course approach to chronic disease epidemiology recognizes the 
importance of time - based on the fact that most of these conditions develop over time - and 
timing - based on the observation that the later effects of a particular exposure depends on the 
stage of life when it occurred - in understanding causal links between exposures and chronic 
diseases at the individual and population levels [81]. Despite recognizing the importance of 
early-life influences on chronic diseases, the life course approach does assume deterministic 
processes that preclude later-life intervention. Indeed, no adult chronic disease is likely to be 
explained as the predetermined outcome of exposures in utero or infancy, but rather as longer-
term consequences of the complex accumulation and interaction of early and later-life 
exposures [81]. 
As with many other chronic diseases, the approach currently used to explain the etiology of 
suboptimal bone strength is built on the premise that there is important tracking of this 
characteristic throughout the life course, modulated by gene-environment interactions [83-86]. 
Accordingly, bone strength of an individual later in life is seen as the result of multiple influences 
acting throughout the whole life course. Two major aspects are thought to determine the risk 
of fracture in adults. One is the amount of bone mineral loss with advancing age, and the other 
is the maximum amount of bone mineral attained during the first decades of life - peak bone 
mass (PBM) [83,85,87]. PBM is the maximal amount of bone mineral accrued within bone 
during childhood and adolescence plus the consolidation that continues beyond the attainment 
of final height [88]. In light of life course epidemiology, optimizing PBM, i.e., to achieve the full 
genetic potential for skeletal mass during adolescence, is likely to reduce the impact of age-
related bone loss later in life (Figure 7) [83,87,89].  
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Figure 7. Diagrammatic representation of the bone mass life-line in individuals who achieve their full 
genetic potential for skeletal mass and in those who do not (reproduced from Heaney et al. [83]) 
 
In comparison to the rate of bone resorption in adulthood, bone accrual before PBM may be a 
stronger predictor of osteoporosis risk later in life. While a 10% increase in peak BMD was 
predicted to delay the development of osteoporosis by 13 years, a 10% change in the age at 
menopause or the rate of non-menopausal bone loss was predicted to delay osteoporosis by 
approximately 2 years (Figure 8) [90]. 
 
 
Figure 8. Delay in the development of osteoporosis predicted in response to a percent change in peak 
bone mass density, age at menopause or the rate of non-menopausal bone loss (reproduced from 
Hernandez et al. [90])  
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Therefore, as the optimization of PBM represents a potential target for interventions aimed at 
reducing the risk of fractures later in life, and evidence is accumulating that early environmental 
influences modulate PBM and fracture risk, childhood and adolescence are seen as sensitive 
periods for improving bone health [91,92].  
In comparison to adolescence, childhood is a period characterized by a slower increase in bone 
mass [93]. However, as bone mass tracks from childhood, bone mass accrual throughout 
adolescence will be partly determined by previous bone properties [93,94]. In light of this, 
differences in skeletal size, shape and mass in adulthood seems to be established as early as 
in the first year of life [95-97]. Additionally, the relatively rapid rate of mineral gain beginning in 
utero and extending to the first years of life, coupled with the plasticity of skeletal development 
in utero, offers the possibility of profound interactions between the genome and early 
environment [98]. Therefore, the first years of life, specifically from fetal life until prepubertal 
years, are currently recognized as crucial to modifying bone traits that track throughout life [98]. 
 
1.6. Early life growth 
Growth is a complex process that occurs throughout in utero development, infancy, childhood, 
puberty and early adulthood [99]. It comprises changes in body size as well as in body 
composition. Regarding linear growth during intrauterine development, the highest velocity is 
observed at about 18 weeks of gestational age and then slows towards the end of gestation. 
Sex-differences in the rate of linear growth in utero have been described with males exhibiting 
a more rapid linear growth than females. In the first year of life, growth velocity of total body 
length averages approximately 25 cm, followed by a decrease in growth to 12.5 cm in the 
second year. Boys grow more rapidly than girls, particularly in the first half year of life, but after 
8 months of age this velocity difference decreases. Between 2 and 4 years of age, the annual 
height velocity decreases to 8 cm, and then to 6 cm until the age of 6 years. A plateau-like 
phase emerges in midchildhood, before puberty, when height velocity approaches 5.5 cm per 
year. During this stage, girls increase in stature slightly more rapidly than boys between 1 and 
4 years but, afterwards, linear growth velocities converge in the sexes until the age of 9 years. 
At around 10 years old in girls and 14 years in boys, the pubertal growth spurt begins [99]. 
Increases in height after 12 months of age are mostly attributable to rapid longitudinal growth 
of the legs in comparison to the spine. Growth velocity of the legs continues to remain around 
twice that of the axial skeleton until puberty [98]. This implies that adverse environmental 
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exposures during prepuberty will lead to greater restriction of the axial skeleton, while those in 
infancy and puberty will produce greater deficits in appendicular growth [98]. 
Body weight also suffers great changes in the beginning of life [99]. In utero, body weight 
increases with a similar temporal pattern to growth in length, except that the maximum velocity 
of weight gain occurs at about 34 weeks. At around 24 weeks of gestational age, weight gain 
diverges between sexes, such that, at 30 to 32 weeks of gestation, boys weigh approximately 
70 g more than girls. At birth, the absolute male-female weight difference is around 130 g. After 
birth, over the first 7 to 10 days of life, newborns lose approximately 10% of their birth weight. 
Neonates are expected to overcome this weight deficit within several weeks, and afterwards, 
during the first 3 months of life, weight gain is close to 30 g per day. Then, the mean weight 
gain is approximately 20, 15 and 12 g per day, in the periods between 3 and 6 months, 6 and 
9 months, and 9 and 12 months, respectively. In the first year of life, the velocity of weight gain 
is slightly higher in males than in females, such that, at 12 months of age boys weigh 
approximately 10 kg and girls 9.5 kg. In the following two years, both boys and girls will gain 
an average of 8 g per day. Then, in midchildhood, weight gain declines to 6 to 7 g per day, and 
at age 7, the mean weight in boys is 23 kg, while in girls, it is 22 kg. Afterwards, during the 
gender-specific years of puberty, weight velocities accelerate by almost two-folds, where males 
gain 13.7 g per day and girls 11.5 g per day [99].  
 
1.7. Early life bone development 
Bone development is characterized by two functionally distinct phases. The first, skeletal 
patterning, occurs during the embryonic period and the position and shape of the various 
skeletal elements is established according to a genetically determined plan. The second, 
mineralization, takes place throughout the first decades of life up to PBM and involves a 
continuous process of bone growth in length and width, by longitudinal and appositional growth, 
respectively [88]. Skeletal formation occurs through two major mechanisms: intramembranous 
(in the skull and facial bones) and endochondral ossification (responsible for longitudinal growth 
of long bones and vertebrae). During intramembranous ossification, osteochondral progenitors 
differentiate directly into osteoblasts, which begin to secrete osteoid, to form membranous 
bone. There is no cartilage model preceding ossification in this type of bone development [98]. 
In contrast, during endochondral ossification that occurs at epiphyseal plates, endochondral 
progenitors differentiate into chondrocytes to form a cartilaginous template of the future bone. 
Then chondrocytes become hypertrophic, degenerate and die as a result of their matrix 
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calcification. Osteoprogenitor cells and blood capillaries will occupy the empty space left by the 
hypertrophic chondrocytes. Osteoprogenitor cells will give rise to osteoblasts, bone forming 
cells that will be responsible for laying down the matrix with mineralized osteoid on the surface 
of the calcified cartilage, increasing the size of the metaphyseal compartment. The remnants 
of the calcified cartilage are then resorbed by cells that break down cartilage, the chondroclasts. 
This process occurs continuously until the cartilage model is fully replaced by bone, meaning 
that the chondrocytes at growth plates exhaust their proliferative capacity, leading to the closure 
of the epiphyses, and cessation of linear growth [100]. In turn, appositional growth occurs 
through modeling, a process characterized by the uncoupling of bone formation and resorption, 
allowing for bone formation to occur in the periosteal surface, while resorption takes place 
within the endosteal surface [54]. Overall, the balance of modeling is in favor of bone formation, 
contributing to increases in diameter and cortical thickness. Throughout skeletal growth, bone 
modeling is the process responsible for substantial changes in the size and shape of bone, 
thereby optimizing its geometry with respect to mechanical properties [36]. The result of 
modeling is an altered spatial disposition of bone tissue that happens in coordination with linear 
growth. Bones may widen or change axis by removal or addition of bone to the appropriate 
surfaces by independent action of osteoblasts and osteoclasts in response to biomechanical 
forces [101]. There are gender-related differences in bone width, which are partly established 
before puberty. While, in males, cortical width increases by periosteal bone formation, in 
females a relatively greater endocortical apposition is observed. Consequently, males build 
longer and wider bones, with a slightly thicker cortex, than females [98]. Besides growth in 
length and modelling, bone remodeling also represents one of the major processes that 
determine bone mass and architecture in children. As described in the “Bone fragility and 
fractures” section, remodeling occurs in a coupled mechanism of formation and resorption. 
Once the skeleton reaches maturity, modeling rates reduce substantially but homeostatic re-
modeling remains active throughout the life course. [102]. From the balance between bone 
formation and resorption in remodeling, bone will adapt structure to function, optimizing its 
resistance to stress. 
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1.8. Factors influencing childhood bone mass accrual 
Increasing evidence has shown that a complex interplay between genetic and environmental 
exposures, acting as early as during fetal life, shapes bone mass acquisition during childhood 
[92,98].  
Studies in twins and families indicate that BMD is a highly heritable trait, with 50% to 80% of 
the variance in BMD being genetically determined [88,103]. Including populations of children 
and adolescents, the largest genome-wide association meta-analysis has successfully 
identified six adult-BMD-associated loci (WNT4, WNT16, TNFSF11, GALNT3, PTHLH and 
FUBP3) and a novel locus encompassing RIN3 to be robustly associated with total body BMD 
[104]. Although there is evidence to suggest that a substantial proportion of the variation in 
bone acquisition and PBM is attributable to genetic factors, current genetic markers are able to 
explain only a small proportion of the variation in individual bone mass [98]. Weak associations 
of each genetic variant with bone phenotypes are indeed expected, since there is a need for 
genetic mechanisms that govern key functions such as skeletal integrity to be redundant, 
pleiotropic and polygenic, in order to avoid perturbation triggered by the environment [105]. An 
evolutionary perspective of osteoporosis has described the condition as a result of increased 
life expectancy combined with a misadaptation to a still young bipedal status. Since bone 
fragility becomes apparent as a phenotype after reproductive years, there is not a clear 
adaptive advantage of having strong bones before and during the reproductive period. This 
would result in unchanged, “archaic” genes that interact with the modern environment causing 
a response that can lead to inefficient adaptation, i.e. bone fragility and subsequent fracture 
[105]. 
 
In addition to heredity, many environmental factors may act in pediatric bone growth and 
density including gender [106], ethnicity [107], nutrition (e.g., calcium, vitamin D, protein) [108], 
physical activity [109], endocrine status (e.g., sex steroids, insulin-like growth factor I) [88] and 
body composition [110]. Additionally, evidence has shown that fracture risk may be 
programmed during intrauterine life [111]. In fact, the rapid rate of mineral apposition and the 
plasticity of skeletal development during fetal life, make the early skeleton susceptible to 
interactions with environmental factors [112].  
This thesis focuses on understanding the effects of anthropometric growth and body 
composition on childhood bone mineralization, and the following sections aim to provide a 
theoretical framework for the specific objectives. 
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1.8.1. Intrauterine influences on childhood bone mass 
Environmental influences acting during intrauterine life may affect both early skeletal 
development and the acquisition of bone mass in childhood. Intrauterine effects impacting on 
childhood bone mass are largely mediated by nutrient supply to the fetus that determines fetal 
growth [108,113]. As an example, maternal nutrition, including maternal intake of calcium, 
phosphorous and protein intake, are thought to exert a direct effect on fetal skeletal growth 
[108]. Other mechanisms by which in utero environmental exposures can influence later child 
bone health include modification of gene expression by inducing epigenetic changes in the 
DNA [114]. Changes may also be induced by alteration in bone tissue differentiation (alteration 
of cell number or imbalance between cell types) or in homeostatic control mechanisms 
(changes in the pattern of hormonal release or tissue sensitivity to these hormones) [98].  
Intrauterine life environmental variables that appear to independently influence bone growth 
and mineral acquisition include maternal diet, and vitamin D, the individual component most 
strongly associated with offspring bone development [117], maternal alcohol consumption, 
caffeine intake, diabetes mellitus and physical activity [88,98]. Because the majority of fetal 
bone is gained during the last trimester, gestational age has likewise been related with bone 
mass in neonates. Additionally, birth season seems to determine newborn total body mass as 
infants born in the winter have lower BMC than those born in the summer [88]. Maternal 
cigarette smoking during pregnancy has also been studied has a potential determinant of 
offspring bone mass but there is no consistent evidence to establish a causal relationship 
between fetal smoke exposure and offspring bone mass via intrauterine mechanisms 
[115,116]. Also, anthropometric maternal characteristics during pregnancy seem to be 
important determinants of offspring bone mineralization. Reduced maternal height, lower 
preconception maternal weight, reduced maternal fat stores during late pregnancy have all 
been associated with reduced whole-body BMC in children [98]. Additionally, maternal 
gestational weight gain during pregnancy was associated with increased bone mineral 
properties of offspring [117,118]. Gestational weight gain is a complex trait that reflects fetal 
growth but also increases in maternal tissues (e.g., blood volume, breast and uterine weight, 
and adipose tissue) [119]. It is the result of the physiology of pregnancy and of the pregnant 
women´s lifestyle, in particular her diet and physical activity. Potential underlying mechanisms 
that explain the positive association between maternal gestational weight gain and bone mass 
later in life include intrauterine programming effects involving increased placental transfer of 
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nutrients during fetal development or a greater exposure to hormones such as leptin and 
estrogen [120,121]. However, in view of previous observations for a broad range of other long-
term child outcomes, including body size, body composition or cardiometabolic and respiratory 
health, it would be likely that the positive effect of gestational weight gain on offspring bone 
mass would be dependent of the maternal weight status at the beginning of pregnancy [122]. 
Also, in light of the current recommendations for healthy gestational weight gain that are based 
on prepregnancy body mass index, it would be relevant to assess the impact of following these 
guidelines on further offspring health outcomes, other than the child health outcomes potentially 
related to gestational weight gain used to define the recommendations. These considerations 
were in fact the starting point to paper I. It is also important to emphasize that maternal 
gestational weight gain is an important potentially modifiable factor and a better understanding 
of its influence on offspring bone mineralization may be relevant to develop strategies to bone 
health promotion. 
 
1.8.2. Postnatal growth-related changes of the skeleton 
During childhood, due to linear growth and increases in muscle mass, the skeleton increases 
in length and width by longitudinal and appositional growth, respectively, as described above. 
The common endocrine control of body composition will determine that linear growth drives 
bone mineral accrual. Indeed, as a result of bone development, BMC and BMD increase 
substantially during childhood as shown in published reference curves for DXA-derived bone 
mineral properties from 5 to 20 years of age [107]. Bone mineral acquisition follows different 
and specific age- and sex-patterns. Bone mass increases steadily during childhood, then its 
accretion accelerates after the onset of puberty and the adolescent growth spurt, peaking 
shortly after height peaks (Figure 9) [85]. 
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Figure 9. Overview of BMD changes throughout the life course (reproduced from Hendrickx et al.[123]) 
 
The most consistent framework to explain the action of environmental determinants on bone 
mineral accrual is the functional model of bone development, based on Frost’s mechanostat 
theory, proposed by Rauch and Schoenau (Figure 10) [124]. This model builds on the premise 
that one-way relations of molecular, cellular and behavioral factors with bone accrual are overly 
simplistic, and bone development should not be seen as the result of the cumulative effect of 
the individual influences of these factors on bone mass or architecture. In fact, a self-assembly 
hypothesis may be correct for the process of biological skeletal patterning, occurring during the 
embryonic development but, once mineralization has started, it is more difficult to explain 
skeletal development on the basis of a similar self-assembly process [124]. Alternatively, and 
according to the mechanostat theory, rather than just being a passive recipient to external 
stimuli, bone tissue regulates itself with the aim of maintaining its structural integrity and 
strength. Accordingly, the central piece of bone regulation is the feedback loop between bone 
deformation (tissue stain) and bone strength. This means that bone physiology is a controlled 
effector-sensor system, where the purpose of homeostatic mechanisms is to maintain the strain 
(i.e. the mechanically induced deformation of bone) to a certain predetermined set point. When 
bone stability is challenged and bone deformation exceeds an acceptable level (the 
mechanostat set point), changes occur in order to add bone tissue at the location where it is 
mechanically necessary. This may be accomplished through changes in mass but also, and 
independently, through changes in the macro or microscopic architecture of bone tissue. During 
growth, bone accrual requires constant regulation due to the need for the skeletal framework 
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to adapt to changing external circumstances. At this period, changes in body size as a 
consequence of both an increase in bone length and an increase in muscle mass are seen as 
challenges to mechanical stability, and the resulting bone deformation is sensed by osteocytes, 
which lead to changes in bone mass and architecture to better adapt the skeleton to the load it 
bears [125]. Additionally, the mechanostat model assumes that, hormonal, nutritional or 
behavioral influences on bone homeostasis act by altering the mechanostat set point or the 
response to a disturbance to that point, i.e., by modifying the effect of mechanical strain on 
bone. Overall, the most relevant aspect of this model is that it places the maintenance of 
mechanical properties at the center of the bone development process [124]. It should be noted 
that, although mechanical stress from muscle contraction is already present during fetal 
development, leading to the beginning of bone mineralization in utero, dynamic strain-
dependent bone signals that challenge mechanical stability become particularly relevant after 
birth. 
The mechanostat theory, that places the bone functional requirement, in response to the 
mechanical stress exerted through gravitational and muscle forces, as the main osteogenic 
stimulus, has been very useful to explain the clear strong cross-sectional associations 
observed between current body size, both in weight and height, and bone mass and density in 
children [126]. At any given age, increased body size is associated with increased BMC and 
BMD reflecting, to a large extent, this adaptation of skeletal modeling to loading [117,127-134]. 
However, this model lacks a temporal dimension and may be limited to clarify potential long-
term effects of changes in body size, such as those occurring during growth, on bone properties 
in a later period in life. Particularly, the long-term influence of increased overall exposure to 
body size, in dose and/or duration, on bone properties as well as whether there exist specific 
periods during growth, where the influence of changes in body size on bone properties are 
more likely to persist later in life, remain understudied.  
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Figure 10. A functional model of bone development based on the mechanostat theory (reproduced 
from Rauch and Schoenau [124]) 
 
 
The increasing interest in modeling growth and identifying whether growth impacts on later 
health outcomes also led to the beginning of studies assessing associations between growth 
and bone health outcomes, including observations of the specific effect of early growth on 
pediatric bone physical properties [135-138]. 
A variety of methods are available to model longitudinal growth data and the choice of method 
will largely depend on the nature of the measurements available and whether assumptions 
inherent in the particular approach are met [138]. Most importantly, and particularly when the 
research objective is to detect the effects of growth in later health and disease outcomes, the 
selection of the statistical approach will largely depend on the question under consideration. 
While models of conditional growth, residual growth and multilevel linear spline, which provide 
measures of growth in different time intervals, allow for the exploration of whether particular 
sensitive periods exist for the effect of growth on a specific outcome, other group-based 
modeling methods, such as a growth mixture model, identify distinctive subgroups of individuals 
that follow similar patterns of growth, and allow relations between overall trajectories of growth 
and the outcome to be uncovered [138-141]. Differences in study results should be, in fact, 
understood in the context of the analytic strategies used. 
To date, research on the effects of early growth during infancy and childhood on bone at a later 
time, has focused on examining the effect of specific growth periods on childhood bone mass 
and density, in order to identify sensitive periods. The results of these studies have suggested 
that the first three years of life are particularly relevant for the effect of growth velocity, both 
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height and weight velocity, on bone mineral accrual, with the magnitude of associations 
decreasing thereafter [135-137]. Regarding the sources of anthropometric measurements used 
to model growth, previous research has mainly relied on data obtained from large birth cohorts, 
where participants are followed at specified intervals, whose timing is defined a priori by 
researchers, and not necessarily related to the participants’ ongoing health care utilization. 
Although anthropometric measurements collected in birth cohort follow-ups remain a valuable 
source of information to study growth, it may be possible to improve the detection of sensitive 
periods of growth if this data is complemented with anthropometric measurements obtained as 
part of routine health care. Routine health care registers represent an additional valuable 
source of information taking into account that visits to healthcare providers, when 
anthropometric measurements are obtained as part of routine health care, are taken at short 
time intervals. This was actually the starting point for paper II where weight and length/height 
growth trajectories, previously obtained through linear spline multilevel models on the basis of 
data collected during routine health examinations were used as exposures to identify sensitive 
periods for the effect of growth in the first 6 years of life on childhood bone mineralization.    
Regarding the effect of overall trajectories of growth, less effort has been dedicated to assess 
the effect of differences in the overall shape of growth since birth on childhood bone mineral 
mass and density [138]. The hypothesis that different trajectories of growth in weight, 
particularly those that are related to an increased amount of exposure to body size, in dose 
and/or duration, may differently impact on later bone mineralization was the starting point for 
paper III.  
An additional aspect that, so far, has not been analyzed is the impact of early life growth on 
childhood bone metabolism. Bone metabolism refers to the processes of bone resorption and 
bone formation that allows bone to adapt structure to function, in response to stress and other 
biomechanical forces. In line with the mechanostat theory, the bone functional requirement in 
response to mechanical stress bone metabolism will be responsible for adaptations of the 
processes of bone formation and resorption in such a way that final bone physical properties 
are maintained. Therefore, the study of bone metabolism during childhood may provide an 
important dynamic dimension that would not be captured by examining only the resulting 
physical properties [142,143]. During formation and resorption processes, bone metabolism 
markers are released into circulation. These markers can be measured in samples of blood 
and urine. In growing children, results from serum bone metabolism markers concentration are 
particularly challenging to interpret as their release into circulation reflect the whole set of 
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processes of bone remodeling, modeling and growth in length. As such, bone metabolism 
markers are mainly used in the clinical setting to diagnose and monitor pediatric diseases [143]. 
Consequently, it is not clear at present whether bone metabolism markers in children can be 
used as independent predictors of bone mass and density, particularly in what concerns 
generally healthy children from population-based samples. This previous observation, in 
addition to the current limited knowledge on relationships between trajectories of growth and 
bone formation and resorption was the starting point for paper IV.  
 
1.8.3. Adiposity and childhood bone mass  
Research on the relationship between fat mass and bone has been driven by the observation 
that increased weight was a protective factor for fragility fracture. The evidence to establish 
relationships between adipose tissue and the growing skeleton has been generated from two 
quite different sets of data that include epidemiological studies and laboratorial studies of 
physiological mechanisms.  
At the population-level, research conducted on children has suggested that increased fat mass 
is a positive independent determinant of bone mass and size, similar to previous findings in 
adults [110,144-146]. As a consequence increased adiposity was considered protective against 
low bone strength in children. However, evidence over the last two decades demonstrating that 
obese children are over-represented in fracture groups [147,148] has raised concerns that 
excess fat mass could have a detrimental effect on bone development in children, by directly 
interfering with bone properties. Even though potential causative explanations for the increased 
risk of fracture in obese children includes greater propensity to falls or greater force generated 
on impact through falls [149,150], the hypothesis that excessive adipose tissue could have 
detrimental effects on bone mass led to a growing number of studies that assessed and 
suggested this deleterious effect [93,151,152].  
Several potential mechanisms may explain direct and indirect effects from fat mass on skeletal 
development. Most of the positive effect of fat mass on bone mass is associated with 
mechanical loading that increases bone formation [153]. Not only does fat mass contribute to 
the direct mechanical action through increased gravitational loading, but also, increases in fat 
mass are associated with compensatory increases in muscle mass that promote bone 
formation [154]. 
In addition to the effects in increasing mechanical load, adipose tissue may influence bone 
metabolism through adipokines or other cytokines [155]. There is increasing evidence that the 
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hormone leptin, secreted by adipocytes, has a role in both the central and peripheral regulation 
of bone formation [156]. Through its effect as a growth factor on chondrocytes of skeletal growth 
centers, leptin directly exerts an osteogenic effect on bone. In addition, leptin has an indirect 
effect on bone formation by influencing other hormones affecting bone density (growth 
hormone, androgens, and cortisol). Leptin also seems to act as a negative regulator of bone 
formation via a central nervous system pathway [157]. It is also suggested that this adipokine 
may contribute to the radial and tibial microstructural change observed in obese children [158]. 
More recently, adiponectin was recognized as an important influence on bone mechanical 
properties that might have an even larger influence on bone phenotypes than leptin [159]. 
There is contradictory literature regarding adiponectin effects on bone from laboratorial studies 
but consistent inverse relationships between circulating adiponectin concentrations and BMD 
are described [160]. Additionally, adipose tissue produces inflammation-related cytokines, such 
as tumor necrosis factor α (TNF-α) and interleukin 6 (IL-6), which may have deleterious effects 
on bone [161]. Adipocytic estrogens are also likely to be involved in the relationships between 
fat and bone. Estrogen has a major role on the regulation of bone growth through its actions 
on osteoblasts, promoting accrual of bone mass on the cortical endosteal surface and in 
trabecular bone [162]. Alternations in the bone marrow compartment have also provided some 
insight into the mechanisms that may result in changes in bone density in childhood obesity 
[163,164]. Since visceral adiposity impairs growth hormone secretion and the response of 
growth hormone secretion to stimuli, this may have a negative impact on bone mass accrual 
[165]. 
Another way by which adiposity may affect bone mass is through its association with insulin 
resistance [166]. In prepubertal obese children, a lower BMC was observed in children with 
prediabetes than in those without prediabetes suggesting a negative effect of abnormal glucose 
regulation on the growing skeleton [167]. This may be explained by systemic inflammation 
associated with insulin resistance that activates bone resorption and further results in reduced 
BMD [168]. Other mechanisms for potential negative effects of impaired glucose metabolism 
on bone may be through alterations in calcium excretion or vitamin D metabolism, pituitary 
inhibition of growth hormone secretion or through increased concentrations of advanced 
glycation end products in collagen [165,167]. This pathway has gained major importance as a 
bone-pancreas endocrine loop has been recently postulated. There is a growing body of basic 
research demonstrating a tight reciprocal regulatory interaction between osteoblast and 
glucose metabolism, mediated to a large extent by insulin and osteocalcin. Insulin activates the 
osteoblast insulin receptor to increase bone formation and resorption, and releases osteocalcin 
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into the systemic circulation, which in turn can increase insulin sensitivity and pancreatic insulin 
secretion [169]. 
In view of all the potential mechanisms that contribute to explain the relationship between fat 
mass and bone properties in children, to date, the relationship between childhood obesity and 
bone mass remains controversial [145]. Conflicting results have been attributed to the 
possibility of changes in the relationship between fat and bone mass throughout different 
growth stages [144]. Additionally, it is possible that the detrimental impact of childhood obesity 
on bone mass in children may be observable only when fat mass accumulation reaches 
excessive levels [170,171]. Moreover, site-specific fat depots may also contribute to different 
results since it is believed that, in opposition to appendicular, visceral adiposity may be the one 
responsible for the negative impact of excessive fat mass on bone development, similar to what 
was described for associations with metabolic complications [170,172]. Furthermore, 
mechanical properties of bone were assessed through several methods, including DXA, 
peripheral quantitative computed tomography, and quantitative ultrasound, and studies have 
reported effects on some but not all measures of bone strength. There is also evidence that 
cortical or trabecular bone may be differentially affected by obesity. Trabecular bone is more 
likely to respond to the effects of fat mass as it is more available for metabolic processes [145].  
 
Nevertheless, any mechanistic explanation of the effect of fat on bone should rely on valid 
effect estimates. There is a generalized observation of a crude positive association between 
adiposity and bone mass. However, results are much more heterogeneous when those 
associations are statistically corrected for overall body size or fat-free mass in order to 
overcome potential confounding. This issue deserves special attention since several studies 
have argued that ‘‘fat mass after adjustment for body weight” actually has a deleterious effect 
on bone [153,173-178]. Correction of variables such as fat mass for others to which they are 
closely related such as weight raises important validity concerns because of their close 
biological - and thus statistical - dependency [179]. Therefore, in order to test the potential for 
adiposity to specifically influence bone mass in children, the starting point for paper V was to 
use an alternative analytical approach to the inclusion of fat mass and body weight in the same 
regression analysis. We took advantage of data obtained outside the domain of physiology and 
used socioeconomic position as a benchmark, i.e. assuming that adiposity is socially-patterned, 
if adiposity is a major cause of bone mass we should also be able to detect a social pattern in 
bone mass. By quantifying the association between socioeconomic position and bone mass 
we inferred on the potential for a specific effect of fat on bone.  
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2. Study objectives 
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By using prospective data from the Generation XXI birth cohort our specific objectives, 
summarized in a schematic plan (Figure 11), were: 
 
1. To quantify the associations between gestational weight gain and bone mineralization 
in offspring, testing early pregnancy body mass index as an effect modifier (Paper I) 
2. To characterize the impact of early life growth on bone mineralization in childhood by:  
a. Identifying sensitive periods for the effect of early growth on childhood bone mass 
(Paper II) 
b. Assessing whether different trajectories of weight gain since birth influence 
childhood bone mineralization (Paper III) 
3. To describe markers of bone turnover in generally healthy children and assess their 
correlations with anthropometric growth and bone mineralization (Paper IV) 
4. To test the potential for adiposity to specifically influence bone mass in children, using 
common causes as a benchmark (Paper V) 
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Figure 11. A conceptual framework of the effects of growth on childhood bone status 
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3. Participants and Methods  
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The objectives of this thesis were accomplished through the analysis of data obtained from the 
Generation XXI birth cohort study, from the baseline and follow-up evaluations at 4 and 7 years 
of age. Specifically, data from a consecutive subsample of 2408 children selected from the 7-
years-old evaluation was used, for whom, besides the core variables common to the whole 
cohort, accepted to do an evaluation of musculoskeletal health and had a valid dual-energy X-
ray absorptiometry (DXA) scan. A general description of Generation XXI participants and data 
collection procedures is provided below. Additional details about the study have been published 
elsewhere [180,181]. The selection of participants eligible for each paper depended on the 
specific objectives of the investigations and is described in detail in the methods sections of 
each individual chapter.  
 
3.1. The Generation XXI cohort study 
Generation XXI is the first Portuguese birth cohort study assembled during 2005 and 2006 in 
the Porto Metropolitan Region. It was established as a multi-purpose prospective population-
based cohort that aims to characterize prenatal and postnatal growth and development, and 
identify their determinants, in order to better understand health in childhood and later in 
adolescence and adulthood, thereby contributing to health gains among the population.  
 
3.1.1. Participants 
Recruitment was conducted between April 2005 and August 2006 at the five public maternity 
units providing obstetrical and neonatal care covering, at the time, the metropolitan area of 
Porto, Portugal: Centro Hospitalar de Vila Nova de Gaia, Centro Hospitalar do Porto - 
Maternidade de Júlio Dinis, Hospital de São João, Centro Hospitalar do Porto - Hospital de 
Santo António and the Unidade Local de Saúde de Matosinhos - Hospital Pedro Hispano. All 
of these maternities corresponded to level III units, with differentiated perinatal support, and in 
2004, were responsible for 91.6% of the deliveries in the whole catchment population, with the 
remaining occurring in private hospitals/clinics.  
All women resident in the catchment area - one of the six municipalities of the metropolitan 
area of Porto (Figure 12) - and who delivered a live-born child with more than 23 weeks of 
gestation in one of the five units, during the cited period, were eligible to participate. Seventy 
percent of eligible mothers were invited and, of these, 91.4% accepted to participate. A total of 
8647 infants and their mothers (n=8495) were enrolled in the cohort study.  
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Figure 12. Representation of the six municipalities of the metropolitan area of Porto 
 
3.1.2. Ethical considerations 
The Generation XXI study protocol complies with the Ethical Principles expressed in the 
Declaration of Helsinki and was approved by the Ethics Committee of the Hospital de São João 
and the University of Porto Medical School. The study protocol also conforms with the national 
legislation and is registered with the Portuguese Data Protection Authority. Procedures were 
developed in order to guarantee data confidentiality and protection. All participants received an 
explanation on the purposes and design of the study. Written informed consent was obtained 
from all parents or legal guardians, and oral assent was obtained from children at each 
evaluation. Alternatively, verbal consent was explicitly solicited for the telephone interviews. 
 
3.1.3. Data collection 
At baseline, in the first 24 to 72 hours after delivery during the hospital stay, trained interviewers 
located at the five hospitals were responsible for presenting the Generation XXI study and 
inviting mothers. Data were collected in a face-to-face interview and clinical records at birth 
were reviewed by the trained interviewers. 
Subsamples of the cohort were evaluated at the ages of 6 months, 15 months and 2 years 
(n=1555, n=1043 and n=855, respectively).  
Four years after birth, between April 2009 and July 2011, a follow-up evaluation of the entire 
cohort was performed and 7459 children, corresponding to 86.3% of the cohort, were 
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reevaluated. Of these, 5987 children (69.2% of the cohort) were evaluated in a face-to-face 
interview, while for 1472 children (17.0% of the cohort), who were unable to attend an in-person 
evaluation, a shorter version of the questionnaire was completed by legal guardians in a 
telephone interview. 
Between April 2012 and April 2014, all families were invited once again to attend the 7-year 
follow-up evaluation of the cohort. Overall, 6889 children were reassessed (79.7% of the entire 
cohort), of which 5849 children (67.6% of the cohort) were evaluated in-person and 1040 
(12.0% of the cohort) provided information by telephone interview. 
A subsequent evaluation of the cohort took place between July 2015 and July 2017, when 
children were 10 years of age, and 6397 children (76.0% of the cohort) were reassessed. 
Currently, the 13-year- old evaluation is ongoing; it started in August 2018 and it is expected to 
be completed in December 2019.  
Follow-up evaluations of the cohort take place at the Departamento de Ciências da Saúde 
Pública e Forenses, e Educação Médica in the University of Porto Medical School. Standard 
procedures have been established and adopted in all evaluations. A multidisciplinary team of 
interviewers and health professionals, that is periodically trained and supervised by the 
Generation XXI administration team, is responsible for the application of structured 
questionnaires, performing the physical examination of children and biological parents and 
extracting information from clinical records and the National Health Service official health 
books.  
The following description of procedures refers specifically to data collection sections for the 
baseline, age four and age seven follow-up evaluations as these were the periods of evaluation 
from which data to accomplish the objectives of this work were obtained.   
 
a) Questionnaires 
Face-to-face interviews using structured questionnaires designed by a multidisciplinary team 
were conducted to obtain information on the following areas:  
 
- Family demographic, socioeconomic, psychosocial circumstances and 
lifestyles: including caregivers date of birth, educational level, working conditions and 
smoking, household income and crowding ,and other socioeconomic indicators of 
psychosocial adversity 
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- Child and family medical history: including existence of chronic diseases, experience 
of pain, intake of medication, vitamin or mineral supplements, healthcare use -  including 
prenatal care - and maternal gynecologic and obstetric history 
 
- Maternal (during pregnancy) and child behaviors: including food intake, sports and 
physical activity 
 
- Pre and throughout pregnancy anthropometrics: at baseline, maternal weights at 
the beginning of pregnancy and immediately predelivery were self-reported by mothers  
 
Data on sensitive topics such as household financial support needs, parental depressive 
symptoms and intimate personal behaviors (e.g. parental discipline) were gathered through 
self-administered questionnaires to parents or legal guardians and children, completed at the 
study site or at home. 
  
b) Physical examination 
Physical examination of the child included anthropometric, cardiovascular (including blood 
pressure assessments), respiratory and a dental evaluation. Measurement devices were 
carefully standardized and regularly calibrated. 
 
- Anthropometric assessment: measurements of length/height and weight using 
infantometers or stadiometers and scales were conducted. Waist, hip, arm and leg 
circumferences were measured using flexible and non-distensible tapes, and body 
composition was assessed by bioelectric impedance (TANITA, Arlington Heights, 
Illinois, USA). All measurements were obtained while the child stood barefoot in light 
indoor clothing.  
 
- Forearm bone mineral density assessment: assessment of forearm bone mineral 
density with a Lunar Peripheral Instant X-ray Imager (PIXI) device (GE Medical 
Systems, Madison, Wisconsin, USA) was conducted during the 7 years-old follow-up 
evaluation. The measurement was performed at the non-dominant distal forearm unless 
there was a reported fracture.  
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The physical examination of biological parents included anthropometric and blood pressure 
assessments. 
 
c) Blood sample collection  
In each evaluation, trained nurses collected child and maternal blood samples drawn from an 
antecubital vein after overnight fasting. All children were offered local dermal analgesia with 
lidocaine/prilocaine (EMLA®). Samples were centrifuged and sera were stored frozen at -80ºC 
in the biobank at the University of Porto Medical School until analyses.  
 
Determinations of bone metabolism markers 
From the 5849 children evaluated in-person at 7 years of age, a subsample of 400 participants 
was selected to measure bone metabolism markers and bioactive molecules including serum 
25-hydroxyvitamin D (25(OH)D), intact parathyroid hormone (PTHi), calcium (Ca) and inorganic 
phosphorus (Pi).  
The sample size was calculated based on expected correlations between bone parameters, in 
order to allow estimating a 0.15 linear correlation coefficient with an 85% power at a 0.05 
significance level and selected based on the following characteristics: 1) to be a singleton full-
term baby (more than 26 weeks of gestation); 2) to have a valid whole body DXA scan at 7 
years (as described below), 3) to have a fasting blood sample collected in the morning with 
enough volume to perform the intended laboratory analyses and, although not exploited in the 
present work, 4) to have serum determinations of glucose and insulin from previous evaluations 
of the cohort and 5) to have information regarding maternal gestational diabetes. 
All analytical measurements were conducted at the clinical pathology laboratory of the Centro 
Hospitalar São João, EPE in Porto and performed according the manufacturer’s instructions 
regarding preventive maintenance, function checks, calibration, and quality control of both tests 
and equipment. Total alkaline phosphatase (tALP) was quantified by a spectrophotometric 
method. Osteocalcin (OC), β-crosslaps (β-CTx), and intact parathyroid hormone (PTHi) 
measurements were performed by electro-chemiluminescence immunoassays (ECLIA). Serum 
25-hydroxyvitamin D concentration (25(OH)D) was determined using a direct competitive 
chemiluminescence immunoassay. Calcium (Ca) was detected by a colorimetric assay and 
inorganic phosphorus (Pi) was determined by a colorimetric assay.  
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d) Review of clinical records, and the National Health Service official pregnancy and 
children’s health book  
At the baseline evaluation, obstetric clinical records held at the maternity units and the National 
Health Service official pregnancy booklet - a record of check-ups, ultrasounds, tests and 
medical notes provided as part of routine primary care to all pregnant women - were reviewed. 
These records were reviewed with the purpose of recovering only data that were missing from 
the baseline questionnaire, including data on prenatal care, pregnancy complications, 
pregnancy anthropometrics, and delivery and neonatal characteristics such as childbirth 
weight, length and gestational age.  
At each follow-up evaluation, legal guardians were asked to bring their children’s National 
Health Service official health and vaccination booklets so data on the child’s development could 
be abstracted. Specifically, from the children’s health book, which is a record of data obtained 
as part of children’s routine health care, the research team abstracted all the length/height and 
weight measurements performed at every medical visit to a health professional. 
 
3.1.4. Additional wave of assessment for musculoskeletal evaluation 
In the 7 years-old follow-up evaluation, a consecutive subsample of children who attended the 
face-to-face interviews between December 1, 2012 and August 31, 2013 was invited to an 
additional wave to assess bone mineral properties and sagittal posture. The selection of this 
subsample was based solely on the funding schedule and equipment availability (Figure 13). 
According to standard manufacturer’s protocol, whole body DXA scans were performed using 
a Hologic Discovery QDR 4500W device (Hologic Inc., Bedford, Massachusetts, USA), 
software version 13.3.0.1., while children were barefoot in light indoor clothing and without 
metal accessories. Nine trained radiology technicians were involved in the DXA evaluations. 
To ensure that the lines between adjacent subregions of the body were placed correctly and to 
exclude images showing unacceptable artefacts, two trained operators checked each scan in 
two independent moments, immediately after acquisition and in a later validation. Standard 
quality assurance tests were performed daily using the spine phantom according to the 
manufacturer’s instructions and the coefficient of variation obtained from repeated phantom 
measurements was below 1%. Bone mineral content (BMC) was obtained and areal bone 
mineral density (aBMD) was expressed as BMC (in g) per projected bone area (in cm2). A 
measure of size-corrected BMC (scBMC) was derived separately for girls and boys by linear 
regression of BMC on bone area and the addition of the resulting residuals to the mean 
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sample’s BMC [182]. Body composition measures, including fat mass (kg) and lean mass (kg), 
were also obtained during DXA scanning. As recommended by the International Society for 
Clinical Densitometry for research in pediatric populations, total body less head (subtotal) 
measures were used [61].  
In this evaluation weight was measured once again in using a digital scale (Xinyu Electronic 
Co., Limited, Zhongshan, China) and height was measured using a wall stadiometer (SECA, 
Hamburg, Germany).  
Of the 3015 children who were eligible to attend the musculoskeletal evaluation (corresponding 
to 43.8% of the participants in the 7 years follow-up and 34.8% of the entire cohort), 80.3% 
(n=2421) agreed to participate and attended the scheduled assessment at Escola Superior De 
Tecnologia da Saúde do Instituto Politécnico do Porto. DXA scans were conducted 
successfully in 2408 children (79.9% of the eligible sample and 27.8% of the entire cohort). 
This additional wave of assessment took place between March 2013 and February 2014 in a 
median (P25, P75) of 62 (15, 225) days after the 7 years-old evaluation (Figure 13).   
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* Fourth box - based on the date of the 7-y participants who refused to participate in the musculoskeletal evaluation (n=257) + 
participants who scheduled three different appointments but did not show up for evaluation, or did not respond to our invitation 
after at least five attempts (n=335) + participant with cerebral palsy that did not cooperate in the evaluation (n=1) 
 
Figure 13. Flow-chart of participants evaluated with a valid dual-energy X-ray absorptiometry scan 
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Figure 14 presents the outline of each of the studies conducted regarding main exposures and 
sample size. 
 
 
Figure 14. Schematic presentation of the main exposures and sample size used in Papers I-V 
 
Integration of the subsets of Generation XXI participants with DXA scan at 7 years of age 
(n=2408), included in the growth analysis (n=5282) and with information regarding maternal 
gestational weight gain and prepregnancy body mass index (n=8033) are represented in Figure 
15. Intentionally, the subset of participants with bone metabolism markers (n=395) is not 
represented in this scheme as it was sampled from the participants with DXA scan.   
 
Figure 15. Subsets of participants within the Generation XXI cohort with information for the main 
variables of interest. The numbers shown in each subset do not match exactly the final numbers of 
participants analyzed in each article due to specific exclusions related to missing data for confounders 
or covariates. DXA - dual-energy X-ray absorptiometry; GWG – Gestational weight gain; PP BMI - 
Prepregnancy body mass index   
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4. Results 
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4.1. Description of bone mineral properties in the Generation XXI birth 
cohort 
In the Generation XXI study, 2408 participants corresponding to 1142 girls (27% of all the girls 
in the cohort) and 1266 boys (28.7% of all the girls in the cohort), had data on DXA-derived 
bone measures at 7 years of age. Mean (standard-deviation) subtotal bone mineral content 
(BMC) and areal density (aBMD) were higher in boys [BMC: 600.9 (85.6) g and aBMD: 0.624 
(0.053) g/cm2] than in girls [BMC: 591.8 (85.6) g and aBMD: 0.624 (0.053) g/cm2], p-values of 
0.009 and <0.001 (Figure 16). As expected, a clear increasing trend in bone mineral properties 
with increasing age was observed [BMC: Pearson correlation coefficient (r)=0.33, p<0.001; 
aBMD: r=0.29, p<0.001] (Figure 17).   
  
Figure 16. Distribution of subtotal bone mineral properties by sex 
 
  
Figure 17. Relationship between age and subtotal bone mineral properties 
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Age- and sex-specific z-scores were computed for BMC and aBMD based on the method, and 
reference values from the Bone Mineral Density in Childhood Study, published by Zemel et al 
[107,183]. In comparison to the non-black children from the United States reference population, 
children from the Generation XXI had a slightly lower mean BMC and aBMD [mean (SD) z-
scores: girls: -0.05 (0.92) and boys: -0.02 (0.86)].  
Tables 1 to 7 present the mean values of BMC and aBMD in girls and boys, according to 
sociodemographic, anthropometric and behavioral characteristics. Mean BMC and aBMD 
increased linearly with height, body weight as well as with body mass index. Positive crude 
dose-response associations between BMC and aBMD and all measures of body composition 
(subtotal lean and fat mass, and body mass percentage), both in girls and in boys, were found 
(Table 1). 
 
Table 1. Mean (SD) bone mineral content (g) and areal density (g/cm2) at 7 years of age, in girls and 
boys, according to current anthropometric characteristics 
 Girls Boys 
 n (%) BMC aBMD n (%) BMC aBMD 
Height z-score a       
< -2.00 10 (0.9) 461.3 (44.5) 0.535 (0.033) 10 (0.8) 412.2 (31.8) 0.522 (0.026) 
-2.00 to -1.1 92 (8.1) 487.7 (45.9) 0.550 (0.036) 103 (8.1) 503.1 (50.0) 0.569 (0.037) 
-1.0 to 0.1 369 (32.3) 544.4 (55.8) 0.583 (0.042) 403 (31.8) 556.7 (57.0) 0.599 (0.041) 
0.0 to 0.9 457 (40.0) 610.5 (63.2) 0.624 (0.046) 471 (37.2) 616.1 (65.4) 0.632 (0.044) 
1 to 1.9 180 (15.8) 674.0 (66.9) 0.660 (0.046) 240 (19.0) 670.2 (67.5) 0.661 (0.043) 
≥ 2 34 (3.0) 739.6 (89.4) 0.702 (0.047) 39 (3.1) 756.2 (82.5) 0.711 (0.044) 
p (trend)  <0.001 <0.001  <0.001 <0.001 
       
Weight z-score a       
< -2.00 3 (0.3) 445.9 (42.0) 0.519 (0.026) 8 (0.6) 418.2 (36.2) 0.516 (0.033) 
-2.00 to -1.1 50 (4.4) 468.2 (46.4) 0.530 (0.031) 56 (4.4) 471.2 (43.1) 0.544 (0.031) 
-1.0 to 0.1 228 (20.0) 521.0 (51.1) 0.563 (0.033) 274 (21.6) 540.0 (50.4) 0.584 (0.033) 
0.0 to 0.9 393 (34.4) 579.0 (58.6) 0.597 (0.035) 435 (34.4) 591.0 (60.1) 0.615 (0.036) 
1 to 1.9 284 (24.9) 630.0 (61.1) 0.638 (0.035) 301 (23.8) 644.0 (69.5) 0.646 (0.037) 
≥ 2 184 (16.1) 683.8 (82.6) 0.688 (0.043) 192 (15.2) 688.3 (77.4) 0.691 (0.041) 
p (trend)  <0.001 <0.001  <0.001 <0.001 
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BMI categories b       
Underweight  2 (0.2) 525.6 (51.8) 0.562 (0.020) 4 (0.3) 419.9 (34.8) 0.510 (0.026) 
Normal weight  673 (58.9) 560.3 (72.8) 0.585 (0.044) 782 (61.8) 576.5 (76.3) 0.604 (0.044) 
Overweight 271 (23.7) 620.5 (78.6) 0.632 (0.046) 272 (21.5) 624.8 (78.2) 0.639 (0.044) 
Obese 196 (17.2) 661.0 (81.2) 0.678 (0.045) 208 (16.4) 665.2 (83.2) 0.679 (0.048) 
p (trend)  <0.001 <0.001  <0.001 <0.001 
       
Quarter of subtotal fat 
mass (kg) 
      
< 5.3 181 (15.8) 510.1 (60.6) 0.558 (0.039) 448 (35.4) 552.1 (72.3) 0.593 (0.044) 
5.3 to 6.8 280 (24.5) 561.0 (61.4) 0.585 (0.037) 312 (24.6) 593.8 (69.7) 0.615 (0.041) 
6.9 to 9.3 320 (28.0) 592.8 (67.7) 0.608 (0.041) 276 (21.8) 632.3 (70.8) 0.638(0.042) 
≥ 9.4 361 (31.6) 655.8 (78.8) 0.664 (0.047) 230 (18.2) 668.1 (84.6) 0.677 (0.049) 
p (trend)  <0.001 <0.001  <0.001 <0.001 
       
Quarter of subtotal lean 
mass (kg) 
      
< 13.2 422 (37.0) 519.1 (49.4) 0.563 (0.033) 207 (16.4) 499.4 (49.5) 0.559 (0.033) 
13.2 to 14.5 280 (24.5) 586.8 (47.9) 0.607 (0.031) 320 (25.3) 559.2 (42.3) 0.597 (0.025) 
14.6 to 16.1 247 (21.6) 636.6 (52.0) 0.641 (0.030) 337 (16.6) 605.0 (50.8) 0.626 (0.029) 
≥ 16.2 193 (16.9) 700.7 (72.3) 0.691 (0.039) 402 (31.8) 683.0 (69.1) 0.676 (0.041) 
p (trend)  <0.001 <0.001  <0.001 <0.001 
       
Quarter of body fat 
mass percentage (%) 
      
< 25.9 120 (10.5) 540.8 (74.9) 0.577 (0.045) 488 (38.6) 575.7 (78.3) 0.607 (0.046) 
25.9 to 30.5 256 (22.4) 562.3 (74.1) 0.586 (0.044) 355 (28.0) 594.8 (85.0) 0.616 (0.051) 
30.6 to 35.9 352 (30.8) 584.2 (78.2) 0.601 (0.049) 240 (19.0) 623.2 (76.1) 0.635 (0.046) 
≥ 36.0 414 (36.2) 631.2 (84.5) 0.647 (0.055) 183 (14.4) 651. 0 (88.6) 0.668 (0.056) 
p (trend)  <0.001 <0.001  <0.001 <0.001 
a World Health Organization reference criteria. Age- and sex-specific weight and height z-scores established 
according to the World Health Organization [184]. 
b According to the World Health Organization classification for BMI-for-age z-score: underweight [<-2 standard 
deviations (SD)]; Normal weight (≥-2SD and ≤+1SD); Overweight (>+1SD and ≤+2SD); Obese (>+2SD) [184,185]. 
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A decreasing trend of the child’s BMC and aBMD was found with increasing educational level 
of main and secondary caregivers. In boys, an increasing household income was negatively 
related with aBMD only. No other differences in mean BMC and aBMD according to 
employment status of the main or the secondary caregiver, household income, family home 
ownership, household crowding, family concern about household expenses, the child’s type of 
school, main caregiver marital status or maternal country of birth, were found (Table 2).  
Table 2. Mean (SD) bone mineral content (g) and areal density (g/cm2) at 7 years of age, in girls and 
boys, according to socioeconomic characteristics at the 7 years of age follow-up evaluation 
 Girls Boys 
 n (%) BMC aBMD n (%) BMC aBMD 
Main caregiver educational 
level a (years of schooling)  
      
≤ 9 434 (38.0) 597.2 (89.4) 0.618 (0.060) 467 (36.9) 605.1 (83.1) 0.627 (0.053) 
10 to 12 347 (30.4) 596.4 (80.6) 0.614 (0.054) 402 (31.8) 603.6 (89.3) 0.626 (0.054) 
> 12 359 (31.4) 580.8 (84.9) 0.603 (0.055) 394 (31.1) 594.1 (83.9) 0.618 (0.051) 
Missing 2 (0.2) 578.7 (41.7) 0.604 (0.038) 3 (0.2) 497.6 (82.9) 0.566 (0.040) 
p (trend)  0.006 0.001  0.047 0.018 
       
Secondary caregiver 
educational level b (years of 
schooling) 
      
≤ 9 556 (49.5) 597.2 (86.7) 0.617 (0.059) 575 (46.2) 604.0 (81.8) 0.626 (0.052) 
10 to 12 300 (26.7) 588.6 (85.4) 0.609 (0.056) 365 (29.3) 600.6 (89.2) 0.624 (0.055) 
> 12 252 (22.4) 581.7 (83.9) 0.603 (0.053) 284 (22.8) 593.0 (88.7) 0.616 (0.052) 
Missing 16 (1.4) 623.6 (75.9) 0.632 (0.053) 20 (1.6) 601.6 (76.5) 0.627 (0.053) 
p (trend)  0.009 0.001  0.020 0.008 
       
Main caregiver employment 
status a  
      
Employed 888 (77.8) 594. 0 (85.2) 0.613 (0.056) 982 (77.6) 603.7 (87.1) 0.625 (0.054) 
Unemployed 202 (17.7) 585.4 (84.5) 0.609 (0.058) 216 (17.1) 591.1 (79.4) 0.618 (0.051) 
Stay-at-home 37 (3.2) 567.7 (90.8) 0.598 (0.063) 44 (3.5) 593.4 (74.6) 0.614 (0.048) 
Other 14 (1.2) 613.0 (104.4) 0.628 (0.066) 23 (1.8) 591.6 (90.8) 0.621 (0.064) 
Missing 1 (0.1) 549.2 0.577 1 (0.1) 531.8 0.588 
p (ANOVA)  0.139 0.243  0.209 0.148 
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Secondary caregiver 
employment status b 
      
Employed  939 (83.5) 592.0 (85.5) 0.612 (0.057) 1044 (83.9) 601.3 (86.8) 0.623 (0.054) 
Unemployed 113 (10.0) 590.1 (83.9) 0.612 (0.058) 127 (10.2) 597.0 (73.2) 0.624 (0.047) 
Stay-at-home 14 (1.2) 612.0 (126.8) 0.614 (0.079) 17 (1.4) 597.1 (101.8) 0.622 (0.071) 
Other 54 (4.8) 590.4 (84.3) 0.612 (0.061) 53 (4.3) 594.5 (85.8) 0.621 (0.055) 
Missing 4 (0.4) 552.3 (86.1) 0.586 (0.047) 3 (0.2) 569.1 (33.6) 0.601 (0.022) 
p (ANOVA)  0.149 0.264  0.072 0.076 
       
Household income 
(EUR/month) 
      
≤ 1000 302 (26.4) 596.7 (90.0) 0.616 (0.061) 332 (26.2) 603.8 (84.5) 0.627 (0.055) 
1001 to 2500 675 (59.1) 591.2 (83.8) 0.612 (0.056) 733 (57.9) 599.0 (83.8) 0.623 (0.052) 
> 2500 141 (12.4) 579.5 (81.7) 0.602 (0.053) 180 (14.2) 603.4 (94.0) 0.622 (0.056) 
Not known or Undisclosed  23 (2.0) 621.8 (96.8) 0.632 (0.060) 21 (1.7) 601.2 (91.3) 0.626 (0.058) 
Missing 1 (0.1) 549.2 0.577 0 NA NA 
p (trend)  0.082 0.034  0.715 0.297 
       
Family home ownership       
No 857 (75.0) 590.7 (84.0) 0.611 (0.056) 966 (76.30) 599.5 (86.4) 0.623 (0.053) 
Yes 271 (23.7) 595.3 (91.1) 0.615 (0.060) 289 (22.83) 605.2 (83.5) 0.627 (0.054) 
Missing 14 (1.2) 589.9  (76.2) 0.613 (0.057) 11 (0.87) 619.6 (65.3) 0.629 (0.044) 
p (t test)  0.450 0.394  0.319 0.269 
       
Household crowding index  
(persons /room) 
      
< 1.0   242 (21.2) 595.6 (78.2) 0.614 (0.053) 293 (23.1) 604.6 (86.4) 0.626 (0.052) 
1.0 452 (39.6) 591.8 (87.5) 0.611 (0.058) 507 (40.0) 599.1 (85.8) 0.623 (0.052) 
1.1-2 392 (34.3) 592.8 (88.1) 0.614 (0.058) 399 (31.5) 600.9 (84.0) 0.624 (0.054) 
> 2 31 (2.7) 554.6 (71.6) 0.589 (0.049) 40 (3.2) 593.8 (101.0) 0.617 (0.061) 
Missing 25 (2.2) 586.0 (90.4) 0.604 (0.061) 27 (2.1) 606.9 (71.4) 0.624 (0.050) 
p (trend)  0.226 0.571  0.400 0.232 
       
Family concern about 
household expenses 
      
Never/rarely  65 (5.7) 592.4 (79.8) 0.609 (0.050) 83 (6.6) 611.9 (87.3) 0.632 (0.054) 
Sometimes/a lot of times  269 (23.6) 584.0 (92.7) 0.606 (0.062) 303 (23.9) 599.5 (87.5) 0.632 (0.054) 
Almost always/always  800 (70.1) 594.0 (83.1) 0.614 (0.056) 874 (69.0) 600.4 (84.8) 0.623 (0.053) 
Missing 8 (0.7) 629.7 (117.9) 0.636 (0.067) 6 (0.5) 602.8 (91.5) 0.633 (0.070) 
p (trend)  0.208 0.070  0.624 0.514 
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Child’s type of school       
Public 1019 (89.2) 591.5 (85.4) 0.612 (0.057) 1135 (89.6) 600.9 (84.8) 0.624 (0.053) 
Private 114 (10.0) 595.4 (87.5) 0.610 (0.055) 120 (9.5) 606.0 (92.1) 0.625 (0.052) 
Other 7 (0.6) 590.8 (110.9) 0.601 (0.060) 10 (0.8) 543.0 (84.2) 0.601 (0.052) 
Missing 2 (0.2) 550.0 (1.1) 0.578 (0.001) 1 (0.1) 653.0 0.674 
p (t-test)   0.641 0.676  0.527 0.845 
       
Main caregiver marital status       
Married/committed 1012 (88.62) 590.7 (86.3) 0.612 (0.058) 1114 87.99) 600.7 (85.4) 0.623 (0.053) 
Single 129 (11.30) 600.7 (80.0) 0.618 (0.052) 151 (11.93) 603.0 (87.0) 0.626 (0.058) 
Missing   1 (0.09)    549.2 0.577 1 (0.08) 575.5 0.593 
p (t-test)  0.212 0.263  0.759 0.598 
       
Maternal country of birth        
Portuguese 1044 (91.42) 592.7 (86.5) 0.613 (0.058) 1162 (91.79) 601.5 (86.2) 0.624 (0.053) 
Non-Portuguese European  8 (0.70) 601.1 (45.2) 0.619 (0.039) 15 (1.18) 590.3 (84.3) 0.615 (0.051) 
African  6 (0.53) 631.4 (67.5) 0.632 (0.027) 9 (0.71) 595.3 (54.6) 0.623 (0.033) 
South American 21 (1.84) 606.6 (71.7) 0.632 (0.027) 13 (1.03) 606.4 (91.0) 0.634 (0.061) 
Other   1 (0.09) 517.7 0.562 0   
Missing   62 (5.43) 567.4 (76.4) 0.599 (0.052) 67 (5.29) 593.8 (77.4) 0.617 (0.049) 
p (ANOVA)  0.141 0.112  0.470 0.375 
a 97.9% biological mother; 1.4% biological father; 0.7% other 
 b 87.2% biological father; 5.5% grandmother; 2.0% non-biological father; 0.8% biological mother; 4.5% other. 
Excluding participants without a second caregiver (n=18 girls and 22 boys). 
NA, not applicable 
 
Boys born to women who smoked during pregnancy or who developed hypertensive disorders 
of pregnancy had increased bone mineral properties at 7 years. We found a trend for lower 
bone mineral properties at 7 years of age in children born from a multiple pregnancy, in 
comparison with singletons, however it was not consistent for both bone mineral properties 
(Table 3).  
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Table 3. Mean (SD) bone mineral content (g) and areal density (g/cm2) at 7 years of age, in girls and 
boys, according to maternal behaviors, clinical conditions and health care use during pregnancy 
 Girls Boys 
 n (%) BMC aBMD n (%) BMC aBMD 
Smoking status during 
pregnancy 
      
No 895 (78.4) 592.7 (86.7) 0.612 (0.057) 1002 (79.2) 598.6 (83.5) 0.621 (0.052) 
Yes 239 (20.9) 587.4 (80.8) 0.611 (0.058) 252 (19.9) 606.3 (90.6) 0.630 (0.057) 
Missing 8 (0.7) 623.8 (100.8) 0.631 (0.064) 12 (1.0) 684.0 (107.0) 0.669 (0.062) 
p (t test)  0.394 0.664  0.195 0.017 
       
Alcohol drinking during 
pregnancy 
      
No 922 (80.7) 591.2 (86.3) 0.612 (0.057) 1050 (82.9) 600.2 (86.5) 0.623 (0.054) 
Yes 142 (12.4) 590.0 (81.6) 0.609 (0.054) 154 (12.2) 602.4 (81.3) 0.625 (0.051) 
Missing 78 (6.8) 602.0 (85.4) 0.620 (0.059) 62 (4.9) 609.7 (80.2) 0.624 (0.050) 
p (t test)  0.871 0.594  0.768 0.650 
       
Number of fetuses       
Singleton 1088 (95.3) 593.1 (86.0) 0.613 (0.057) 1209 (95.5) 601.7 (86.0) 0.624 (0.053) 
Multiple 54 (4.7) 565.0 (72.0) 0.600 (0.052) 57 (4.5) 583.8 (73.0) 0.610 (0.046) 
p (t test)  0.018 0.103  0.121 0.054 
       
Gestational diabetes       
No 1086 (95.1) 591.6 (85.7) 0.612 (0.057) 1178 (93.0) 600.4 (85.7) 0.623 (0.053) 
Yes 53 (4.6) 601.8 (81.3) 0.620 (0.056) 82 (6.5) 606.5 (82.3) 0.631 (0.051) 
Missing 3 (0.3) 500.5 (82.0) 0.544 (0.036) 6 (0.5) 635.2 (109.4) 0.651 (0.066) 
p (t test)  0.397 0.320  0.529 0.201 
       
Hypertensive disorders of 
pregnancy 
      
No 1116 (97.7) 591.7 (85.3) 0.612 (0.057) 1234 (97.5) 599.3 (84.5) 0.622 (0.053) 
Yes 23 (2.1) 607.7 (97.1) 0.625 (0.061) 26 (2.0) 669.3 (101.7) 0.668 (0.058) 
Missing 3 (0.3) 500.5 (82.0) 0.544 (0.036) 6 (0.5) 635.2 (109.4) 0.651 (0.066) 
p (t test)  0.376 0.275  <0.001 <0.001 
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First antenatal visit 
(weeks of gestation) 
      
≤ 12 989 (86.6) 590.5 (87.3) 0.611 (0.058) 1118 (88.3) 601.2 (85.9) 0.624 (0.053) 
> 12 81 (7.1) 601.6 (73.8) 0.617(0.051) 82 (6.5) 596.0 (84.5) 0.622 (0.051) 
Missing 72 (6.3) 599.9 (73.6) 0.617 (0.052) 66 (5.2) 602.6 (81.2) 0.622 (0.051) 
p (t test)  0.267 0.407  0.600 0.791 
 
A trend for increased bone mineral properties at 7 years was observed in girls and boys born 
with great weight for gestational age. There were no clear associations between BMC and 
aBMD at 7 years old and type of delivery, gestational age at birth, levels of cord blood 
adipokines, growth during the immediate postnatal period (newborn weight change) or duration 
of exclusively breastfeeding (Table 4).    
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Table 4. Mean (SD) bone mineral content (g) and areal density (g/cm2) at 7 years of age, in girls and 
boys, according to birth and infant characteristics 
 Girls Boys 
 n (%) BMC aBMD n (%) BMC aBMD 
Type of delivery       
Vaginal 710 (62.2) 590.4 (83.7) 0.610 (0.056) 750 (59.2) 601.7 (85.4) 0.624 (0.053) 
Caesarean section 432 (37.8) 594.2 (88.6) 0.615 (0.058) 516 (40.8) 599.8 (85.8) 0.623 (0.053) 
p (t test)  0.463 0.152  0.704 0.791 
       
Gestational age at birth 
(weeks)  
      
< 37 (preterm) 97 (8.5) 580.7 (92.9) 0.608 (0.059) 112 (8.8) 592.6 (84.6) 0.617 (0.055) 
≥ 37 (full term) 1045 (91.5) 592.8 (84.9) 0.613 (0.057) 1153 (91.1) 601.8 (85.7) 0.624 (0.053) 
Missing 0   1 (0.1) 570.5 0.626 
p (t test)  0.184 0.414  0.279 0.164 
       
Weight for gestational age a        
Small  171 (15.0) 566.1 (83.3) 0.599 (0.058) 181 (14.3) 578.4 (82.8) 0.613 (0.053) 
Adequate 867 (75.9) 595.1 (84.2) 0.613 (0.056) 992 (78.4) 604.4 (85.0) 0.625 (0.053) 
Large 50 (4.4) 652.2 (93.4) 0.651 (0.062) 35 (2.8) 648.4 (102.7) 0.649 (0.055) 
Missing 54 (4.7) 565.0 (72.0) 0.600 (0.052) 58 (4.6) 583.6 (72.4) 0.611 (0.046) 
p (trend)  <0.001 <0.001  <0.001 <0.001 
       
Quarters of umbilical cord 
blood adiponectin (µg/ml) 
      
< 24.7 51 (19.0) 584.1 (85.2) 0.612 (0.059) 90 (30.8) 595.6 (83.7) 0.617 (0.052) 
24.7 to 31.3 82 (30.5) 576.9 (80.8) 0.604 (0.056) 59 (20.2) 570.3 (78.3) 0.607 (0.051) 
31.4 to 38.2 71 (26.4) 588.5 (79.0) 0.609 (0.058) 72 (24.7) 583.2 (84.6) 0.614 (0.054) 
≥ 38.3 65 (24.2) 572.1 (78.0) 0.597 (0.055) 71 (24.3) 586.3 (81.1) 0.617 (0.049) 
Not measured 873 595.4 (86.9) 0.614 (0.057) 974 605.7 (86.0) 0.626 (0.053) 
p (trend)  0.729 0.256  0.381 0.848 
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Quarters of umbilical cord 
blood leptin (ng/ml) 
< 9.5 45 (16.7) 580.0 (78.9) 0.606 (0.051) 98 (33.6) 592.4 (90.2) 0.615 (0.055) 
9.5 to 14.2 52 (19.3) 557.3 (61.2) 0.589 (0.045) 86 (29.4) 578.5 (79.1) 0.610 (0.052) 
14.3 to 23.8 69 (25.6) 589.6 (87.1) 0.610 (0.062) 71 (24.3) 593.1 (75.0) 0.621 (0.049) 
> 23.9 103 (38.3) 585.5 (83.6) 0.609 (0.060) 37(12.7) 566.6 (80.0) 0.607 (0.048) 
Not measured 873 595.4 (86.9) 0.614 (0.057) 974 605.7 (86.0) 0.626 (0.053) 
p (trend)  0.424 0.552  0.245 0.675 
       
Quarters of umbilical cord 
blood resistin (ng/ml) 
      
< 47.5 54 (20.1) 578.9 (76.8) 0.606 (0.057) 87 (29.8) 597.2 (82.3) 0.620 (0.052) 
47.5 to 60.8 65 (24.2) 577.3 (76.2) 0.602 (0.056) 75 (25.7) 565.8 (78.2) 0.603 (0.052) 
60.9 to 79.5 71 (26.4) 583.8 (88.2) 0.608 (0.061) 70 (24.0) 595.1 (93.6) 0.622 (0.056) 
≥ 79.6 79 (29.4) 580.1 (80.0) 0.603 (0.054) 60 (20.6) 580.3 (69.1) 0.611 (0.042) 
Not measured 873 595.4 (86.9) 0.614 (0.057) 974 605.7 (86.0) 0.626 (0.053) 
p (trend)  0.886 0.909  0.432 0.636 
       
Quarters of newborn weight 
change (%)  
      
< -8.0 78 (27.4) 571.3 (85.7) 0.598 (0.059) 78 (24.7) 595.1 (84.0) 0.622 (0.054) 
-8.0 to -6.9  68 (23.9) 581.3 (80.9) 0.610 (0.053) 80 (25.3) 591.6 (86.3) 0.617 (0.054) 
-6.8 to -5.7 63 (22.1) 590.2 (81.6) 0.608 (0.052) 84 (26.6) 591.6 (78.3) 0.621 (0.052) 
≥ -5.6 76 (26.7) 575.7 (72.5) 0.605 (0.053) 74 (23.4) 581.2 (79.2) 0.613 (0.050) 
Not measured 857 596.1 (87.0) 0.615 (0.058) 950 604.6 (86.5) 0.625 (0.053) 
p (trend)  0.445 0.388  0.256 0.304 
       
Exclusively breastfeeding 
duration (months)  
      
Never 36 (3.2) 575.1 (77.0) 0.606 (0.058) 37 (2.9) 622.4 (91.0) 0.633 (0.056) 
< 3 400 (35.0) 597.1 (86.4) 0.617 (0.059) 459 (36.3) 602.5 (88.4) 0.625 (0.055) 
3 to 5 453 (39.7) 580.2 (80.6) 0.603 (0.053) 478 (37.8) 602.4 (83.9) 0.624 (0.052) 
≥ 6 30 (2.6) 604.1 (77.6) 0.617 (0.051) 27 (2.1) 611.1 (86.9) 0.630 (0.055) 
Missing 223 (19.5) 606.8 (93.0) 0.622 (0.060) 265 (20.9) 591.6 (82.3) 0.618 (0.051) 
p (trend)  0.188 0.045  0.467 0.560 
a Small and large for gestational age were defined as <10th and >90th percentile, respectively, of sex-specific 
Kramer growth charts [186]. 
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Girls and boys with history of growth problems had decreased bone mineral properties at 7 
years of age. In girls, history of asthma was related with increased aBMD but not with BMC. 
There were no differences in mean BMC and aBMD at age 7 according to history of fracture, 
and history of gastrointestinal, liver, kidney or musculoskeletal disease. There were also no 
relevant BMC and aBMD differences between regular use of medication, number of medical or 
dentist appointments, number of visits to emergency departments or hospitalizations in the 
previous year, with the exception of a borderline increase in aBMD in girls that had been 
hospitalized once or more in the previous year, in comparison with those without 
hospitalizations. Increased mean bone mineral properties were found in children accessing 
hospital clinics for routine care, in comparison to those followed by a general practitioner from 
the National Health Service or by a private doctor, but this crude association was observed in 
boys only (Table 5). 
Table 5. Mean (SD) bone mineral content (g) and areal density (g/cm2) at 7 years of age, in girls and 
boys, according to disease history and health care use 
 Girls Boys 
 n (%) BMC aBMD n (%) BMC aBMD 
Fracture        
No  1077 (94.3) 591.9 (85.1) 0.612 (0.057) 1193 (94.2) 600.6 (85.9) 0.612 (0.057) 
Yes 61 (5.3) 591.6 (96.2) 0.612 (0.063) 68 (5.4) 605.2 (80.3) 0.612 (0.063) 
Missing 4 (0.4) 559.4 (69.4) 0.591 (0.039) 5 (0.4) 621.5 (72.6) 0.591 (0.039) 
p (t test)  0.974 0.915  0.667 0.514 
       
Asthma       
No  1071 (93.8) 590.8 (85.9) 0.611 (0.057) 1177 (93.0) 601.6 (85.4) 0.624 (0.053) 
Yes 62 (5.4) 606.6 (82.6) 0.629 (0.056) 77 (6.1) 597.1 (88.8) 0.624 (0.058) 
Missing 9 (0.8) 609.8 (70.1) 0.624 (0.062) 12 (1.0) 559.5 (81.0) 0.604 (0.058) 
p (t test)  0.157 0.020  0.657 0.960 
       
Growth problems        
No  1127 (98.7) 592.7 (85.3) 0.613 (0.057) 1251 (98.8) 601.5 (85.4) 0.613 (0.057) 
Yes 10 (0.9) 493.8 (84.3) 0.553 (0.058) 6 (0.5) 503.7 (96.5) 0.553 (0.058) 
Missing 5 (0.4) 576.3 (45.2) 0.605 (0.026) 9 (0.7) 584.5 (66.2) 0.605 (0.026) 
p (t test)  <0.001 <0.001  0.005 0.002 
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Gastrointestinal 
problems 
      
No  1074 (94.0) 592.0 (86.1) 0.612 (0.057) 1200 (94.8) 601.8 (85.5) 0.612 (0.057) 
Yes 62 (5.4) 586.2 (78.9) 0.611 (0.057) 63 (5.0) 588.0 (85.4) 0.611 (0.057) 
Missing 6 (0.5) 621.9 (69.7) 0.642 (0.058) 3 (0.2) 539.4 (82.6) 0.642 (0.058) 
p (t test)  0.604 0.868  0.212 0.186 
       
Kidney or liver 
problems 
      
No  1090 (95.4) 591.9 (85.9) 0.612 (0.057) 1179 (93.1) 600.1 (85.7) 0.623 (0.053) 
Yes 41 (3.6) 589.9 (79.0) 0.608 (0.053) 73 (5.6) 617.6 (76.6) 0.632 (0.050) 
Missing 11 (1.0) 589.9 (88.7) 0.610 (0.063) 14 (1.1) 584.1 (109.3) 0.606 (0.061) 
p (t test)  0.883 0.669  0.088 0.172 
       
       
Musculoskeletal 
problems 
      
No  1087 (95.2) 592.3 (86.2) 0.612 (0.057) 1213 (95.8) 601.7 (85.3) 0.612 (0.057) 
Yes 42 (3.7) 581.1 (74.2) 0.603 (0.051) 38 (3.0) 580.9 (79.2) 0.603 (0.051) 
Missing 13 (1.1) 587.3 (69.8) 0.612 (0.050) 15 (1.2) 591.0 (118.7) 0.612 (0.050) 
p (t test)  0.408 0.271  0.138 0.127 
       
Regular use of any 
medication or 
supplementation  
      
No 975 (85.4) 593.4 (85.7) 0.613 (0.057) 1043 (82.4) 602.2 (85.3) 0.613 (0.057) 
Yes 150 (13.1) 580.8 (84.0) 0.604 (0.054) 211 (16.7) 596.4 (87.9) 0.604 (0.054) 
Missing 17 (1.5) 596.1 (90.3) 0.617 (0.063) 12 (1.0) 572.5 (59.1) 0.617 (0.063) 
p (t test)  0.094 0.073  0.375 0.389 
       
Hospitalizations in the 
previous year  
      
0 1076 (94.2) 590.7 (85.8) 0.611 (0.057) 1169 (92.3) 601.9 (85.7) 0.624 (0.053) 
≥1 60 (5.2) 609.2 (82.5) 0.627 (0.055) 93 (7.4) 587.7 (83.3) 0.616 (0.051) 
Missing 6 (0.5) 615.7 (65.1) 0.628 (0.050) 4 (0.3) 628.8 (78.8) 0.641 (0.043) 
p (trend)  0.104 0.044  0.122 0.161 
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Medical appointments 
in the previous year 
      
0 105 (9.2) 589.2 (94.2) 0.610 (0.061) 90 (7.1) 614.4 (78.3) 0.632 (0.048) 
1 340 (29.8) 585.8 (80.7) 0.608 (0.056) 352 (27.8) 598.7 (83.6) 0.622 (0.053) 
2 245 (21.4) 597.2 (90.2) 0.618 (0.059) 288 (22.8) 603.1 (86.9) 0.623 (0.053) 
3 162 (14.2) 589.5 (84.6) 0.609 (0.056) 189 (14.9) 595.7 (87.8) 0.622 (0.055) 
≥4 286 (25.0) 596.0 (84.7) 0.615 (0.056) 343 (27.1) 601.3 (87.1) 0.625 (0.054) 
Missing 4 (0.4) 631.0 (69.9) 0.626 (0.044) 4 (0.3) 553.1  (59.2) 0.605 (0.042) 
p (trend)  0.184 0.203  0.528 0.965 
       
Dentist appointments in 
the previous year 
      
0 341 (29.9) 598.1 (94.6) 0.616 (0.061) 440 (34.8) 595.4 (83.5) 0.622 (0.053) 
1 363 (31.8) 588.3 (76.7) 0.611 (0.053) 388 (30.6) 603.7 (82.0) 0.625 (0.051) 
2 217 (19.0) 592.2 (87.4) 0.612 (0.059) 200 (15.8) 601.3 (89.5) 0.623 (0.054) 
≥3 212 (18.6) 586.3 (83.5) 0.607 (0.054) 227 (17.9) 606.0 (91.8) 0.624 (0.056) 
Missing 9 (0.8) 614.3 (67.7) 0.624 (0.050) 11 (0.9) 615.8 (87.6) 0.640 (0.052) 
p (trend)  0.228 0.091  0.255 0.924 
       
Visits to emergency 
department in the 
previous year    
      
0 509 (44.6) 590.9 (85.0) 0.611 (0.057) 499 (39.4) 603.6 (87.3) 0.625 (0.055) 
1 294 (25.7) 596.1 (87.5) 0.614 (0.059) 361 (28.5) 602.4 (81.5) 0.624 (0.050) 
2 164 (14.4) 585.2 (82.4) 0.608 (0.054) 198 (15.6) 595.6 (88.7) 0.621 (0.054) 
≥3 156 (13.7) 591.2 (88.5) 0.613 (0.058) 187 (14.8) 597.2 (84.1) 0.621 (0.052) 
Missing 19 (1.7) 611.2 (77.4) 0.637 (0.052) 21 (1.7) 597.3 (99.4) 0.625 (0.057) 
p (trend)  0.818 0.999  0.363 0.514 
       
Healthcare provision       
NHS GP a 767 (67.2) 591.7 (86.0) 0.613 (0.058) 787 (62.2) 603.0 (82.2) 0.625 (0.051) 
Private doctor 246 (21.5) 592.1 (82.4) 0.611 (0.055) 345 (27.2) 590.1 (86.9) 0.616 (0.052) 
Hospital clinic 66 (5.8) 587.6 (92.7) 0.608 (0.058) 69 (5.4) 617.6 (104.0) 0.636 (0.066) 
Other 3 (0.3) 546.5 (23.1) 0.581 (0.011) 5 (0.4) 571.6 (54.8) 0.604 (0.041) 
Missing 60 (5.3) 598.3 (88.8) 0.614 (0.061) 60 (4.7) 619.9 (92.8) 0.641 (0.061) 
p (ANOVA)  0.805 0.696  0.028 0.008 
a National Health Service General practitioners 
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In girls, there were no clear crude associations between bone mineral properties and physical 
activity. In boys, mean bone mineral properties increased with increasing time spent in sports 
practice and with increasing time spent watching TV on weekend days, although the last 
relationship was not consistent for the two measures of bone mineralization (Table 6). 
 
Table 6. Mean (SD) bone mineral content (g) and areal density (g/cm2) at 7 years of age, in girls and 
boys, according to physical activity 
 Girls Boys 
  n (%) BMC aBMD n (%) BMC aBMD 
Time spent watching TV per 
weekday (minutes) 
      
< 30 123 (10.8) 610.0 ( 91.5) 0.625 (0.059) 110 (8.7) 589.4 (100.9) 0.618 (0.064) 
30 to 59 346 (30.3) 584.8 (79.2) 0.608 (0.054) 341 (26.9) 600.9 (83.6) 0.623 (0.050) 
60 to 119 509 (44.6) 592.0 (87.8) 0.611 (0.058) 582 (46.0) 601.2 (84.2) 0.624 (0.052) 
≥ 120 157 (13.8) 591.3 (85.9) 0.614 (0.058) 229 (18.1) 606.1 (84.0) 0.627 (0.054) 
Missing 7 (0.6) 609.6 (92.2) 0.629 (0.059) 4 (0.3) 597.2 (93.2) 0.633 (0.056) 
p (trend)  0.346 0.628  0.174 0.218 
       
Time spent watching TV per 
weekend day (minutes)  
      
< 60 78 (6.8) 594.6 (92.6) 0.614 (0.060) 64 (5.1) 572.5 (89.6) 0.605 (0.058) 
60 to 119 294 (25.7) 590.4 (83.8) 0.612 (0.058) 255 (20.1) 603.5 (86.2) 0.625 (0.052) 
120 to 179 369 (32.3) 586.8 (84.4) 0.608 (0.057) 380 (30.0) 602.7 (85.3) 0.624 (0.052) 
≥ 180 388 (34.0) 597.1 (87.0) 0.616 (0.057) 557 (44.0) 602.0 (84.5) 0.625 (0.053) 
Missing 13 (1.1) 593.3 (76.0) 0.610 (0.045) 10 (0.8) 591.6 (94.8) 0.624 (0.071) 
p (trend)  0.567 0.366  0.056 0.036 
       
Time spent in active play 
per weekday (minutes) 
      
< 30 414 (36.2) 596. 6 (85.0) 0.615 (0.056) 415 (32.8) 606.0 (88.4) 0.626 (0.056) 
30 to 59 251 (22.0) 588.9 (76.7) 0.611 (0.055 ) 257 (20.3) 600.9 (86.1) 0.624 (0.052) 
60 to 119 346 (30.3) 586.7 (90.4) 0.609 (0.060) 409 (32.3) 594.0 (82.8) 0.619 (0.052) 
≥ 120 123 (10.8) 596.8 (91.6) 0.615 (0.055) 175 (13.8) 605.1 (84.0) 0.626 (0.049) 
Missing 8 (0.7) 581.4 (74.3) 0.608 (0.057) 10 (0.8) 601.3 (89.6) 0.627 (0.055) 
p (trend)  0.210 0.327  0.194 0.249 
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Time spent in active play 
per weekend day (minutes) 
      
< 60 106 (9.3) 592.6 (81.1) 0.612 (0.055) 92 (7.3) 610.6 (98.1) 0.630 (0.064) 
60 to 119 254 (22.2) 587.8 (81.4) 0.609 (0.055) 263 (20.8) 601.9 (85.2) 0.624 (0.054) 
120 to 179 316 (27.7) 591.0 (92.4) 0.611 (0.061) 374 (29.5) 603.5 (88.6) 0.626 (0.055) 
≥ 180 452 (39.6) 594.5 (84.7) 0.614 (0.056) 527 (41.6) 597.3 (81.2) 0.621 (0.049) 
Missing 14 (1.2) 591.7 (70.7) 0.611 (0.042) 10 (0.8) 581.7 (82.0) 0.614 (0.055) 
p (trend)  0.587 0.432  0.159 0.190 
       
Time spent in sports 
practice per week (minutes)  
      
< 60 101 (8.8) 581.5 (93.5) 0.603 (0.060) 140 (11.1) 599.9 (92.9) 0.624 (0.060) 
60 to 179 530 (46.4) 592.3 (87.3) 0.612 (0.057) 508 (40.1) 596.3 (79.6) 0.621 (0.049) 
180 to 239 230 (20.1) 594.0 (78.4) 0.614 (0.054) 233 (18.4) 596.3 (87.8) 0.620 (0.054) 
≥ 240 256 (22.4) 593.6 (85.5) 0.615 (0.058) 357 (28.2) 612.8 (89.5) 0.631 (0.055) 
Missing 25 (2.2) 585.0 (84.9) 0.615 (0.055) 28 (2.2) 577.8 (67.7) 0.606 (0.043) 
p (trend)  0.267 0.106  0.032 0.022 
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No clear dose-response relations between daily calcium, vitamin D or energy intakes and BMC 
or aBMD in Generation XXI children were observed (Table 7). 
 
Table 7. Mean (SD) bone mineral content (g) and areal density (g/cm2) at 7 years of age, in girls and 
boys, according to calcium, vitamin D and total energy intakes 
 Girls Boys 
 n (%) BMC aBMD n (%) BMC aBMD 
Calcium intake (mg/day)       
< 800 348 (30.5) 585.9 (83.7) 0.608 (0.056) 328 (25.9) 600.9 (84.6) 0.622 (0.053) 
800 to 999 311 (27.2) 593.9 (89.7) 0.613 (0.060) 297 (23.5) 597.0 (85.2) 0.623 (0.052) 
1000 to 1199 211 (18.5) 596.4 (83.2) 0.616 (0.056) 293 (23.1) 596.5 (85.4) 0.620 (0.054) 
≥ 1200 240 (21.0) 591.7 (83.7) 0.612 (0.056) 322 (25.4) 608.8 (87.3) 0.629 (0.054) 
Missing 32 (2.8) 605.6 (95.2) 0.620 (0.060) 26 (2.0) 599.0 (80.4) 0.623 (0.042) 
p (trend)  0.193 0.156  0.342 0.210 
       
Vitamin D intake (µg/day)       
< 2.0 402 (35.2) 594.7 (87.7) 0.614 (0.060) 391 (30.9) 598.3 (87.2) 0.623 (0.054) 
2.0 to 2.4 360 (31.5) 586.7 (81.3) 0.610 (0.055) 412 (32.5) 607.7 (85.7) 0.628 (0.052) 
≥ 2.5 348 (30.5) 592.5 (84.3) 0.612 (0.056) 437 (34.5) 597.1 (84.2) 0.620 (0.053) 
Missing 32 (2.8) 605.6 (95.2) 0.620 (0.059) 26 (2.0) 599.0 (80.4) 0.623 (0.043) 
p (trend)  0.976 0.812  0.978 0.812 
       
Total energy intake (kcal/day) a       
< 1400 214 (18.7) 591.8 (89.3) 0.612 (0.060) 195 (15.4) 602.6 (96.8) 0.626 (0.060) 
1400 to 1599 263 (23.0) 596.7 (90.3) 0.616 (0.060) 238 (18.8) 595.8 (80.8) 0.620 (0.050) 
1600 to 1999 466 (40.8) 590.2 (80.7) 0.612 (0.054) 560 (44.2) 601.4 (82.9) 0.624 (0.051) 
≥ 2000 167 (14.6) 585.9 (84.9) 0.606 (0.055) 247 (19.5) 603.9 (87.5) 0.626 (0.056) 
Missing 32 (2.8) 605.6 (95.2) 0.620 (0.060) 26 (2.0) 599.0 (80.4) 0.623 (0.043) 
p (trend)  0.576 0.361  0.590 0.693 
a Using the USDA’s Guidelines (U.S. Department of Agriculture & U.S. Department of Health and Human Services, 2010) 
estimated energy requirements for moderately active children aged 4 to 6 years (1400–1600 kcal).  
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4.2. Gestational Weight Gain and Offspring Bone Mass: Different 
Associations in Healthy Weight versus Overweight Women 
 
Teresa Monjardino, Ana Henriques, Carla Moreira, Teresa Rodrigues, Nuno 
Adubeiro, Luísa Nogueira, Cyrus Cooper, Ana Cristina Santos, Raquel Lucas 
(J Bone Miner Res. 2019 Jan;34(1):38-48) 
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Supplemental data  
 
Brief description of the Generation XXI Birth Cohort  
Generation XXI is the first prospective Portuguese population-based birth cohort and aims to 
characterize prenatal and postnatal growth and development, identifying their determinants in 
order to understand several aspects of childhood health and to extend follow-up up to 
adulthood, thereby contributing to health gains among the population.  
Recruitment was conducted between April 2005 and August 2006 at the five public maternity 
units providing obstetrical and neonatal care covering the metropolitan area of Porto, Portugal. 
All are level III units and, in 2004, were responsible for 91.6% of the deliveries in the whole 
catchment population, with the remaining occurring in private hospitals/clinics. All mothers who 
delivered a live-born child with more than 23 weeks of gestation in one of the five units, during 
the cited period, and resident in the catchment area, were eligible to participate. Seventy 
percent of the eligible mothers were invited to participate and 91.4% accepted resulting in 8,647 
infants enrolled in the cohort study. During the hospital stay, in 24 to 72 hours after delivery, 
trained interviewers were responsible for the study presentation and subsequent invitation of 
the mothers.  
Descriptive data of baseline characteristics of the original study population is presented in 
Supplemental table S1. 
Four years after birth, between April 2009 and July 2011, a follow-up evaluation was performed 
and 7459 children, corresponding to 86.3% of the entire cohort, were reevaluated.  
Between April 2012 and April 2014, all families were invited once again to attend the 7-years’ 
reevaluation of the cohort and 6,889 children were reassessed (79.7% of the entire cohort).  
Similar procedures were adopted throughout all the evaluations. In the face-to-face interviews 
at baseline and at both follow-ups, information was collected by interviewers, using structured 
questionnaires concerning the child’s health and health of the mother. Data on demographic, 
socioeconomic and psychosocial circumstances and lifestyles were collected. Personal and 
family medical history, including gynecologic and obstetric history and prenatal care, was also 
inquired.  
Physical examination of the child including anthropometric, cardiovascular, respiratory and 
dental evaluation was conducted. An anthropometric evaluation of the mother was performed 
at baseline and both follow-ups by the interviewers. Blood samples were collected. Routine 
primary care data regarding the child’s development were periodically extracted from the 
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Child’s Health Book. Clinical records at birth and the Pregnancy Booklet were also reviewed to 
retrieve data on prenatal care, pregnancy complications, delivery and neonatal characteristics. 
In the 7 years of age follow-up evaluation a consecutive subsample of 3,015 children, 
corresponding to those children assessed between December 2012 and August 2013 (43.8% 
of the participants in the 7 years follow-up) was additionally invited to undergo a whole body 
dual-energy X-ray absorptiometry (DXA). Scanning was successfully performed in 2,408 
children (79.9% of the eligible sample and 27.8% of the entire cohort). This additional 
evaluation took place between March 2013 and February 2014.   
For all the evaluations, interviewers were trained by a multidisciplinary team and were 
responsible for the application of the questionnaires to the participants, for the physical 
examination of both family members. DXA scans were performed and evaluated immediately 
after acquisition by a technician and later validated by a second technician, both with at least 5 
years of experience. 
Generation XXI study protocol conforms to the ethical principles outlined in the Declaration of 
Helsinki and was approved by the Ethics Committee of the Hospital de São João and the 
University of Porto Medical School and is registered with the Portuguese Authority of Data 
Protection. Written informed consent was obtained from all parents or legal guardians and oral 
assent was obtained from children at each evaluation. 
 
Supplemental table S1. Baseline characteristics of Generation XXI participants 
Maternal characteristics at birth of child (n=8,495)  
Age, mean (SD), years 29.0 (5.6) 
Less than 9 years of formal education (%) 33.4 
Unemployment (%) 20.0 
Less than 1000 € of monthly household income (%) 40.6 
Parity higher than 1 before index pregnancy (%) 10.5 
Gestational diabetes in index pregnancy (%) 6.7 
Hypertensive disorders of pregnancy in index pregnancy (%) 2.3 
First antenatal visit after 12 weeks of gestational age (%) 11.1 
Child characteristics (n=8,647)  
Multiples (%) 1.7 
Girls (%)  49.0 
Gestational age at birth, mean (SD), weeks 38.5 (1.9) 
Small for gestational agea (%) 14.7 
Large for gestational agea (%) 4.1 
aSmall and large for gestational age were defined as <10th and >90th percentile, respectively, of sex-specific Kramer growth 
charts.   
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Supplemental figure S1. Flowchart of the participants included for analysis, from Generation XXI 
cohort 
Notes: * participants who refused to participate in the DXA evaluation (n=257) + participants who scheduled three 
different appointments but did not show up for evaluation, or did not respond to our invitation after at least five 
attempts (n=335) plus one participant with cerebral palsy that did not cooperate 
DXA, dual-energy X-ray absorptiometry; GWG, gestational weight gain; BMI, body mass index. 
8,647 participants (49.0% girls) 
Generation XXI at birth (2005-2006)  
5,849 participants 
Follow-up evaluation at 7 years of age (2012-2014) 
by face-to-face interview
3,015 participants
Consecutively selected based on the date of 7-year-old follow-up 
evaluation (1.12.2012 to 31.8.2013)
2,421 participants
DXA scan
Exclusions:
Refusals, n=593*
Without phone contacts, n=1
2,408 participants 
Valid DXA scan
Exclusions:
Technical issues, n=13
2,167 participants  (46.8% girls)
With valid DXA scan and with data on maternal GWG 
and BMI
Exclusions:
Multiple pregnancies, n=111
Without information on 
maternal GWG, n=115
Without information on 
maternal BMI, n=15
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Supplemental table S2. Maternal and child characteristics from included and excluded participants 
 Included Excluded 
Maternal characteristics n  n  
Age at delivery, mean (SD), years 2,167 29.9 (5.1) 6,322 28.6 (5.8) 
No. (%) of women by educational level     
≤9 years 
2,165 
859 (39.7) 
6,274 
3,302 (52.6) 
10-12 years 624 (28.8) 1,634 (26.0) 
>12 years 682 (31.5) 1,338 (21.3) 
No. (%) of women by employment status     
Employed 
2,162 
1,711 (79.1) 
6,232 
4,278 (68.6) 
Unemployed 336 (15.5) 1,339 (21.5) 
Housewife 71 (3.3) 422 (6.8) 
Student 39 (1.8) 174 (2.8) 
Other 5 (0.2) 19 (0.3) 
No. (%) of women by monthly household income     
≤1000 € 
2,119 
654 (33.1) 
5,995 
2,313 (43.4) 
1001–2000 € 961 (48.6) 2,248 (42.2) 
>2000 € 361 (18.3) 766 (14.4) 
Not known/no answer 143 668 
No. (%) of women by previous pregnancies     
None 
2,150 
1,271 (59.1) 
6,188 
3,464 (55.9) 
One or more 879 (40.9) 2,724 (44.0) 
No. (%) of women by early pregnancy BMI groupsa     
Under/normal weight 
2,167 
1,392 (64.2) 
5,998 
3,994 (66.6) 
Overweight/obese 775 (35.8) 2,004 (33.4) 
Weight gain during pregnancy, mean (SD), kg 2,167 13.2 (5.3) 5,869 12.7 (5.6) 
No. (%) of women by smoking status during pregnancy     
Never smoked 
2,152 
1,702 (79.1) 
6,233 
4,716 (75.7) 
Ever smoked 450 (20.9) 1,517 (24.3) 
Child characteristics     
No. (%) of children by sex     
Girl  
2,167 
1,015 (46.8) 
6,480 
3,221 (49.7) 
Boy 1,152 (53.2) 3,259 (50.3) 
Gestational age at birth, mean (SD), weeks 2,167 38.7 (1.6) 6,459 38.4 (2.0) 
Birth weight, mean (SD), g 2,167 3,197.6 (475.8) 6,479 3,132.3 (556.6) 
Age at 7 years follow-up evaluation, mean (SD), months 2,167 85.2 (2.5) 3,682 85.9 (3.1) 
Weight at 7 years, mean (SD), kg 2,165 26.0 (5.0) 3,669 26.4 (5.4) 
BMI at 7 years, mean (SD), kg/m2 2,164 16.9 (2.4) 3,669 17.1 (2.6) 
 
Notes: a According to the standard World Health Organization definition 
 
BMI, body mass index.
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Results for artefactual explanations for the findings  
 
 
Supplemental figure S2. Gestational weight gain distribution in under/normal weight and 
overweight/obese women showing substantial overlap of values in the two groups 
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Supplemental table S3. Linear regression coefficients (95% CI) for associations between potential confounders and the exposure, i.e. maternal gestational 
weight gain, in under/normal weight and overweight/obese women, suggesting no different associations between potential confounders and gestational weight 
gain by maternal BMI group 
Potential confounders Under/normal weight Overweight/obese 
Maternal age at delivery, years  8.01 (-4.86, 20.87) -4.57 (-23.61, 14.47) 
Maternal height, cm 0.11 (0.07, 0.16) 0.05 (-0.01, 0.11) 
Maternal educational level 
>12 years 
10-12 years 
≤9 years 
 
Ref. 
0.79 (0.15, 1.44) 
0.74 (0.14, 1.34) 
 
Ref. 
0.53 (-0.58, 1.64) 
-0.70 (-1.73, 0.33) 
Employment status 
Employed 
Unemployed 
Housewife/student/other 
 
Ref. 
0.73 (0.00, 1.46) 
1.16 (-0.08, 2.39) 
 
Ref. 
0.25 (-0.81, 1.32) 
-0.90 (-2.51, 0.70) 
Monthly household income 
>2000 € 
1001–2000 € 
≤1000 € 
 
Ref. 
0.10 (-0.59, 0.79) 
0.81 (0.05, 1.56) 
 
Ref. 
-0.59 (-1.88, 0.70) 
-0.98 (-2.30, 0.33) 
Previous pregnancies 
None 
One or more 
 
Ref. 
-0.42 (-0.95, 0.11) 
 
Ref. 
-2.29 (-3.07, -1.50) 
Smoking status during pregnancy 
Never smoked  
Ever smoked 
 
Ref. 
1.44 (0.84, 2.06) 
 
Ref. 
2.43 (1.39, 3.46) 
Gestational diabetes 
No  
Yes 
 
Ref. 
-1.46 (-2.72, -0.20) 
 
Ref. 
-1.40 (-2.75, -0.04) 
Offspring gestational age at birth, weeks 0.67 (0.52, 0.83) 0.43 (0.19, 0.67) 
Offspring sex 
Girl 
Boy 
 
Ref. 
-0.24 (-0.76, 0.27) 
 
Ref. 
0.30 (-0.50, 1.10) 
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Supplemental table S4. Linear regression coefficients (95% CI) for associations between potential confounders and the outcomes, i.e. offspring bone mass 
properties at 7 years of age, in under/normal weight and overweight/obese women, suggesting no different associations between potential confounders and 
bone measures by maternal BMI group 
 Under/normal weight Overweight/obese 
Potential confounders z-BMC z-aBMD z-scBMC z-BMC z-aBMD z-scBMC 
Maternal age at delivery, 
years  
-0.01 (-0.02, 0.00) -0.01 (-0.02, -0.00) -0.01 (-0.02, -0.00) -0.01 (-0.02, 0.00) -0.02 (-0.03, -0.00) -0.03 (-0.04, -0.01) 
Maternal height, cm 0.04 (0.04, 0.05) 0.04 (0.03, 0.04) 0.00 (-0.00, 0.01) 0.05 (0.04, 0.06) 0.04 (0.03, 0.05) 0.02 (0.00, 0.03) 
Maternal educational level 
>12 years 
10-12 years 
≤9 years 
 
Ref. 
0.07 (-0.05, 0.20) 
0.07 (-0.05, 0.19) 
 
Ref. 
0.08 (-0.04, 0.21) 
0.12 (-0.00, 0.24) 
 
Ref. 
0.07 (-0.05, 0.19) 
0.17 (0.06, 0.28) 
 
Ref. 
0.19 (-0.01, 0.39) 
0.12 (-0.06, 0.31) 
 
Ref. 
0.22 (0.02, 0.42) 
0.17 (-0.02, 0.36) 
 
Ref. 
0.20 (-0.02, 0.41) 
0.19 (-0.01, 0.39) 
Employment status 
Employed 
Unemployed 
Housewife/student/other 
 
Ref. 
0.07 (-0.08, 0.22) 
0.18 (-0.07, 0.43) 
 
Ref. 
0.03 (-0.11, 0.18) 
0.12 (-0.12, 0.37) 
 
Ref 
-0.08 (-0.22, 0.06) 
-0.02 (-0.26, 0.21) 
 
Ref. 
0.01 (-0.18, 0.20) 
-0.12 (-0.41, 0.17) 
 
Ref. 
0.04 (-0.15, 0.23) 
-0.08 (-0.36, 0.21) 
 
Ref. 
0.07 (-0.13, 0.28) 
0.00 (-0.30, 0.32) 
Monthly household income 
>2000 € 
1001–2000 € 
≤1000 € 
 
Ref. 
0.04 (-0.10, 0.18) 
0.07 (-0.08, 0.22) 
 
Ref. 
0.06 (-0.07, 0.20) 
0.10 (-0.05, 0.26) 
 
Ref. 
0.09 (-0.04, 0.22) 
0.12 (-0.02, 0.26) 
 
Ref. 
-0.18 (-0.42, 0.05) 
-0.15 (-0.39, 0.09) 
 
Ref. 
-0.13 (-0.37, 0.10) 
-0.10 (-0.34, 0.14) 
 
Ref. 
-0.02 (-0.28, 0.24) 
-0.03 (-0.28, 0.22) 
Previous pregnancies 
None 
One or more 
 
Ref. 
-0.13 (-0.24, -0.02) 
 
Ref. 
-0.14 (-0.25, -0.04) 
 
Ref. 
-0.10 (-0.20, 0.00) 
 
Ref. 
-0.05 (-0.19, 0.09) 
 
Ref. 
-0.08 (-0.23, 0.06) 
 
Ref. 
-0.14 (-0.30, 0.01) 
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Smoking status during 
pregnancy 
Never smoked  
Ever smoked 
 
Ref. 
-0.00 (-0.13, 0.12) 
 
Ref. 
0.05 (-0.07, 0.18) 
 
Ref. 
0.14 (0.02, 0.26) 
 
Ref. 
0.02 (-0.17, 0.21) 
 
Ref. 
0.09 (-0.10, 0.28) 
 
Ref. 
0.21 (0.01, 0.41) 
Gestational diabetes 
No  
Yes 
 
Ref. 
0.08 (-0.17, 0.34) 
 
Ref. 
0.12 (-0.14, 0.36) 
 
Ref. 
0.15 (-0.09, 0.39) 
 
Ref. 
0.06 (-0.19, 0.30) 
 
Ref. 
0.14 (-0.11, 0.38) 
 
Ref. 
0.21 (-0.05, 0.47) 
Offspring gestational age at 
birth, weeks 
0.01 (-0.02, 0.05) 0.01 (-0.02, 0.05) -0.00 (-0.03, 0.03) -0.01 (-0.06, 0.03) -0.01 (-0.05, 0.04) 0.01 (-0.04, 0.05) 
Offspring sex 
Girl 
Boy 
 
Ref. 
-0.00 (-0.10, 0.10) 
 
Ref. 
-0.00 (-0.10, 0.10) 
 
Ref. 
0.00 (-0.09, 0.10) 
 
Ref. 
0.01 (-0.13, 0.16) 
 
Ref. 
0.02 (-0.12, 0.16) 
 
Ref. 
0.01 (-0.14, 0.16) 
 
aBMD, areal bone mineral density; BMC, bone mineral content; GWG, gestational weight gain; scBMC, size-corrected bone mineral content. 
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Abstract 
 
Background: To identify sensitive periods for the effect of early life growth on childhood 
bone mass we compared the associations between weight and length/height velocities 
from birth to age six and bone mineral content (BMC) at 7 years of age. 
 
Methods: We analyzed data from 1853 participants from the Generation XXI birth 
cohort scanned with a whole body dual-energy X-ray absorptiometry system. Velocities 
of growth in weight and length/height were obtained through linear spline multilevel 
models on the basis of data collected during routine health examinations. Using linear 
regression we computed associations of birth weight, birth length, five weight velocities 
(“early neonatal”: 0-10 days, “early infancy”: 10 days-3 months, “late infancy”: 3-12 
months, “early childhood”: 1-3 years, and “later childhood”: 3-6 years) and four 
length/height velocities (“early infancy”: 0-3 months, “late infancy”: 3-12 months, “early 
childhood”: 1-3 years, and “later childhood”: 3-6 years) with outcomes BMC, height and 
height-adjusted BMC at age seven. Confounding by maternal and child characteristics 
was addressed and effects of growth velocities were adjusted to preceding growth. 
 
Results: Weight and length/height velocities up to the age of six were associated with 
increased bone mass and height at 7 years with the strongest associations observed for 
growth in early childhood. In this age period, after concurrent height and confounder 
adjustment, one standard deviation (SD) increase in weight velocity was associated with 
higher BMC z-scores: 0.27 (95% CI: 0.22, 0.32) in girls and 0.24 (95% CI: 0.19, 0.29) in 
boys. Height velocity was also associated with greater height-adjusted BMC z-score: 
0.12 (95% CI: 0.07, 0.17) per SD in girls and 0.11 (95% CI: 0.06, 0.16) in boys. The 
pattern of associations was similar, albeit attenuated, after adjusting for preceding 
growth. 
 
Conclusion: Growth in second and third years of life may represent a sensitive period 
for the effect of growth on childhood bone mass, partly through their effect on concurrent 
body size.  
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Introduction 
 
Body size, as measured by height and weight, is amongst the strongest determinants of 
bone mineral properties throughout life, largely reflecting skeletal adaptation to loading, 
as well as the close constitutional relation between anthropometrics and body 
composition [1, 2]. Beyond its short-term mechanical effect, there is growing evidence 
that the velocity of growth in height and weight during infancy and childhood is a probable 
determinant of later bone mass and density [3-5]. In addition, our previous work has 
shown that the overall trajectory of weight gain from birth is likely to contribute to 
cumulative bone mass accrued before puberty, since children in above-average weight 
gain trajectories had higher bone mineral content and areal density at age seven than 
those who gained less weight, with the strongest associations for children with persistent 
weight gain since birth [6]. Nevertheless, from an etiologic perspective, there is an 
increasing interest in the identification of sensitive periods, during which programmed 
phenotypes such as bone mass may be particularly responsive to growth velocity [7, 8]. 
This may provide insights into the timing in childhood when targeted interventions to 
promote bone health are most promising. 
 
Previous studies of two interval cohorts that examined the effect of specific growth 
periods on childhood bone mass have found that growth in the first three years of life has 
the strongest associations with bone properties, with the magnitude of associations 
decreasing thereafter [9-12]. Despite adding valuable evidence, interval cohorts are by 
definition examined as part of periodic follow-up assessments whose timing is defined a 
priori by researchers and whose frequency is necessarily lower than in the context of 
health care provision. Height and weight records obtained as part of routine health care 
are a valuable source of information collected at short time intervals that may be used to 
complement interval cohort data in order to refine the identification of meaningful periods 
of growth [13]. Specifically, we believe that examining growth velocity during time periods 
defined empirically on the basis of a large amount of observed data may improve 
precision in the identification of sensitive periods for the effect of height and weight 
changes on bone mass measured using dual-energy X-ray absorptiometry (DXA). 
 
Therefore, our objective was to compare, across different age periods defined on the 
basis of empirical growth data, the associations of height and weight velocities with DXA-
derived bone mass at 7 years of age in a large birth cohort.  
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Materials and Methods 
 
The Generation XXI cohort  
All pregnant women delivering live-born infants between April 2005 and August 2006 at 
each of the five level III maternity units covering the metropolitan area of Porto were 
invited to participate. Overall, 8647 infants with gestational age above 23 weeks and their 
mothers were enrolled (91.4% participation). These children were followed up at ages 4, 
7 and 10 years. The 13 years evaluation is ongoing as of May 2019. At ages four and 
seven, 7459 (86.3%) and 6889 (79.7%) children, respectively, had follow-up data. The 
present study is based on a subsample of 1853 of those children, whose selection criteria 
and comparison with the remaining cohort participants are described below. The Ethics 
Committee of Hospital de São João approved the study protocol. The study complies 
with the Ethical Principles expressed in the Helsinki Declaration and with the national 
legislation and is registered with the Portuguese Authority for Data Protection. In all 
evaluations, participants were informed about the potential discomfort caused by 
participation and only children providing oral assent and whose legal guardians provided 
written informed consent were considered participants. Detailed descriptions of the 
Generation XXI cohort have been published elsewhere [14, 15]. 
 
Growth trajectories  
Birth weight and length were obtained from clinical records held at the maternity units 
and subsequent weight and length/height measurements were abstracted from the 
National Health Service official children’s health books. At the 4 years follow-up 
evaluation, legal guardians were asked to provide, whenever possible, all measures of 
the child’s weight and length/height from books, comprising data from birth up to 70 
months of age, which allowed to model growth up to the age of 6 years. Average weight 
and length/height growth trajectories were then estimated with linear spline multilevel 
models. Full details on the modelling of growth trajectories have been described 
elsewhere [13]. Briefly, the best-fitting splines for length/height and weight, in both girls 
and boys, had knots at 3 months, 12 months and 3 years, with an extra knot at 10 days 
for weight. These models were the ones that best fitted observed data and provided 
interpretable summaries of the pattern of growth throughout childhood. Thus, 
length/height growth was modelled as four linear splines while weight growth was 
modelled as five linear splines, characterized by different linear growth rates that are 
initially higher and then decrease with age (Table 1, from reference [13]). From these 
models, we obtained individual estimates of weight velocity for five age periods (“early 
neonatal”: 0 to 10 days, “early infancy”: 10 days to 3 months, “late infancy”: 3 to 12 
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months, “early childhood”: 1 to 3 years, and “later childhood”: 3 to 6 years) and 
length/height velocity for four age periods (“early infancy”: 0 to 3 months, “late infancy”: 
3 to 12 months, “early childhood”: 1 to 3 years, and “later childhood”: 3 to 6 years).  
At 7 years of age, height and weight were updated by trained examiners according to 
standard procedures. Height was measured with a wall stadiometer to the nearest 0.1 
cm and weight was measured with a digital scale to the nearest 0.1 kg, while the child 
was barefoot and in light clothing. 
 
Table 1. Estimated birth weight, length and growth velocities from birth to 6 years predicted by 
linear spline multilevel models for 5282 children in Generation XXI (Howe LD, et al. (2016) Stat 
Methods Med Res 25: 1854-1874 [13]) 
 Girls Boys Girls Boys 
 Weight (kg) Length (cm) 
Birth 3.11 (0.40) 3.22 (0.43) 48.33 (1.87) 48.97 (1.94) 
 Weight velocities (kg/month) Length/height velocities (cm/month) 
Early neonatal 0.42 (0.64) 0.52 (0.70) 
3.79 (0.22) 4.12 (0.22) 
Early infancy 0.87 (0.16) 0.99 (0.17) 
Late infancy 0.40 (0.08) 0.41 (0.09) 1.70 (0.17) 1.70 (0.18) 
Early childhood 0.22 (0.05) 0.22 (0.05) 0.90 (0.07) 0.88 (0.07) 
Later childhood 0.19 (0.05) 0.18 (0.05) 0.53 (0.02) 0.51 (0.02) 
Values represent mean (standard deviation) of birth weight and length, weight velocities and length/height 
velocities in girls (n=2611) and boys (n=2671)  
Weight velocities for early neonatal (0–10 days), early infancy (10 days–3 months), late infancy (3–12 
months), early childhood (1–3 years) and late childhood (3–6 years) periods. Length/height velocities for 
early infancy (0–3 months), late infancy (3–12 months), early childhood (1–3 years) and late childhood (3–6 
years) periods. 
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DXA-derived bone variables 
At the 7 years follow-up, a subsample of children consecutively attending the evaluation 
(43.8% of the participants) were invited to undergo a whole body DXA. Selection was 
chronologic and solely related with equipment availability. Scans were performed using 
a Hologic Discovery QDR® 4500W device (Hologic Inc., Bedford, Massachusetts, USA), 
software version 13.3.0.1 according to standard manufacturer protocols while children 
were barefoot in light indoor clothing and without metal accessories. We obtained total 
body less head bone mineral content (g) (BMC) [16]. Two trained operators checked all 
scans independently and excluded those showing unacceptable artefacts. 
 
Potential confounders 
Maternal and child factors which have been previously associated with early growth and 
skeletal development through genetic or environmental effects (maternal pre-pregnancy 
body mass index (BMI), smoking status during pregnancy, age and educational level at 
childbirth, and child gestational age) were reported in the baseline questionnaire 
completed within 72 hours after delivery, and complemented with information retrieved 
from birth records. 
 
Statistical analysis 
Analyses presented in this paper were restricted to the 1853 (48.0% girls) participants 
included in the growth analysis, who had a valid DXA scan and with complete data on all 
potential confounders. Specifically, of the 7459 participants who attended the 4-year-old 
follow-up evaluation, 2077 did not provide growth data from health records and 100 were 
excluded because they were twins, whose birth weight and subsequent growth rates 
differ considerably from those of singletons. We also excluded 732 participants who did 
not attend the 7 years evaluation, 2259 who were not invited for bone densitometry on 
the basis of equipment availability, 377 who refused to perform the DXA scan, 11 whose 
images had unacceptable technical quality and 50 who did not have complete data for 
all potential confounders. 
Birth weight and birth length, as well as the five weight velocities and the four 
length/height velocities predicted by the linear spline model, were standardized (z-
scored) by sex. Age- and sex-specific z-scores for BMC and height based on the means 
and standard deviations (SD) derived from the study sample (n=1853) were computed. 
Race was not collected or taken into account in the calculation of any of the z-scores 
since the Portuguese Constitution explicitly forbids the collection of statistical data on 
race, ethnicity or skin color. In terms of potential impact, immigration is comparatively 
infrequent in the region of Porto compared to other Western European settings or the 
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USA: only 4.5% of Generation XXI mothers are first-generation migrants, of whom 3.5% 
from non-European countries [17]. 
 
DXA-derived measures of bone mass are strongly influenced by body size, which in turn 
is a result of overall growth trajectories up to the point of measurement. To address this, 
we selected the following three outcomes, all measured at age seven: DXA-derived 
BMC, height, and height-adjusted BMC (through standard multivariate regression 
adjustment), the latter being an approach to estimate of skeletal growth relative to height 
up to that point, more closely related to cumulative bone growth than to the physical 
properties of bone tissue. 
Linear regression models were used to quantify associations between each of the 
exposures (birth weight, birth length, early neonatal weight velocity, early infancy 
weight/length velocity, late infancy weight/length velocity, early childhood weight/height 
velocity and later childhood weight/height velocity) and each of the outcomes measured 
at age 7: BMC, height, and height-adjusted BMC. Regression coefficients represent the 
change in each standardized outcome per one standard deviation increase in birth 
weight/length or in weight or length/height velocity in each age period. 
We examined the effects of growth on bone outcomes with 4 models. Model 1 represents 
the crude analysis. Model 2 was adjusted for potential confounders (maternal age, 
educational level, pre-pregnancy body mass index, smoking during pregnancy and child 
gestational age). Model 3 was similar to model 2 with further adjustment for earlier 
growth, i.e. each weight or height velocity was adjusted for birth weight or height, 
respectively, plus all of the preceding velocities. For weight growth, a model 4 with 
additional adjustment for birth length, preceding length/height velocities, and 
length/height velocity over the same age period was fitted to obtain estimates for body 
weight after accounting for statural growth. Due to the well-documented sex differences 
in growth and bone accrual since early stages [18, 19], all analyses were stratified by 
sex. This was an a priori decision, even though when we formally tested for interaction 
by including cross-product terms with each weight and length/height velocity and sex in 
the regression models, we found no evidence of statistical interaction. 
Sensitivity analyses were conducted to test the robustness of our findings. Owing to 
possible differences in growth profile, analyses excluding preterm children and children 
born to women who gained excessive weight during pregnancy, one group at a time, 
were carried out. 
Statistical analyses were carried out with the use of Stata software, version 11.2 for 
Windows (Stata Corp. LP, College Station, Texas, USA).  
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Results 
 
Characteristics of the 1853 children and their mothers included in our study are 
summarized in Table 2. Compared with the remaining cohort participants, children 
included in our study were similar with regard to maternal prepregnancy BMI, gestational 
age, birth weight and birth length. Those included were more likely to have older mothers 
(mean 30.2 years vs 28.6 years) with higher education (32% vs 22%) and employed 
(79% vs 69%) and less likely to report a monthly household income lower than 1000€ 
(31% vs 38%). As shown in Table 2, using as reference all Generation XXI participants 
eligible for growth analysis, mean z-scores for length and weight velocities in the sample 
included are very close to zero, suggesting that the sample was on average very similar 
to the remaining participants at each age period. There were no differences between 
girls and boys in maternal characteristics, gestational age at birth and weight at 7 years. 
However, when compared to boys, girls were slightly lighter and shorter at birth, shorter 
at 7 years of age and more likely to have lower DXA-derived bone mass. 
 
Table 2. Maternal and child characteristics: Generation XXI, Porto, Portugal 
 Girls (n=889) Boys (n=964) p a 
Maternal characteristics    
Age at childbirth (years), mean (SD) 30.4 (5.1) 30.1 (5.0) 0.135 
Educational level (years), n (%)    
≤ 9 364 (40.9) 371 (38.5) 
0.425 
10-12 239 (26.9) 283 (29.4) 
>12 286 (32.2) 310 (32.2) 
Prepregnancy BMI (kg/m2), mean (SD) 24.6 (4.7) 24.3 (4.1) 0.186 
Ever smoked during pregnancy, n (%) 186 (20.9) 188 (19.5) 0.447 
Child characteristics    
Gestational age at birth (weeks), mean (SD) 38.8 (1.6) 38.7 (1.6) 0.232 
Preterm birth, n (%) 51 (5.7) 67 (7.0) 0.285 
Birth weight, mean (SD)    
Crude (g) 3146.6 (471.6) 3242.4 (480.9) <0.001 
Z-score, WHO reference b -0.24 (1.09) -0.27 (1.07) 0.560 
Birth length, mean (SD)    
Crude (cm) 48.4 (2.0) 49.1 (2.3) <0.001 
Z-score, WHO reference b -0.38 (1.09) -0.40 (1.22) 0.647 
Weight velocity (Z-score c), mean (SD)    
Early neonatal 0.04 (0.98) 0.00 (1.05) 0.437 
Early infancy -0.01 (0.98) 0.01 (0.98) 0.745 
Late infancy 0.03 (0.96) -0.02 (0.97) 0.228 
Early childhood  -0.01 (1.03) -0.06 (0.92) 0.327 
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Later childhood  -0.03 (1.03) -0.07 (0.92) 0.385 
Length/height velocity (Z-score c), mean (SD)    
Early infancy 0.03 (0.98) 0.07 (1.02) 0.441 
Late infancy -0.04 (1.02) -0.00 (0.99) 0.411 
Early childhood  -0.06 (1.03) -0.01 (0.97) 0.219 
Later childhood  0.03 (1.07) 0.02 (1.07) 0.831 
Weight at 7 years, mean (SD)    
Crude (kg) 27.3 (5.9) 27.0 (5.1) 0.272 
Z-score, WHO reference b 0.76 (1.13) 0.70 (1.16) 0.220 
Height at 7 years, mean (SD)    
Crude (cm) 124.1 (5.5) 125.2 (5.6) <0.001 
Z-score, WHO reference b 0.18 (0.91) 0.20 (0.98) 0.634 
DXA-derived BMC at 7 years (g), mean (SD) 591.6 (85.4) 600.8 (86.4) 0.021 
a Maternal and child characteristics were compared between girls and boys with two-sample Student’s t or 
chi-squared tests. 
b Age and sex-specific Z-scores computed using WHO reference data [18]. 
c Sex-specific Z-scores of length/height and weight velocities predicted by the linear spline multilevel models 
computed based on the means and standard deviations derived from 5282 children from Generation XXI 
[13]. 
Age intervals in weight growth: early neonatal (0–10 days), early infancy (10 days–3 months), late infancy 
(3–12 months), early childhood (1–3 years) and late childhood (3–6 years). Age intervals in length/height 
growth: early infancy (0–3 months), late infancy (3–12 months), early childhood (1–3 years) and late 
childhood (3–6 years).  
SD, standard deviation; BMI, body mass index; BMC, bone mineral content; DXA, dual-energy X-ray 
absorptiometry. 
 
Figures 1 and 2 show estimates of the associations between weight and length/height 
velocities and BMC, height and BMC adjusted for height at 7 years of age, after 
adjustment for confounders only (model 2) and after additional adjustment for previous 
growth (model 3). Numerical values of all regression coefficients for models 1 through 4 
are presented in Supplemental Tables 1 and 2. 
 
Birth anthropometry 
Birth weight was positively associated with bone mass and height in crude and adjusted 
analysis (Figure 1, models 2 and 4 and Supplemental Table 1, model 1). Birth length was 
positively associated with BMC and height (Figure 2, model 2 and Supplemental Table 
2, model 1). Adjustment for height at 7 years largely attenuated associations between 
birth anthropometry and BMC (Figures 1 and 2, panels e) and f) and Supplemental 
Tables 1 and 2). 
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Weight velocity 
Crude and confounder-adjusted estimates revealed a lack of association between early 
neonatal weight velocity and childhood bone mass (Figure 1, model 2 and Supplemental 
Table 1, model 1). Additional adjustment for birth weight and length originated negative 
associations between early neonatal weight velocity and 7-years-old BMC, height and 
BMC adjusted for height. In contrast, weight velocity in the subsequent four age periods 
predicted childhood bone mass and height significantly and positively. We found the 
strongest associations for early childhood weight velocity: after confounder adjustment, 
1 SD increase in weight velocity during the second and third years of life was associated 
with average increases in BMC z-score of 0.57 (95% CI: 0.52, 0.62) in girls and 0.57 
(95% CI: 0.51, 0.63) in boys and in height z-score of 0.54 (95% CI: 0.49, 0.60) and 0.57 
(95% CI: 0.51, 0.63) (Figure 1, model 2). Adjustment for height measured concurrently 
to BMC clearly attenuated all associations from early infancy up to later childhood 
towards the null, even though associations of early childhood growth with BMC persisted: 
1 SD increase in early childhood weight velocity was associated with average increases 
in height-adjusted BMC z-score of 0.27 (95% CI: 0.22, 0.32) in girls and 0.24 (95% CI: 
0.19, 0.29) in boys. All estimates were also attenuated upon adjustment for birth weight 
and preceding weight velocities, but the same overall pattern remained with positive 
associations for all periods after 10 days of age and greater magnitudes for weight 
velocity during early childhood (Figure 1, model 3). Additional adjustment for preceding 
and concurrent velocities of growth in length/height was responsible for further 
attenuation of most estimates, with the exception of those between later childhood weight 
velocity and bone and height measures (Supplemental Table 1, model 4). Nevertheless, 
associations remained strongest for weight velocity during early childhood. 
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Figure 1. Adjusted linear regression coefficients (95% CI) for the associations between weight velocities and 
bone mass and height at 7 years of age 
a) BMC - Girls 
 
b) BMC – Boys
 
c) Height - Girls 
 
d) Height - Boys 
 
e) BMC adjusted for height - Girls 
 
f) BMC adjusted for height - Boys 
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Legend: Regression coefficients (95% CI) that represent the change in standardized BMC (a and b), height 
(c and b) and BMC adjusted for height (e and f) per 1 standard deviation increase in birth weight or in weight 
velocity in each age period, in girls (left) and boys (right).  
Diamond: estimates adjusted for maternal age, educational level, pre-pregnancy body mass index, smoking 
during pregnancy and child gestational age (model 2). Square: estimates additionally adjusted for birth 
weight and all of the preceding weight velocities (model 3). 
Age intervals: early neonatal (0–10 days), early infancy (10 days–3 months), late infancy (3–12 months), 
early childhood (1–3 years) and late childhood (3–6 years).  
BMC, bone mineral content. 
 
Height velocity 
Length/height velocities in early infancy, late infancy and early childhood were positively 
associated with BMC and height at seven, while later childhood height velocity was only 
associated with height, with the largest effect estimates being observed during early 
childhood. In girls and boys, respectively, after confounder adjustment, 1 SD increase in 
early childhood height velocity was associated with average increases in BMC z-score 
of 0.45 (95% CI: 0.40, 0.51) and 0.51 (95% CI: 0.45, 0.56) and in height z-score of 0.53 
(95% CI: 0.48, 0.59) and 0.64 (95% CI: 0.59, 0.69) (Figure 2, model 2). As observed for 
weight, adjustment for concurrent height resulted in an attenuation of the estimates but 
stronger associations for height velocity in early childhood remained: 1 SD increase in 
height velocity during the second and third years of life was associated with average 
increases in adjusted for height BMC z-score of 0.12 (95% CI: 0.07, 0.17) in girls and 
0.11 (95% CI: 0.06, 0.16) in boys.  Also, birth length and preceding length/height 
velocities adjustment resulted in an attenuation of the estimates (Figure 2, model 3). We 
found little evidence of association between height velocity in later childhood and bone 
mass (Figure 2, models 2 and 3 and Supplemental Table 2, model 1). 
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Figure 2. Adjusted linear regression coefficients (95% CI) for the associations between length/height 
velocities and bone mass and height at 7 years of age
a) BMC - Girls 
 
b) BMC – Boys 
 
c) Height - Girls 
 
d) Height - Boys 
 
e) BMC adjusted for height - Girls 
 
f) BMC adjusted for height - Boys 
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Legend: Regression coefficients (95% CI) that represent the change in standardized BMC (a and b), height 
(c and b) and BMC adjusted for height (e and f) per 1 standard deviation increase in birth length or in 
length/height velocity in each age period, in girls (left) and boys (right). 
Diamond: estimates adjusted for maternal age, educational level, pre-pregnancy body mass index, smoking 
during pregnancy and child gestational age (model 2). Square: estimates additionally adjusted for birth length 
and all of the preceding length/height velocities (model 3). 
Age intervals: early infancy (0–3 months), late infancy (3–12 months), early childhood (1–3 years) and late 
childhood (3–6 years).  
BMC, bone mineral content. 
 
 
 
Weight vs. height velocities 
We found that, in earlier periods, specifically during infancy, length/height velocity was 
more strongly associated with bone mass at 7 years than weight velocity, while, in early 
and later childhood, weight velocity stronger correlate with bone mass (Supplemental 
Table 3). Our results for height were remarkably consistent with those obtained for BMC, 
which suggest that the relations between growth and bone mass in children are to a large 
extent attributable to body size. The direction of the associations was also similar for 
males and females, with only minor differences in the magnitude of the estimates that 
were not consistently stronger for one gender. 
Results from sensitivity analyses after excluding children born preterm, or children born 
to women who gained excessive weight during pregnancy, showed a similar pattern of 
associations to those observed for the whole sample.  
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Discussion 
 
In this population-based birth cohort, height and weight velocity in the first 6 years of life 
were associated with bone mass at age seven. In comparison to the remaining periods, 
growth between 1 and 3 years presented the strongest associations with childhood DXA-
derived bone mass. Despite a strong statistical dependence on body size, this finding 
held for both height and weight, and in both genders. Our study suggests that the toddler 
years might be a particularly sensitive period for the effect of growth on bone 
development. If a causal interpretation is to be extracted, our results point to the 
importance of identifying disturbances to normal growth in early childhood that may 
impact bone health before peak bone mass. From a practical point of view, this study 
also highlights the informative potential of complementing data from interval cohorts with 
children’s routine health information, with the objective of improving the detection of 
sensitive periods in life course research. 
 
The generalized assumption that prepubertal bone mass tracks up until peak bone mass 
and that both determine bone mass into older ages deserves discussion. Studies in 
several contexts have generally suggested that both body size in the first year of life, as 
well as growth in height in the first 2 years, are predictive of adolescent and adult bone 
mass [5, 20-24]. However, evidence of bone mass tracking in longitudinal studies is 
relatively short-term and its implications are contingent on the assumption of the peak 
bone mass model [25, 26]. While it is undeniable that childhood is an important period 
for the attainment of bone strength because of the great amount of bone mineral acquired 
during this stage, the relevance of early life bone mass acquisition for adult bone strength 
has been questioned [27, 28]. If bone mass is governed by a homeostatic system acting 
in the short-term with any perturbation tending to be corrected over time (as per the 
mechanostat theory), bone mass may depend primarily on recent conditions rather than 
on the distant past [29]. This work was restricted to estimating an effect of early life 
growth on later bone mass in prepubertal children and the extent to which such an 
influence could persist up to peak bone mass and beyond to decrease the risk of fragility 
fracture is unclear. 
 
DXA-derived BMC measurements are strongly dependent on growth and partially reflect 
bone size rather than the intrinsic properties of the mineralized tissue. In order to clarify 
the size dependency of bone mass we used as outcomes not only BMC but also height 
at age 7, as a measure of linear growth, and BMC adjusted to height, as a measure of 
bone mass relative to body size. The latter outcome aimed to provide an estimate of 
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skeletal growth relative to height up to that point, more closely related to cumulative bone 
growth than to the physical properties of bone tissue. The fact that associations of growth 
velocities with BMC were strongly attenuated once height was taken into account was 
expected given the close constitutional relation between bone mass and height. 
Nevertheless, we acknowledge that the inclusion of current height measurements in the 
models may represent an adjustment for an intermediate step and could have introduced 
some degree of collider bias [30]. 
 
A number of practical limitations should be noted. First, our study population is composed 
of children born in Portugal, whose mothers are comparatively homogeneous in terms of 
geographical origin. In addition, of the overall cohort, 21.4% of children had information 
on growth and bone variables to be included in the analyses of this study. This proportion 
is the result of both design choices and attrition or missing data. Children who did not 
participate were more likely to have lower socioeconomic position than those included in 
the study, but overall the magnitude of the differences was minor. Also, participants and 
nonparticipants were similar in terms of the main exposures under study: birth weight, 
birth length, and growth velocities at each age period. Therefore, we do not expect 
nonparticipation in Generation XXI follow-up assessments to be strongly related to the 
study’s research question [31]. Another limitation is the fact that growth measures 
obtained from routine child health records are typically performed by different health 
professionals with different equipment. Although we were unable to test the validity of 
routinely-collected length/height measurements in Portugal, this source of information 
has previously shown little systematic error [32]. Random error is more likely, which 
would probably reduce the statistical power, although we do not expect this to have had 
a major impact on our results [33]. Moreover, although we collected detailed information 
on potential confounding variables, residual confounding due to unmeasured 
sociodemographic and lifestyle factors could still influence the results. 
 
Despite those potential limitations, our results were consistent with four previous studies 
that have used regression with measures of conditional growth, residual growth model 
or two-stage and joint multilevel linear spline models to analyze associations between 
growth and bone mass and density (aBMD) in children [9, 10, 12]. In a sample of 628 
children from the Southampton Women’s Survey (SWS), positive associations between 
growth in height in 1-year time intervals and bone measures at 4 years of age were 
reported, which were stronger for growth up to 1 year (for BMC) and between 1 and 2 
years (for aBMD), than for subsequent growth intervals [9]. Also in SWS, the first and 
second years of life were identified as the most important age periods for the effect of 
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conditional growth in height on bone mass at 6 years of age [10]. More recently in SWS 
participants, stronger associations with 6-year BMC was shown for growth in height 
between 1 and 3 years (through residual growth models), between birth and 6 months 
(through two-stage multilevel linear spline models) or between 1 and 3 years (through 
joint multilevel linear spline models) [11]. Only one study assessed the effect of both 
height and weight velocities on childhood bone mass and density and suggested different 
sensitive periods for their effects on aBMD at 6 years of age. In this study from 
Generation R, weight velocity in the first year of life had the strongest positive association 
with aBMD, whereas height velocity during the second and third years of life contributed 
most strongly to aBMD. For BMC, the strongest positive associations were found during 
the first year of life, for both height and weight velocities [12]. A general observation from 
previous studies that we also replicate here is a lack of gender heterogeneity in sensitive 
periods in this life stage. 
 
Our results are also coherent with studies in populations of adolescents and adults that 
point to the first two years of life, in comparison to subsequent periods, as the most 
important for the effect of height velocity on BMC/aBMD from 15 to 20 years, on 
BMC/aBMD in the third decade of life and on BMC at 60 years of age [5, 23, 24]. Our 
results contradict, however, previous research on the effect of weight velocity on later 
adolescent and early old age bone mass, where growth closer to the age of bone mass 
assessment was more strongly associated to DXA-derived bone measures [3, 5]. In 
another study, weight velocity during childhood was irrelevant as a determinant of bone 
mass and density at 60 years of age, after entering adult height into the models [24]. 
Direct comparison with previous research is hampered by differences in the periods of 
growth identified, which were defined almost always as relative changes in height and 
weight in interval cohorts, whose timing of measurement is planned in a single 
chronological age that does not necessarily correspond to the biological age and its 
intraindividual variation [34]. 
 
Positive associations between faster growth in weight or height and childhood bone mass 
are expected, and likely to be explained by the accretion of both adipose and muscle 
tissue, which promote osteogenesis both through increased mechanical loading and via 
the effects of secretory products such as growth hormone (GH), leptin, and cortisol [35]. 
Therefore, variations in the magnitude of effect estimates between different age periods 
should be largely attributable to changes in these underlying mechanisms. Our results 
suggest that the strong association with bone mass of growth in early childhood, in 
comparison to other early life periods, is related to biological changes specific to the 
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second and third years of life. A documented underlying change in this life stage includes 
a change from predominantly GH-independent to GH-dependent growth [36]. In addition 
to this long-term process, however, we believe that the most likely explanation for the 
singularity of that period in relation to the remaining stages is the relatively fast 
acquisition of the vertical posture and the attainment of independent walking at around 
12 to 18 months of age, with corresponding changes in gravitational and muscular stimuli 
to the skeleton [37, 38]. The onset of locomotion seems to be a key macrostructural 
factor in defining the amount of physical strain imposed on spinopelvic and lower limb 
bone tissue, as already suggested in our previous work with posture that showed a clear 
association between sagittal morphotype and bone mass [39]. Changes in this balance 
of forces are so great from 1 to 3 years that growth in later periods may become 
comparatively less relevant. From the statistical point of view, this is compatible with later 
growth being less predictive of bone mass and observable as a decrease in the 
magnitude of the associations towards later childhood. 
 
As a starting point, we estimated the effects of birth length and weight as markers of 
prenatal growth. As in previous studies, we found that body size at birth was positively 
associated with later bone mass, but less strongly than postnatal growth [9, 10, 12, 40]. 
After birth size adjustment, we found an inverse association between early neonatal 
weight velocity and childhood bone mass. This is in agreement with our observation that 
early neonatal weight velocity was inversely related to weight velocities in subsequent 
age periods (Supplemental Figure 1) which may be due to compensatory growth. Due to 
national policy, early neonatal measurements are particularly frequent in Portugal, which 
provides high data density in our sample but scarce opportunities for comparison with 
other settings. 
 
An additional relevant finding was on the balance between height and weight velocities 
in terms of their associations with bone mineral content across periods. Length/height 
velocity was more strongly associated with bone mass than weight velocity in the earlier 
periods, whereas the relative contribution of weight velocity grew stronger later on in 
childhood. Indeed, height velocity in later childhood showed weak or negligible (and in 
one case even inverse) associations with bone mass. This pattern of associations 
probably reflects linear growth as the main driver of bone accrual in the earlier stages, 
later surpassed by an increasing importance of changes to bone diameter imposed by 
weight gain through gravitational and muscle forces [12]. 
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In addition to generally corroborating the body of evidence of the first three years of life 
as a sensitive period for childhood bone mass, the present study adds important 
evidence. Specifically, it suggests the strongest role for growth during the toddler years, 
regarding both height and weight velocities and possibly a major contribution of the 
upright posture. We believe our analytical approach makes the present results 
particularly robust since we studied velocities of growth defined from an empirical 
approach. By taking advantage of a large amount of data, we were able to identify growth 
periods from statistical knot points that indicate changes in average observed velocities 
that are likely to have relevant biological meaning. The advantages of linear spline 
multilevel models to summarize childhood growth have been described in detail [13, 41]. 
Briefly, this approach models growth data efficiently as it allows using all available data, 
taking into account different timing and number of measurements between individuals, 
and not restricting the analysis to those with complete data at all times. In this way, this 
approach identifies age intervals that differ in velocity of growth, rather than using 
arbitrary intervals limited by data availability, and deals efficiently with collinearity 
between repeated measures and bias due to missing data [13, 34]. In Generation XXI, 
linear spline multilevel models have shown good fit to the observed data. Also, the knot 
points identified were similar to those in other settings where the same analytical 
approach was used, which supports the validity of this model to identify periods of growth 
that are biologically, as well as statistically, relevant [13]. We opted to use DXA, the 
preferred method to assess bone status in children due to its good accuracy, short 
analysis time, safety, low cost, and wide availability [42]. Importantly, BMC measured by 
DXA has been shown to be an accurate predictor of fracture risk, which is ultimately a 
key clinical validation [43]. We also used measurements of total body less head which is 
the recommended option for obtaining DXA-derived bone measures in pediatric 
research, due to precision and reproducibility [16]. In addition, our effect estimates were 
robust to several sensitivity analyses, as well as to adjustments to maternal and child 
factors, representing potential confounding by genetic and environmental characteristics, 
and to adjustments to previous growth. 
 
In this population-based prospective cohort, growth in the first six years of life predicted 
bone mass at 7 years of age, partly through concurrent body size. Possibly due to the 
adoption of the upright position and the development of walking abilities, our findings 
identify the second and third years of life as a potential sensitive period of growth for 
skeletal development.  
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Supplemental Table 1. Linear regression coefficients (95% CI) for the associations between birth weight and weight velocities and bone mineral content and height at 7 
years of age 
 Girls Boys 
 BMC Height BMC adjusted for height BMC Height BMC adjusted for height 
 β 95% CI β 95% CI β 95% CI β 95% CI β 95% CI β 95% CI 
Model 1                   
Birth weight 0.29 0.22 0.36 0.27 0.20 0.35 0.12 0.06 0.17 0.20 0.13 0.27 0.25 0.18 0.32 0.05 0.00 0.09 
Early neonatal weight velocity   0.04 -0.03 0.11 0.02 -0.05 0.09 0.05 0.00 0.09 -0.02 -0.08 0.04 0.00 -0.06 0.06 -0.01 -0.05 0.03 
Early infancy weight velocity   0.29 0.22 0.35 0.29 0.22 0.35 0.11 0.06 0.15 0.28 0.22 0.34 0.28 0.22 0.35 0.09 0.04 0.13 
Late infancy weight velocity   0.40 0.34 0.47 0.41 0.35 0.47 0.11 0.06 0.16 0.38 0.32 0.44 0.39 0.33 0.45 0.11 0.06 0.15 
Early childhood weight velocity   0.58 0.53 0.63 0.53 0.47 0.58 0.30 0.25 0.34 0.58 0.52 0.64 0.57 0.51 0.63 0.25 0.20 0.30 
Later childhood weight velocity   0.54 0.49 0.60 0.48 0.42 0.53 0.28 0.24 0.33 0.56 0.50 0.62 0.50 0.44 0.56 0.26 0.21 0.31 
Model 2                   
Birth weight 0.36 0.28 0.44 0.41 0.32 0.49 0.09 0.02 0.15 0.30 0.21 0.39 0.35 0.26 0.44 0.07 0.01 0.14 
Early neonatal weight velocity   0.01 -0.06 0.09 0.02 -0.05 0.10 0.00 -0.04 0.05 -0.05 -0.11 0.02 -0.03 -0.10 0.04 -0.01 -0.06 0.03 
Early infancy weight velocity   0.30 0.24 0.37 0.29 0.23 0.36 0.12 0.08 0.17 0.28 0.22 0.35 0.30 0.24 0.36 0.08 0.04 0.13 
Late infancy weight velocity   0.40 0.34 0.46 0.42 0.35 0.48 0.11 0.06 0.16 0.38 0.31 0.44 0.39 0.33 0.45 0.10 0.05 0.15 
Early childhood weight velocity   0.57 0.52 0.62 0.54 0.49 0.60 0.27 0.22 0.32 0.57 0.51 0.63 0.57 0.51 0.63 0.24 0.19 0.29 
Later childhood weight velocity   0.53 0.48 0.59 0.49 0.43 0.55 0.26 0.22 0.31 0.55 0.49 0.61 0.51 0.45 0.57 0.25 0.20 0.30 
Model 3                   
Early neonatal weight velocity   -0.41 -0.50 -0.31 -0.44 -0.54 -0.34 -0.10 -0.17 -0.03 -0.25 -0.33 -0.17 -0.26 -0.33 -0.18 -0.07 -0.12 -0.01 
Early infancy weight velocity   0.25 0.17 0.32 0.22 0.15 0.29 0.13 0.08 0.19 0.26 0.19 0.32 0.27 0.21 0.34 0.08 0.03 0.13 
Late infancy weight velocity   0.33 0.25 0.40 0.32 0.25 0.39 0.11 0.05 0.16 0.34 0.27 0.40 0.36 0.29 0.42 0.10 0.05 0.15 
Early childhood weight velocity   0.46 0.41 0.51 0.42 0.36 0.48 0.26 0.21 0.30 0.47 0.41 0.53 0.45 0.39 0.51 0.23 0.18 0.29 
Later childhood weight velocity   0.19 0.11 0.27 0.14 0.06 0.22 0.13 0.07 0.20 0.22 0.14 0.30 0.12 0.04 0.21 0.16 0.09 0.22 
Model 4                   
Birth weight 0.27 0.15 0.39 0.14 0.02 0.26 0.16 0.07 0.24 0.17 0.05 0.29 0.08 -0.03 0.20 0.12 0.04 0.20 
Early neonatal weight velocity   -0.40 -0.50 -0.30 -0.42 -0.52 -0.32 -0.10 -0.18 -0.03 -0.24 -0.32 -0.17 -0.25 -0.32 -0.17 -0.07 -0.12 -0.01 
Early infancy weight velocity   0.14 0.06 0.22 0.01 -0.06 0.09 0.17 0.11 0.22 0.15 0.07 0.22 0.07 0.00 0.14 0.10 0.04 0.15 
Late infancy weight velocity   0.17 0.09 0.25 0.12 0.05 0.19 0.09 0.03 0.15 0.17 0.09 0.25 0.11 0.04 0.17 0.09 0.03 0.15 
Early childhood weight velocity   0.36 0.31 0.42 0.24 0.18 0.29 0.24 0.19 0.29 0.33 0.26 0.39 0.16 0.10 0.21 0.24 0.18 0.30 
Later childhood weight velocity   0.19 0.11 0.27 0.14 0.07 0.22 0.14 0.07 0.21 0.27 0.18 0.35 0.18 0.11 0.24 0.18 0.11 0.25 
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Tables show standardized regression coefficients (95% CI) that represent the change in standardized BMC, height and BMC adjusted for height per 1 standard deviation increase in birth weight 
or in weight velocity in each age period, in girls and boys.  
Model 1: crude analysis. Model 2: adjustment for maternal age, educational level, pre-pregnancy body mass index, smoking during pregnancy and child gestational age. Model 3: Model 2 + 
adjustment for birth weight and all of the preceding weight velocities. Model 4: Model 3 + adjustment for birth length, all of the preceding and concurrent length/height velocities.  
Age intervals: early neonatal (0–10 days), early infancy (10 days–3 months), late infancy (3–12 months), early childhood (1–3 years) and late childhood (3–6 years).  
BMC, bone mineral content. 
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Supplemental Table 2. Linear regression coefficients (95% CI) for the associations between birth length and length/height velocities and bone mineral content and height at 
7 years of age 
 Girls Boys 
 BMC Height BMC adjusted for height BMC Height BMC adjusted for height 
 β 95% CI β 95% CI   β 95% CI β 95% CI   
Model 1                   
Birth length 0.27 0.19 0.35 0.35 0.27 0.43 0.06 0.00 0.12 0.19 0.12 0.26 0.30 0.24 0.37 0.00 -0.05 0.04 
Early infancy height velocity  0.31 0.25 0.38 0.45 0.39 0.52 0.00 -0.05 0.05 0.32 0.26 0.38 0.45 0.40 0.51 0.01 -0.03 0.06 
Late infancy height velocity 0.32 0.26 0.38 0.38 0.33 0.44 0.01 -0.04 0.06 0.35 0.29 0.41 0.42 0.37 0.48 0.05 0.00 0.09 
Early childhood height velocity 0.45 0.40 0.51 0.53 0.48 0.59 0.12 0.07 0.17 0.51 0.45 0.57 0.64 0.59 0.69 0.11 0.05 0.16 
Later childhood height velocity 0.05 -0.01 0.11 0.09 0.03 0.15 0.00 -0.04 0.05 0.04 -0.02 0.10 0.05 0.00 0.11 0.01 -0.03 0.05 
Model 2                   
Birth length 0.36 0.26 0.45 0.53 0.43 0.62 0.01 -0.06 0.08 0.30 0.21 0.39 0.00 0.00 0.00 0.00 -0.07 0.06 
Early infancy height velocity  0.33 0.27 0.40 0.46 0.40 0.52 0.02 -0.02 0.07 0.32 0.26 0.38 0.46 0.40 0.51 0.01 -0.03 0.06 
Late infancy height velocity 0.39 0.33 0.45 0.45 0.39 0.51 0.06 0.00 0.11 0.42 0.35 0.48 0.52 0.46 0.58 0.06 0.00 0.11 
Early childhood height velocity 0.45 0.40 0.51 0.53 0.48 0.59 0.12 0.07 0.17 0.51 0.45 0.56 0.64 0.59 0.69 0.11 0.06 0.16 
Later childhood height velocity 0.06 0.00 0.13 0.09 0.03 0.16 0.02 -0.02 0.07 0.05 -0.01 0.11 0.07 0.01 0.13 0.00 -0.04 0.05 
Model 3                   
Early infancy height velocity 0.32 0.26 0.38 0.44 0.38 0.50 0.03 -0.02 0.08 0.30 0.25 0.36 0.43 0.38 0.48 0.01 -0.03 0.06 
Late infancy height velocity 0.36 0.29 0.43 0.39 0.33 0.45 0.06 0.00 0.12 0.38 0.32 0.45 0.46 0.40 0.52 0.06 0.00 0.12 
Early childhood height velocity 0.35 0.29 0.41 0.41 0.35 0.46 0.13 0.08 0.19 0.40 0.34 0.46 0.50 0.46 0.55 0.11 0.06 0.17 
Later childhood height velocity 0.00 -0.10 0.09 -0.06 -0.14 0.02 0.04 -0.04 0.11 -0.10 -0.19 -0.02 -0.17 -0.23 -0.10 -0.01 -0.08 0.06 
 
Tables show standardized regression coefficients (95% CI) that represent the change in each standardized BMC, height and BMC adjusted for height per 1 standard deviation increase in birth 
length or in length/height velocity in each age period, in girls and boys.  
Model 1: crude analysis. Model 2: adjustment for maternal age, educational level, pre-pregnancy body mass index, smoking during pregnancy and child gestational age. Model 3: Model 2 + 
adjustment for birth length and all of the preceding length/height velocities.  
Age intervals: early infancy (0–3 months), late infancy (3–12 months), early childhood (1–3 years) and late childhood (3–6 years).  
BMC, bone mineral content.  
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Supplemental Table 3. Linear regression coefficients (95% CI) for the associations of birth weight and birth length (adjusted for each other) and weight and length/height 
velocities (adjusted for each other) with bone mass at 7 years of age 
 Girls Boys 
 β 95% CI β 95% CI 
Birth weight 0.27 0.15 0.39 0.17 0.05 0.29 
Birth length 0.14 0.01 0.28 0.19 0.08 0.31 
Early infancy weight velocity 0.17 0.10 0.25 0.15 0.04 4.28 
Early infancy length velocity 0.24 0.17 0.31 0.25 0.03 7.36 
Late infancy weight velocity 0.27 0.20 0.35 0.21 0.04 5.69 
Late infancy length velocity 0.25 0.17 0.32 0.28 0.04 7.08 
Early childhood weight velocity 0.45 0.39 0.51 0.38 0.04 10.21 
Early childhood height velocity 0.21 0.15 0.27 0.29 0.03 8.41 
Later childhood weight velocity 0.55 0.49 0.60 0.59 0.03 18.22 
Later childhood height velocity -0.06 -0.12 -0.01 -0.10 0.03 -3.70 
 
Tables show standardized regression coefficients (95% CI) that represent the change in standardized BMC per 1 standard deviation increase in birth weight/length or in the weight/length/height velocity in each age period, 
in girls and boys.  
In each age period models are adjust for maternal age, educational level, pre-pregnancy body mass index, smoking during pregnancy and child gestational age. 
Age intervals for weight velocities: early infancy (10 days–3 months), late infancy (3–12 months), early childhood (1–3 years) and late childhood (3–6 years). Age intervals for length/height velocities: early infancy (0–3 
months), late infancy (3–12 months), early childhood (1–3 years) and late childhood (3–6 years).  
BMC, bone mineral content. 
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Supplemental Figure 1: Pearson correlation coefficients between birth weight and weight velocities in each age period 
 
Age intervals: early neonatal (0–10 days), early infancy (10 days–3 months), late infancy (3–12 months), early childhood (1–3 years) and late childhood (3–6 years).  
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Abstract 
 
Purpose: We aimed to describe remodeling markers in generally healthy prepubertal 
children using total alkaline phosphatase (tALP), osteocalcin (OC) and β-isomerized C-
terminal telopeptides of type I collagen (β-CTx) serum concentrations and to estimate 
markers’ correlations with anthropometric growth (height, weight, body mass index and 
trajectories of weight gain) as well as bone mineral content (BMC) and areal density 
(aBMD). 
 
Methods: We assessed 395 7-year-old children from the Generation XXI cohort with 
tALP, OC and β-CTx concentrations determined from a fasting venous blood sample and 
BMC/aBMD measured by dual-energy X-ray absorptiometry. Gender-specific reference 
intervals for tALP, OC and β-CTx in 7-year-old children were established by calculating 
the 2.5th and 97.5th percentiles. Pearson and partial correlation coefficients (controlling 
for sex, age, body size and season) between bone markers and growth measures were 
computed.  
 
Results: tALP increased with height (rpartial controlled for sex=0.26, 95% CI: 0.17, 0.35), 
was higher in overweight than in healthy weight children, and in children who gained 
weight above average during infancy. No correlations were found between OC or β-CTx 
and growth. In girls, OC was slightly correlated with subtotal BMC (rpartial=0.22, 95% CI: 
0.08, 0.35), subtotal aBMD (rpartial=0.20, 95% CI: 0.06, 0.33) and lumbar spine aBMD 
(rpartial=0.23, 95% CI: 0.09, 0.36). tALP and β-CTx were not correlated with any of the 
DXA-derived bone measures. 
 
Conclusion: This study contributed to the description of bone turnover at 7 years of age 
and suggested that bone metabolism markers measured in a single point in time have 
limited ability to describe anthropometric growth and bone mass in generally healthy 
prepubertal children. 
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Introduction 
 
Serum bone metabolism markers are bone-derived molecules released into circulation 
as a result of osteoblast or osteoclast activity that can be used to describe bone formation 
or resorption, respectively [1]. In adults, bone turnover markers reflect the lifelong 
process of bone remodeling, and have been proposed as independent predictors of bone 
density and fracture risk [2, 3]. They have also been used to assist the selection of drug 
treatments for osteoporosis and to monitor the effectiveness of antiresorptive therapies 
[4, 5]. 
In children, the meaning of bone metabolism markers is more complex, as they reflect 
not only background homeostatic remodeling but also two intensive processes that are 
hallmarks of growth, i.e. bone modeling and linear growth of the skeleton [6]. As such, 
bone metabolism markers are mainly used in clinical pediatrics for the monitoring of 
certain chronic conditions that interfere with bone homeostasis and thus with normal 
skeletal growth and development, including osteogenesis imperfecta, juvenile idiopathic 
arthritis, and chronic kidney disease [7]. Much less is known about the usefulness of 
bone formation and resorption markers to describe bone development or growth 
trajectories in the healthy skeleton. From a practical perspective, for instance in large-
scale epidemiological studies aiming to assess bone mineralization in population-based 
samples of children, measurement of serum levels bone formation and resorption could 
be an interesting alternative to bone mass estimation using dual-energy X-ray 
absorptiometry (DXA), since the former may demand lower resources, while avoiding 
radiation exposure [7]. Bone metabolism markers have also the potential to be more 
sensitive to short-term changes to bone turnover rates [6]. Nevertheless, it is not clear at 
present whether serum levels of bone metabolism markers add useful information to 
describe childhood growth, given their high preanalytical variability [8]. 
Most previous studies exploring the relation between bone metabolism markers and 
growth have used cross-sectional designs and have described associations in relatively 
small samples of children, with wide age ranges [9-17]. Additionally, most existing 
evidence was obtained from convenience or clinical-based samples where distributions 
of bone markers are not necessarily representative of those in the source population [18, 
19]. Therefore, by using data from a population-based sample of prepubertal children of 
the same age, we aimed to describe bone formation and resorption markers using total 
alkaline phosphatase (tALP), osteocalcin (OC) and β-isomerized C-terminal telopeptides 
of type I collagen (β-CTx), and to assess whether those bone metabolism markers are 
associated with DXA-derived bone properties and anthropometric growth up to seven 
years of age. 
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Material and Methods  
 
We used data from a sub-sample of 395 children, recruited and followed up as part of 
Generation XXI, a prospective birth cohort assembled in 2005/06 at public maternity units 
in Porto, Portugal [20,21]. 
 
Generation XXI cohort assembly and follow-up 
All live infants with more than 23 weeks of gestation, born in one of the five public 
maternity units in the Porto Metropolitan Area, between April 2005 and August 2006, 
were eligible to participate. Of the invited mothers, 91.4% accepted to participate and 
their 8647 infants were enrolled in the cohort study. Seven years after birth (April 2012 
to April 2014), all Generation XXI participants were invited to a follow-up evaluation and, 
of the initial cohort, 5849 (67.6%) were interviewed face to face. In each evaluation, we 
obtained written informed consent from parents or legal guardians and additional oral 
assent from children at 7 years of age. The study protocol complies with the 1964 
Declaration of Helsinki and was approved by the Ethics Committee of University of Porto 
Medical School/Hospital de São João, Porto, Portugal, and registered with the 
Portuguese Data Protection Authority.  
 
Study sample 
From the 5849 children evaluated at 7 years of age we selected a subsample of 400 
participants to measure bone metabolism markers and bioactive molecules: serum 25-
hydroxyvitamin D (25(OH)D), intact parathyroid hormone (PTHi), calcium (Ca) and 
inorganic phosphorus (Pi). Sample size was calculated based on expected correlations 
between bone parameters, in order to allow estimating a 0.15 linear correlation 
coefficient with an 85% power at a 0.05 significance level. These participants were 
selected based on the following characteristics: 1) to be a singleton full-term baby (more 
than 36 weeks of gestation); 2) to have a valid whole body DXA scan at 7 years, 3) to 
have a fasting blood sample collected in the morning with enough volume to perform the 
intended laboratory analyses. From all participants with the aforementioned 
characteristics, we randomly selected 200 boys and 200 girls. After samples were sent 
for analysis, we excluded a further five children as their samples were hemolytic, icteric 
or lipemic, leaving 395 children for the current analysis (49.9% girls). 
Children included in the present study were not different from the remaining cohort 
regarding sex distribution (49.9% girls vs. 49.0%, p = 0.719), height at 7 years of age 
(123.3 vs. 123.7 cm, p = 0.146) and weight at 7 years of age (25.9 vs. 26.2 kg, p = 0.176). 
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However, participants included had lower bone mineral content (BMC) (585.0 g in 
included vs. 604.8 g in excluded participants, p<0.001) than those excluded. 
 
Blood sampling and serum determinations  
At the 7 years of age follow-up evaluation, we collected blood samples drawn from an 
antecubital vein, in the morning after overnight fasting. All children were offered local 
dermal analgesia with lidocaine/prilocaine (EMLA®). Blood samples were collected in 
Vacumed® vacuum tubes with gel separator plus clot activator (FL medical, Italy), 
allowed to clot for 20 minutes at room temperature and centrifuged for 15min at 1500 ×g. 
Serum was aliquoted and kept frozen at -80 ºC in the biobank at the University of Porto 
Medical School until the day of analysis. All analytical measurements presented in this 
paper were conducted at the clinical pathology laboratory of the Centro Hospitalar São 
João, EPE in Porto, Portugal, in June 2014, after being thawed according to standard 
operating procedures. 
Total alkaline phosphatase (tALP) was quantified by a spectrophotometric method based 
on the conversion of p-nitro-phenylphosphate (pNPP) to p-nitrophenol (pNP) measured 
at 410/480 nm on an Olympus AU5400 analyzer (Beckman Coulter Inc., USA) (the 
detection range of the kit, defined  by  the  detection  limit and  the  calibration  curve  
maximum  concentration, is 5-1500 units/l, U/l).  
Osteocalcin (OC), β-isomerized C-terminal telopeptides of type I collagen (β-crosslaps, 
β-CTx), and parathyroid hormone measurements were performed by electro-
chemiluminescence immunoassays (ECLIA) in a Cobas e411 analyzer (Roche 
Diagnostics GmbH, Mannheim, Germany) [22]. The Elecsys N-MID Osteocalcin assay 
(Roche Cobas, Roche Diagnostics, Mannheim, Germany) detects both the stable N-
terminal mid-fragment of OC (amino acids 1–43) and intact Osteocalcin (aminoacids 1–
49) (detection range: 0.500-300 µg/l). The Elecsys β-crosslaps assay/serum quantifies 
all degradation fragments of the C-terminal telopeptide region of type I collagen α1 chain 
that contain the β-isomerized octapeptide EKAHD-β-GGR twice (β-CTx) [23]. This test 
uses two mouse monoclonal antibodies directed against different regions of the EKAHD-
β-GGR octapeptide (detection range: 10-6000 ng/l). Parathyroid hormone was measured 
as PTHi, a single polypeptide chain containing 84 amino acids. Two different monoclonal 
antibodies, directed against the aminoacid regions 26-32 (N-terminal) and 37-42 (C-
terminal) were used (detection range: 0.127-530 pmol/l).  
Serum 25(OH)D concentration was determined using LIAISON® 25-OH Vitamin D Total 
assay (DiaSorin, Saluggia, Italy), a direct competitive chemiluminescence immunoassay 
which recognizes 25 (OH) vitamin D2 and 25 (OH) vitamin D3 and is fully automated 
using a Liason platform (detection range: 4.0-150 ng/ml) [24]. 
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Ca and Pi were determined using the Olympus AU5400 analyzer. Ca was detected by a 
colorimetric assay where Calcium ions (Ca2+) react with Arsenazo III and produce an 
intense purple color complex (detection range: 1-5 mmol/l) (Beckman Coulter AU System 
Calcium Arsenazo, Beckman Coulter). Pi was determined by a colorimetric assay were 
the absorbance at 340/380 nm is directly proportional to the Pi level in the sample 
(Beckman Coulter AU System Inorganic Phosphorus Reagent, Beckman Coulter) 
(detection range: 0.32-6.40 mmol/l).  
All analytical measurements were performed according the manufacturer’s instructions 
regarding preventive maintenance, function checks, calibration, and quality control of 
both tests and equipment. All samples tested underwent automated interference analysis 
for hemolysis, hyperbilirubinemia and lipemia. 
 
Physical examination  
Anthropometry was obtained while the child stood barefoot in light indoor clothing. 
Weight was measured to the nearest 0.1kg using a digital scale (TANITA, Arlington 
Heights, IL, USA) and height was measured to the nearest 0.1cm using a wall 
stadiometer (SECA, Hamburg, Germany). Body mass index (BMI, kg/m2) was calculated 
as the ratio of weight to height squared and BMI-for-age values were classified according 
to the World Health Organization reference data for BMI z-score into the following 
categories: normal weight (≤+1 SD) and overweight (>+1 SD, including children with 
overweight and obesity) [25]. In our sample no children were underweight according to 
the cut-off value <-2 SD. The definition of weight trajectories in the cohort was based on 
an extensive body of anthropometric measurements abstracted from the children's 
health books, recorded in routine care, from birth until the age of 6 years. Four different 
weight trajectories for both sexes combined were identified through normal mixture 
modeling for model-based clustering and labelled “normal weight gain”, “weight gain 
during infancy”, “weight gain during childhood” and “persistent weight gain”, as previously 
described [26] (Supplemental figure 1). 
Whole body DXA scans were performed in a Hologic Discovery QDR® 4500W device 
(Hologic Inc., Bedford, Massachusetts), according to standard manufacturer protocols in 
light clothing and without metal accessories. Total body less head (subtotal) and lumbar 
spine (LS) BMC was obtained and areal bone mineral density (aBMD) was expressed 
as BMC (in g) per projected bone area (in cm2) [27]. We performed daily standard quality 
assurance tests using the spine phantom. Scans were evaluated immediately after the 
scanning procedure and later validated by a second well-trained radiology technician. 
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Data analysis  
For the description of reference intervals, according to the C28-A3 International 
Federation of Clinical Chemistry and Clinical Laboratory and Standards Institute 
guidelines (C28-A3 CLSI/IFCC guidelines), data were examined for outlier observations 
using frequency histograms and Dixon outlier range statistic as follows. Estimation of 
D/R ratio, where D is the absolute difference between the most extreme observation 
(large or small) and the next largest (or smallest) observation and R is the range of all 
observations (maximum-minimum) was estimated. If the ratio D/R exceeds 1/3, then the 
extreme observation is deleted, otherwise all datum is kept [28]. Using this procedure, 
no extreme values were detected as outliers for any of the bone markers distributions. 
Concentrations of bone metabolism markers are presented as medians, and the interval 
limits were determined by calculating the rank numbers for the 2.5th and 97.5th percentiles 
of the distribution [28]. The season during which blood samples were collected was 
combined into two categories: summer (April-September) and winter months (October-
March). 
Two-sample t test, Mann–Whitney test and chi-square test were used to compare boys 
and girls with regard to bone markers concentrations, age, anthropometrics (height, 
weight, BMI and trajectories of weight gain), 25(OH)D, PTHi, Ca and Pi.  
Correlations were estimated using parametric statistics (Pearson correlation coefficients) 
to assess crude relationships among bone metabolism markers and between bone 
markers and age, height, weight and DXA-derived BMC and aBMD. To account for the 
effects of age, sex, body size (height and weight) and season on the relationships studied 
we computed Pearson partial correlations (rpartial). Correlations below 0.20 were 
interpreted as very weak, between 0.2 and 0.4 as weak and between 0.4 and 0.6 as 
moderate. Concentrations of bone markers were compared between BMI groups using 
Mann–Whitney test and between weight gain trajectories using ANOVA. Mean values of 
bone markers concentrations, adjusted for sex, age and season were estimated through 
ANCOVA and comparisons between BMI groups were performed using nlcom command 
in Stata. Mean values of bone markers concentrations according to weight gain 
trajectories were additionally adjusted for current body size (height and weight at 7 years 
of age) and comparisons between trajectories were performed using Wald test (testparm 
command in Stata). Post-hoc pairwise comparison of adjusted means between 
trajectories were performed with the Tukey-Kramer correction for multiple comparison. 
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Sensitivity analyses  
To assess the impact of vitamin D deficiency on the relationships between bone markers 
and anthropometrics and BMC/aBMD, we recalculated correlations after excluding 
children with serum 25(OH)D below 20 ng/ml [29] (n=153), and compared these 
estimates with those obtained for the whole sample. Additional sensitivity analyses to 
assess the impact of hypo- or hypercalcemia and hypo- or hyperphosphatemia were 
carried out by excluding children with serum Ca or Pi concentrations outside reference 
intervals established by the instrument manufacturer  (Ca below 2.2 mmol/l or above 2.7 
mmol/l, n=58; Pi below 1.292 mmol/l or above 2.261 mmol/l, n=3) [30].  
All statistical analyses were conducted by using Stata version 11.2 for Windows (Stata 
Corp. LP, College Station, Texas, USA). 
 
Results 
 
Sample characteristics  
In our sample of 7-year-old children, reference intervals expressed as 2.5th to 97.5th 
percentile were 159 to 439 U/l for serum tALP and 470 to 1690 ng/l for β-CTx. Since 
mean OC concentration was higher in girls than in boys (87.9 versus 82.1 µg/l, 
respectively, p=0.003), reference intervals are presented separately by sex: 52.5 to 
137.7 µg/l in girls and 50.0 to 129.9 µg/l in boys. Seasonal variation of bone metabolism 
markers was observed, with increased levels of tALP (p<0.001) and β-CTx (p=0.003) in 
children sampled in summer (n=314) than in those sampled in winter months (n=81) 
(Table 1). 
There were no differences between girls and boys in age, weight and BMI distributions. 
Girls were slightly shorter than boys (122.7 versus 123.8 cm, p=0.022) had lower serum 
Pi concentration (1.63 versus 1.66 mmol/l, p=0.025), and were more likely to have a 
trajectory of weight gain during childhood. Serum vitamin D level was higher in samples 
of participants evaluated in summer than in winter months (p<0.001). Vitamin D 
insufficiency was present in 45.6% children while vitamin D deficiency was present in 
38.7% children [29] (Table 1). 
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Table 1. Anthropometrics and serum concentrations of vitamin D, parathyroid hormone, calcium, phosphorus and bone metabolism markers, in girls and boys 
(n=395) 
 TOTAL Girls (n=197) Boys (n=198) Comparison between 
genders 
 Mean ± SD or Median (P25, P75) or n (%) p-value a 
Age (months) 84.1 (83.6, 84.5) 83.9 (83.7, 84.5) 84.1 (83.6, 84.6) 0.674 
Height (cm) 123.3 ± 5.1 122.7 ± 4.9 123.8 ± 5.2 0.022 
Weight (kg) 25.2 (22.6, 28.1) 24.9 (22.6, 28.1) 25.2 (22.7, 28.2) 0.774 
BMI categories (%) b     
Normal weight 262 (66.3) 127 (64.5) 135 (68.2) 
0.719 
Overweight 81 (20.5) 42 (21.3) 39 (19.7) 
Obese 52 (13.2) 28 (14.2) 24 (12.1) 
Growth trajectories (%)     
Normal weight gain 243 (67.5) 110 (61.1) 133 (73.9) 
0.004 
Weight gain during infancy 23 (6.4) 9 (5.0) 14 (7.8) 
Weight gain during childhood 54 (15.0) 38 (21.1) 16 (8.9) 
Persistent weight gain 40 (11.1) 23 (12.8) 17 (9.4) 
Missing data for growth trajectory 
assignment 
35 17 18  
25(OH)D (ng/ml)   
Total sample 
 
21.8 (17.7, 26.3) 
 
22.0 (17.7, 26.6) 
 
21.7 (17.8, 26.0) 
0.756 
Collected in summer c 23.0 (19.0, 28.0) 23.3 (19.1, 28.2) 22.6 (18.5, 27.8)  
Collected in winter d 17.2 (14.1, 21.1) 16.2 (12.9, 20.9) 18.0 (14.8, 21.8)  
Vitamin D insufficiency (%) e 180 (45.6) 83 (42.1) 97 (49.0)  
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Vitamin D deficiency (%) e 153 (38.7) 81 (41.1) 72 (36.7) 0.583 
PTHi (pmol/l) 3.24 (2.63, 3.83) 3.28 (2.65, 3.88) 3.20 (2.60, 3.74) 0.608 
Ca (mmol/l) 2.5 (2.4, 2.6) 2.5 (2.4, 2.6) 2.5 (2.4, 2.6) 0.308 
Pi (mmol/l) 1.64 ± 0.16 1.63 ± 0.16 1.66 ± 0.16 0.025 
 P50th (P2.5th - P97.5th)  
tALP (U/l) f     
Total sample 260 (159, 439) 258 (153, 439) 262 (167, 445) 0.820 
Collected in summer g 269 (175, 445) 272 (167, 459) 265 (175, 445)  
Collected in winter d 228 (139, 396) 220 (134, 396) 239 (139, 584)  
OC (µg/l)     
Total sample 85.2 (50.3, 134.8) 87.9 (52.5, 137.7) 82.1 (50.0, 129.9) 0.003 
 Collected in summer c 85.6 (51.6, 136.5) 88.3 (52.5, 140.6) 82.2 (51.1, 130.2)  
Collected in winter d 83.6 (50.0, 124.3) 85.2 (59.6, 127.9) 81.6 (48.6, 114.5)  
β-CTx (ng/l)     
Total sample 1030 (470, 1690) 1040 (450, 1690) 1005 (510, 1690) 0.258 
Collected in summer c 1040 (500, 1690) 1075 (450, 1700) 1025 (530, 1680)  
Collected in winter d 940 (470, 1380) 930 (500, 1320) 940 (440, 1700)  
 
a Two-sample t-test, Mann–Whitney or chi-square tests as appropriate  
b According to World Health Organization reference data for BMI z-score: normal weight (≤1 SD), overweight (>1 SD and ≤2 SD) and obesity (>2 SD) (de Onis, et al., Bull World 
Health Organ, 2007) 
c n=314 (154 Girls + 160 Boys) 
d n=81 (43 Girls + 38 Boys) 
e According to the Endocrine Society (United States), vitamin D insufficiency is defined as serum 25(OH)D of 21–29 ng/ml and vitamin D deficiency as serum 25(OH)D below 20 
ng/ml (Holick, et al., J Clin Endocrinol Metab, 2011)  
f n=394 (197 Girls + 197 Boys) 
g n=313 (154 Girls + 159 Boys) 
Abbreviations: BMI, body mass index; 25(OH)D, 25-hydroxyvitamin D; PTHi, intact parathyroid hormone; Ca, calcium, Pi, inorganic phosphorus; tALP, total alkaline phosphatase; 
OC, osteocalcin; β-CTx, β-crosslaps  
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Relationship between bone remodeling markers 
In both sexes, positive moderate correlations between OC and β-CTx were found, even 
after controlling for age, body size and season effects (girls: rpartial=0.40, 95% CI: 0.28, 
0.51 and boys: rpartial=0.46, 95% CI: 0.34, 0.56). No relevant correlations were observed 
between tALP and OC (girls: rpartial=0.02, 95% CI: -0.12 0.16 and boys: rpartial=0.07, 95% 
CI: -0.07, 0.21) or between tALP and β-CTx (girls: rpartial=0.13, 95% CI: -0.01, 0.27 and 
boys: rpartial=0.00, 95% CI: -0.14, 0.14) (Table 2). 
 
Table 2. Pearson correlation and partial correlation coefficients among bone metabolism 
markers, in girls and boys (n=395) 
  Girls (n=197) 
  tALP OC β-CTx 
  Coefficient 95% CI Coefficient 95% CI Coefficient 95% CI 
B
o
y
s
 (
n
=
1
9
8
) 
tALP  r=0.06 -0.08, 0.20 r=0.18 0.04, 0.31 
rpartial=0.02 -0.12, 0.16 rpartial=0.13 -0.01, 0.27 
OC r=0.11 -0.03, 0.25  r=0.40 0.28, 0.51 
rpartial=0.07 -0.07, 0.21 rpartial=0.40 0.28, 0.51 
β-CTx r=0.06 -0.08, 0.20 r=0.47 0.36, 0.58   
rpartial=0.00 -0.14, 0.14 rpartial=0.46 0.34, 0.56 
 
Abbreviations: tALP, total alkaline phosphatase; OC, osteocalcin; β-CTx, β-crosslaps; r, Pearson correlation 
coefficient; rpartial, Pearson partial correlation coefficient (age, body size and season controlled); 95% CI, 
95% confidence interval.   
 
 
Bone metabolism markers and age and anthropometrics   
Correlations between age and tALP and β-CTx were very weak and attenuated after 
accounting for sex and season effects (rpartial=0.14, 95% CI: 0.04, 0.23 and rpartial=0.08, 
95% CI: -0.02, 0.17, respectively) (Fig 1a and Fig 1c).  
As regards anthropometrics, tALP was slightly correlated with height (r=0.30, 95% CI: 
0.20, 0.38) (Fig 1d) and weight (r=0.26, 95% CI: 0.16, 0.35) (Fig 1g) while correlations 
between height or weight and OC or β-CTx were irrelevant (Fig 1e, Fig 1f, Fig 1h and 
Fig 1i). After accounting for the effect of sex, age and season, the positive relationship 
between height and tALP was attenuated (rpartial=0.26, 95% CI: 0.17, 0.35) (Fig 1d). 
Comparing BMI groups, we observed that overweight children had higher tALP 
concentration than normal weight children [mean (95% CI) adjusted for sex, age and 
season: 287 (275, 300) versus 263 (254, 272) U/l, p=0.002] (Fig 1j). Also for tALP, we 
153 
 
observed that, in comparison to children in a “normal weight gain” trajectory [mean (95% 
CI) adjusted for sex, age and season: 268 (259, 278) U/l)], those in the trajectories of 
“weight gain during infancy” presented slightly higher serum concentrations [308 (278, 
339) U/l, p=0.018] (Fig 1m). For OC and β-CTx, we observed no differences in serum 
concentrations by BMI groups or by trajectories of weight gain (Fig 1k, Fig 1l, Fig 1n and 
Fig 1o).  
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Fig 1. Serum concentrations of bone metabolism markers in relation to age and 
anthropometrics (n=395). (a) tALP in relation to age.  (b) OC in relation to age. (c) β-CTx in 
relation to age. (d) tALP in relation to height. (e) OC in relation to height. (f) β-CTx in relation to 
height. (g) tALP in relation to weight. (h) OC in relation to weight. (i) β-CTx in relation to weight. 
(j) tALP by BMI groups. (k) OC by BMI groups. (l) β-CTx by BMI groups. (m) tALP by trajectories 
of weight gain. (n) OC by trajectories of weight gain. (o) β-CTx by trajectories of weight gain. 
 
Panels a) to i): the solid line represents the mean and the dotted lines ± 2SD; r, Pearson correlation 
coefficient, rpartial, Pearson partial correlation coefficient (correlations between bone metabolism markers and 
age were controlled for sex and season; between bone metabolism markers and height were controlled for 
sex, age and season; between bone metabolism markers and weight were controlled for sex, age, height 
and season). For better data visualization, the participant with 95months of age is not represented in Panels 
a) to c).  
Panels j) to l): p, p-values from the Mann–Whitney test for comparisons between BMI groups; padjusted, p-
values from the nlcom postestimation command for comparisons between BMI groups (means of bone 
metabolism markers were adjusted for sex, age and season).  
Panel m) to o): p, p-values from ANOVA for comparisons between trajectories of weight gain; padjusted, p-
values from the testparm Stata command for comparisons between trajectories of weight gain (means of 
bone metabolism markers were adjusted for sex, age, current body size and season). 
Abbreviations: tALP, total alkaline phosphatase; OC, osteocalcin; β-CTx, β-crosslaps; BMI, body mass 
index, 95% CI, 95% confidence interval.  
 
 
Bone metabolism markers and DXA-derived bone measures 
Overall, Table 3 shows that correlations between bone metabolism markers and DXA-
derived BMC and aBMD were positive but modest in magnitude. Crude correlations with 
BMC and aBMD were slightly stronger for tALP than for OC or β-CTx. Serum OC was 
slightly stronger correlated with BMC/aBMD in girls than in boys. However, after 
computing partial correlations accounting for age, body size and season effects, tALP 
was no longer correlated with bone mass, neither in girls nor in boys. In girls only, weak 
positive correlations between OC and subtotal BMC (rpartial=0.22, 95% CI: 0.08, 0.35), 
subtotal aBMD (rpartial=0.20, 95% CI: 0.06, 0.33) and lumbar spine aBMD (rpartial=0.23, 
95% CI: 0.09, 0.36) were observed. β-CTx was not correlated with any of the DXA-
derived bone measures. 
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Table 3. Pearson correlation and partial correlation coefficients between bone metabolism markers and bone mineral content and density, in girls and boys 
(n=395) 
  Subtotal BMC Lumbar spine BMC Subtotal aBMD Lumbar spine aBMD 
  Coefficient 95% CI Coefficient 95% CI Coefficient 95% CI Coefficient 95% CI 
tALP 
Girls r=0.25 0.12, 0.38 r=0.18 0.05, 0.32 r=0.24 0.11, 0.37 r=0.19 0.06, 0.33 
 rpartial=0.02 -0.12, 0.16 rpartial=0.08 -0.06, 0.22 rpartial=0.02 -0.12, 0.16 rpartial=0.09 -0.05, 0.23 
Boys r=0.24 0.11, 0.37 r=0.22 0.08, 0.35 r=0.22 0.08, 0.35 r=0.20 0.06, 0.33 
  rpartial=0.11 -0.03, 0.25 rpartial=0.13 -0.01, 0.27 rpartial=0.10 -0.04, 0.23 rpartial=0.13 -0.01, 0.26 
OC 
Girls r=0.23 0.09, 0.36 r=0.14 0.00, 0.28 r=0.20 0.06, 0.33 r=0.26 0.12, 0.38 
 rpartial=0.22 0.08, 0.35 rpartial=0.10 -0.04, 0.23 rpartial=0.20 0.06, 0.33 rpartial=0.23 0.09, 0.36 
Boys r=0.19 0.05, 0.32 r=0.06 -0.08, 0.20 r=0.14 0.00, 0.28 r=0.13 -0.01, 0.27 
  rpartial=0.08 -0.06, 0.21  rpartial=-0.07 -0.21, 0.07 rpartial=0.04 -0.10, 0.18 rpartial=0.06 -0.08, 0.19 
β-CTx 
Girls r=0.07 -0.07, 0.21 r=0.08 -0.06, 0.22  r=0.01 -0.13, 0.15 r=0.04 -0.10, 0.18 
 rpartial=0.11 -0.03, 0.25 rpartial=0.04 -0.10, 0.18 rpartial=0.03 -0.11, 0.17 rpartial=0.05 -0.09, 0.19 
Boys r=0.10 -0.04, 0.24 r= 0.07 -0.07, 0.21 r=0.06 -0.08, 0.20 r=0.09 -0.05, 0.22 
  rpartial=0.04 -0.10, 0.18  rpartial=-0.02 -0.16, 0.12 rpartial=-0.00 -0.14, 0.14 rpartial=0.06 -0.08, 0.19  
 
Abreviations: tALP, total alkaline phosphatase; OC, osteocalcin; β-CTx, β-crosslaps; BMC, bone mineral content; aBMD, areal bone mineral density; r, Pearson correlation 
coefficient; rpartial, Pearson partial correlation coefficient (age, body size and season controlled); 95% CI, 95% confidence interval.  
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Sensitivity analyses  
After excluding children with vitamin D deficiency (n=153), with hypo- and hypercalcemia 
(n=58) or hypo- and hyperphosphatemia (n=3), one group at a time, correlation 
coefficients between bone metabolism markers and anthropometrics and DXA-derived 
bone measures remained similar to those obtained for the whole sample of children 
before exclusion of these subjects. 
 
Discussion  
 
In this study, we described reference intervals for tALP, OC and β-CTx in a population-
based sample of 7-year-old children. We found a moderate correlation between serum 
concentrations of bone-specific metabolism markers OC and β-CTx, likely representing 
the dynamic nature of bone turnover. The non-specific bone marker tALP was slightly 
more correlated than OC or β-CTx with bone mass and anthropometric variables, 
probably reflecting the overall trajectory of anthropometric growth up to the time of 
measurement. 
 
There has been growing interest in the quantification of bone metabolism markers in the 
clinical setting as they may provide a dynamic, short-term measure of skeletal status, 
which is not captured by bone physical properties alone [2]. So far, no single individual 
parameter has fulfilled all the criteria for an ideal marker of bone formation or resorption 
[6]. The clinical utility of bone markers is challenged by high intraindividual variation, lack 
of specificity for bone tissue, release during different anabolic and catabolic processes 
and influence of non-skeletal processes on circulating levels [31]. Also, no single marker 
is sufficiently precise to be used for prognostic purposes, as concentration changes of 
candidate molecules are neither site- nor disease-specific [6]. An additional challenge is 
posed in the interpretation of bone metabolism markers as a prognostic tool, in 
populations of children and adolescents, because it is impossible to distinguish 
treatment-induced changes from the physiological age-related decline in these bone 
markers [31]. Furthermore, some bone metabolism markers, such as OC, may reflect, at 
the same time, both bone formation and resorption processes [31]. Because there is no 
specific bone marker to assess bone modeling, remodeling or epiphyseal growth, 
concentrations of markers in children represent the combined effects of these different 
biological processes [6]. This means that equal serum levels of bone metabolism 
markers can be found both in children with high bone remodeling and low rate of growth 
as well as in normally growing children [32]. 
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In addition to limitations in inferring the biological significance of bone metabolism 
markers, the definition of pediatric reference intervals is limited by their substantial pre-
analytical variability and by heterogeneity in analytical methods [8]. Pre-analytical 
sources of variability include uncontrollable factors (such as sex, age, pubertal 
development, growth velocity, ethnicity, physical activity, nutritional status, or 
pathological conditions (e.g. diabetes, liver diseases, growth hormone deficiency, 
vitamin D deficiency, or recent fracture) and drugs), and controllable factors such as 
circadian rhythm, seasonal variation or fasting status [8]. The main sources of undesired 
pre analytical variability of tALP are related to age, pubertal status and sex, as well as 
lack of bone specificity [32]. Regarding OC, pre-analytical variability is mostly related to 
age and circadian rhythm [8]. β-CTx also exhibits significant circadian rhythm and is 
influenced by food intake, as well as age [8]. Analytical variability further contributes to 
variation of reference intervals, due to lack of standardization and harmonization of 
quantification methods and to inter-laboratory variation, even when the same method is 
used [33]. Attempts to establish reference intervals have also been limited by the small 
sample sizes of most previous investigations, which have also been frequently 
conducted in hospital settings [33]. Indeed, reference values obtained from facility-based 
samples may not be applicable to the general pediatric population as intervals in the 
former are generally wider [34]. 
 
To account for those limitations, our approach in the present study was to use data from 
a comparatively large population-based sample of children of the same age, whose 
samples were drawn in the morning, after an overnight fast. Nevertheless, our reported 
reference values are directly applicable only to children of the same age whose samples 
were tested using laboratory methods similar to ours [28], as supported by our 
comparison of the present results with previous descriptions (Supplemental tables 1 to 
3). Regarding 25(OH)D, PTHi, Ca and Pi we found that concentrations in our sample 
were within published reference intervals although no previous studies have reported 
sex differences in serum concentration of Pi [35, 36]. However, our findings on the 
relationships between bone metabolism markers and anthropometrics or DXA-derived 
bone measures are more dependent on the relative positions of children in the 
distribution of each marker and less on absolute value of marker concentrations, which 
makes for safer generalization of the magnitude of associations to other contexts. 
 
We found a positive correlation between OC and β-CTx, in agreement with findings in 
other samples of prepubertal children [17] but in contrast with one study including 5 to 
10 year-old children [14]. Positive relationships between bone-specific formation and 
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resorption markers are expected, and reflect the nature of bone turnover as a tightly 
regulated dynamic mechanism of formation and resorption [6]. Our absence of 
correlation between tALP and OC corroborates previous findings [37] but contradicts 
more recent results that showed direct correlations among formation markers [13, 38]. 
The recent hypothesis that OC is a marker of bone turnover as a whole, reflecting not 
only bone formation but also resorption, may explain its less consistent associations with 
other formation markers [39]. Our results also differed from previous findings that 
disclosed a positive relationship between ALP and β-CTx. However, other studies have 
assessed bone-specific ALP rather than total ALP [38]. In addition, since previous 
studies have looked at wider age ranges, results are not straightforwardly comparable to 
ours in children of the same age. 
 
Overall, weak correlations among bone markers are probably due to the coexistence of 
different biological processes at different anatomical regions and bone surfaces during 
skeletal growth. In addition, markers are released during different stages of bone 
formation and resorption, and have different elimination pathways and serum half-lives, 
which may affect their relations at different time points during growth [6].  
 
Our results were indicative of a weak positive effect of age on tALP concentrations, which 
corroborates previous findings of an age-related increase in tALP, expected to peak at 
approximately 10-12 years of age in girls and 13-15 years in boys, and detectable around 
7 years of age [35, 36, 40-43]. At this age, tALP was slightly correlated with height. Also, 
higher concentrations were observed in overweight when compared to healthy weight 
participants, and in children who gained weight above-average during infancy, in 
comparison to those in an average weight gain trajectory. These modest positive 
relationships between tALP and anthropometric growth, which were not apparent for the 
bone-specific markers OC and β-CTx, suggest that tALP is a more specific marker of the 
child’s overall growth trajectory up to the time of measurement. Positive correlations 
between bone-specific ALP and anthropometric measures have been reported 
elsewhere [38] while others shown no effect of BMI on tALP values [44]. Our results did 
not support previously described positive correlations between OC and height and weight 
[10, 14], between CTX and weight [14] and height [13, 38] or the finding of decreased 
OC values in obese when compared to healthy weight children [11, 12]. However, in 
accordance to our findings, a number of other studies have contributed with evidence of 
a lack of association between height, weight or BMI and OC [9, 10, 13, 14, 39, 44] and 
height or BMI and β-CTx [44]. Increased formation markers in taller and heavier children 
are likely reflecting greater growth velocity, inducing increased bone formation in 
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response to greater mechanical strain [13, 32]. Accordingly, CTX may also correlate with 
height since increased periosteal modeling also implies removal of bone at the 
endocortical surface [45]. To the best of our knowledge, our study is the first to estimate 
relationships between bone markers and growth trajectories from birth. Given the lack of 
relationships between OC or β-CTx and trajectories of weight gain we believe that, 
contrarily to dimensions of skeletal growth, such as BMC, that are clearly shaped by the 
overall weight trajectory, markers of bone metabolism are not related to overall weight 
trajectories [46]. The lack of associations between OC or β-CTx and the remaining 
anthropometric growth indices supports this assertion. 
 
Bone metabolism markers were also only weakly correlated with DXA-derived BMC and 
aBMD. Additional adjustments for age, body size and season attenuated those 
relationships only for OC and only in girls. This suggests that measurements of bone 
metabolism markers at a single point in time do not reflect bone mineralization status in 
the general prepubertal population and are unlikely to be helpful for monitoring the status 
of bone mineral accrual in non-clinical settings. These findings are consistent with the 
premise that bone markers reflect instantaneous metabolic activity and do not directly 
translate physical dimensions that result from the cumulative process of bone gain 
throughout several years [6]. In prepubertal children, some previous studies have also 
found no relationship between tALP, OC or β-CTx and whole body (WB) and LS BMC or 
BMD [14, 15, 35]. Other studies disclosed, however, consistent positive relationships 
between tALP and OC and WB and LS BMC, in boys [16] and between OC and CTX 
and WB and LS BMC/BMD, in both sexes [15, 17]. In older pubertal children, inverse 
correlations between serum OC or CTX and BMD were disclosed [9, 15], which is 
expected because, during puberty, bone turnover decreases with advancing sexual 
maturation while, at the same time, bone mass accrual continues up to peak bone mass 
[7]. Some authors have also described site-specific associations between bone 
metabolism markers and bone mass during puberty, disclosing stronger relationships in 
anatomical sites with more trabecular bone (e.g. LS BMC) than with cortical bone (FN 
BMC), possibly due to higher metabolic activity of trabecular when compared to cortical 
bone [47]. In our study, however, bone markers were not correlated with either cortical 
or trabecular bone when we computed correlations between bone markers and BMC and 
aBMD at the LS and lower limbs (S1 File, S4 Table). 
 
This study extends previous evidence by assessing the usefulness of bone markers to 
describe growth in a population-based sample of children with longitudinal 
anthropometric data. In particular, we were able to investigate for the first time the 
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relationships of bone markers with weight gain trajectories since birth. We also quantified 
bone metabolism markers at the same chronological age for all participants. 
Furthermore, blood samples were all collected in the morning after overnight fasting to 
avoid the variability associated to the circadian rhythm. In addition, reference intervals 
were described according the statistical approach recommended in the C28-A3 
CLSI/IFCC guidelines [28]. However, we should acknowledge a limitation in our use of 
tALP instead of bone-specific ALP. Serum variations of tALP are not as accurate as 
bone-specific ALP to detect subtle changes in bone formation [6]. Nevertheless, when 
liver ALP is stable and remains within normal values, tALP represents a valid marker of 
bone turnover [31]. 
 
In the future, it will be interesting to investigate time changes in bone markers and 
whether those are associated with changes in bone mass and density across the 
lifespan. In particular, it might be important to explore how puberty relates to bone 
formation and resorption. Although we were not able to assess sexual development in 
this evaluation, we expect that the vast majority of children from the general population 
were prepubertal at 7 years of age, as observed in previous population-based samples 
of the same age [48, 49]. 
 
In conclusion, we found weak or negligible associations of bone metabolism markers 
with different indices of growth, suggesting limited ability of those markers to predict bone 
mass and overall growth in 7-year-old children from the general population.  
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Supplemental table 1. Reference intervals for serum total alkaline phosphatase concentrations (U/l) 
First author, year Age (years) N Analytic platform P50 (P2.5, P97.5) 
Both sexes 
Generation XXI, 2019 7 393 Beckman Coulter Olympus AU5400 analyzer 260 (159, 439) 
Wanjian, 2017 [1] 6-12 175 Beckman Coulter AU5800 analyzer (48.8, 445.9) 
Abou El Hassan, 2015 [2] 1-10 391 Beckman Coulter AU analyzer  (160, 381) 
Buchanan, 2015 [3] 5-13 121 Cobas Integra 400 plus analyzer 278 (IC95%: 174, 460) 
Ridefelt, 2014 [4] 2-8 234 Abbott Architect ci8200 analyzer (111, 277) 
Hilsted, 2013 [5] 7-8 228 Roche Modular Analytics P/ISE-System analyzer (154, 358) 
Girls 
Generation XXI, 2019 7 197 Beckman Coulter Olympus AU5400 analyzer 258 (153, 439) 
Zierk, 2017 [6] 7 3785 Roche Cobas analyzer 217 (127, 345) 
Cho, 2014 [7] 6-12 988 Hitachi 7600 analyzer (123, 330) 
Hilsted, 2013 [5] 7-8 135 Roche Modular Analytics P/ISE-System analyzer (157, 365) 
Huang, 2011 [8] 6-11 36 Roche P-modular analyzer (157, 359) 
Boys 
Generation XXI, 2019 7 196 Beckman Coulter Olympus AU5400 analyzer 262 (167, 445) 
Zierk, 2017 [6] 7 4237 Roche Cobas analyzer 208 (125, 323) 
Cho, 2014 [7] 6-12 1094 Hitachi 7600 analyzer (118, 341) 
Hilsted, 2013 [5] 7-8 93 Roche Modular Analytics P/ISE-System analyzer (149, 345) 
Huang, 2011 [8] 6-15 75 Roche P-modular analyzer (136, 414) 
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Supplemental table 2. Reference intervals for serum osteocalcin concentrations (µg/l) 
First author, year Age (years) N Assay/Analytic platform P50 (P2.5, P97.5) 
Both sexes 
Generation XXI, 2019 7 395 Roche Cobas e411 analyzer 85.2 (50.3, 134.8) 
Bayer, 2014 [9] 7.1 - 8 15 Roche Elecsys analyzer (12.5, 232.5) 
Manjon, 2004 [10] 4-10 25 Metra Biosystems NovoCalcin assay Mean (IC95%:): 15.128 (12.30, 17.95) 
Girls 
Generation XXI, 2019 7 197 Roche Cobas e411 analyzer 87.9 (52.5, 137.7) 
Huang, 2011 [8] 6-10 33 Roche P-modular analyzer (61.4, 136.2) 
Rauchenzauner, 2007 [11] 7 32 Active Human Osteocalcin IRMA 19.96 (P3, P97: 7.90, 50.44) 
Vietri, 2006 [12] 6.1-8 207 DiaSorin LIASON analyzer Mean: 69.06 (31.46, 92.10) 
Seydewitz, 2001 [13] 6-8 25 Immulite immunoanalyzer 31.3 (P5, P95: 18.6, 62.0) 
Cioffi, 1997 [14] 7 42 CIS Bio International IRMA  72.6 (P25, P75: 53, 97) 
Boys 
Generation XXI, 2019 7 198 Roche Cobas e411 analyzer 82.1 (50, 129.9) 
Huang, 2011 [8] 6-9 30 Roche P-modular (56.5, 152.1) 
Rauchenzauner, 2007 [11] 7 32 Active Human Osteocalcin IRMA 19.54 (P3, P97: 8.12, 47.00) 
Vietri, 2006 [12] 6.1-8 209 DiaSorin LIASON analyzer Mean: 65.6 (27.48, 98.36) 
Seydewitz, 2001 [13] 6-8 34 Immulite immunoanalyzer 31.6 (P5, P95: 10.6, 50.5) 
Cioffi, 1997 [14] 7 51 CIS Bio International IRMA 66.8 (P25, P75: 49, 104) 
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Supplemental table 3. Reference intervals for serum β-crosslaps concentrations (ng/l) 
First author, year Age (years) N Assay/Analytic platform P50 (P2.5, P97.5) 
Both sexes 
Generation XXI, 2019 7 395 Roche Cobas e411 analyzer 1030 (470, 1690) 
Crofton, 2002 [15] 1-9 124 Osteometer Biotech ELISA 352 (95% CI: 146, 818) 
Girls 
Generation XXI, 2019 7 197 Roche Cobas e411 analyzer 1040 (450, 1690) 
De Melo, 2018 [16]  6-9 23 Roche Cobas e170 analyzer (565, 1570) 
Gennai, 2016 [17] 7 NA Technogenetics-Bouty DSX system 2000 (P10, P90: 500, 3000) a 
Herrmann, 2014 [18] 7.5 186 Roche ECLIA Modular E17 1260 (P3, P97: 750, 1770) b 
Alberti, 2011 [19] 7-8 NA Immunodiagnosticsystems ELISA 2078 (1413, 3410) 
Huang, 2011 [8] 6-10 33 Roche P-modular (820, 2060) 
Rauchenzauner, 2007 [11] 7 32 Osteometer Biotech One Step ELISA 1836 (P3, P97: 897, 3109) 
Boys 
Generation XXI, 2019 7 198 Roche Cobas e411 analyzer 1005 (510, 1690) 
De Melo, 2018 [16] 6-9 28 Roche Cobas e170 analyzer (509, 1697) 
Gennai, 2016 [17] 7 NA Technogenetics-Bouty DSX system 1500 (P10, P90: 300, 3300) a 
Herrmann, 2014 [18] 7.0-7.9 198 Roche ECLIA Modular E17 1230 (P3, P97: 750, 1710) b 
Alberti, 2011 [19] 7-8 NA Immunodiagnosticsystems ELISA 2151 (1285, 2902) 
Huang, 2011 [8] 6-9 29 Roche P-modular (1050, 2380) 
Rauchenzauner, 2007 [11] 7 32 Osteometer Biotech One Step ELISA 1637 (P3, P97: 787, 2794) 
 
a Abstracted from visual inspection of the reference curves  
b Assuming a mean height of 126 cm in girls and 127 cm in boys  
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Supplemental figure 1. Weight trajectories in the Generation XXI cohort 
 
Solid line, “normal weight gain” trajectory; dashed-dotted line, “weight gain during infancy” trajectory; dashed line, “weight gain during childhood” trajectory; dotted line, 
“persistent weight gain” trajectory. 
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Supplemental table 4. Pearson correlation and partial correlation coefficients between bone metabolism markers and bone mineral content and density in 
lower limbs, in girls and boys (n=395) 
  Lower limbs BMC Lower limbs aBMD 
  Coefficient 95% CI Coefficient 95% CI 
tALP 
Girls r=0.26 0.12, 0.38 r=0.25 0.12, 0.38 
 rpartial=0.04 -0.11, 0.17 rpartial=0.04 -0.10, 0.18 
Boys r= 0.26 0.13, 0.39 r=0.22 0.08, 0.35 
  rpartial=0.15 0.01,0.28 rpartial=0.09 -0.05, 0.23 
OC 
Girls r=0.25 0.11, 0.38 r=0.18 0.04, 0.31 
 rpartial=0.25 0.12, 0.38 rpartial=0.16 0.02, 0.30 
Boys r=0.18 0.04, 0.31 r=0.14 0.00, 0.28 
  rpartial=0.06 -0.08, 0.20 rpartial=0.05 -0.08, 0.19 
β-CTx 
Girls r=0.08 -0.06, 0.22 r=0.01 -0.13, 0.15 
 rpartial=0.11 -0.03, 0.25 rpartial=0.04 -0.10, 0.18 
Boys r=0.09 -0.05, 0.22 r=0.06 -0.08, 0.20 
  rpartial=0.00 -0.14, 0.14 rpartial=0.00 -0.14, 0.14 
 
Abreviations: tALP, total alkaline phosphatase; OC, osteocalcin; β-CTx, β-crosslaps; BMC, bone mineral content; aBMD, areal bone mineral density; r, 
Pearson correlation coefficient, rpartial, Pearson partial correlation coefficient (age, body size and season controlled), 95% CI, 95% confidence interval.   
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Abstract 
 
Background: We tested the potential for adiposity to specifically influence bone mass 
in children, using the association between socioeconomic position (SEP) and fat mass 
as a benchmark. 
 
Methods: We used data from 2408 7-year-old children born in 2005/6, recruited as part 
of the Generation XXI cohort (Porto, Portugal). Weight and height were measured using 
standard methods and body composition (fat mass, lean mass and bone mineral content) 
was estimated using whole-body dual-energy X-ray absorptiometry. Socioeconomic 
position was characterized using 10 context-appropriate indicators: caregivers’ 
educational level and occupation, household income, child’s type of school, caregiver 
smoking, maternal smoking during pregnancy, hiring a housekeeper and taking holidays 
away. Associations were estimated using linear regression coefficients and 95% 
confidence intervals. Sensitivity analysis was conducted by excluding children more 
susceptible to nonparticipation or attrition. 
 
Results: By design, all SEP indicators were associated with fat mass. Bone mineral 
content was associated with the educational level of the main (less than higher vs. higher 
education, standardized coefficient and 95% CI: 0.15; 0.07, 0.24) and secondary (0.13; 
0.03, 0.22) caregivers and with the occupations of the main (blue and lower white vs. 
upper white collar: 0.12; 0.03, 0.20) and secondary (0.10; 0.01, 0.18) caregivers. 
Associations were negligible with the six remaining SEP indicators. A similar pattern was 
found for lean mass and height. Sensitivity analysis did not change our findings. 
 
Conclusions: Using social causes as benchmark, fat mass likely has a small specific 
effect on bone mineral content beyond its contribution to body size in childhood.  
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Introduction 
 
Fragility fractures are, and will likely remain, frequent causes of death and impairment in 
older adults [1,2]. Bone physical properties have emerged as a useful proxy for fracture 
risk since they convey the resistance of bone to external trauma in addition to other less 
well defined components of frailty [3]. An additional practical advantage of studying 
physical properties of bone is the possibility to estimate these using noninvasive methods 
long before fracture events are expected but when prevention strategies might be the 
most effective [4,5]. 
 
Of all the evidence that has been produced on the causes of bone fragility, arguably the 
most consistently reported besides age is body size [6]. At any given age, it is a 
generalized observation that larger individuals have higher bone mineral density and 
content [7,8]. This provides empirical support for theoretical models of bone 
mineralization that place mechanical demands as the main osteogenic stimulus, 
particularly during growth [9]. Changes to body size are seen as challenges to 
mechanical stability that induce changes in bone mass and architecture to better adapt 
the skeleton to the load it bears [6]. In view of the overwhelming evidence against excess 
adiposity, this makes for a very particular population health challenge since it implies that 
higher weight leads to improved bone properties [10]. As a consequence, several 
epidemiologic investigations, including our own previous work, have attempted to isolate 
endocrine effects of adiposity on bone properties using explicit or implicit structural 
modeling [11-13]. After statistically accounting for weight, most studies have concluded 
for a small but deleterious effect of adiposity on bone physical properties [14], typically 
discussed on the basis of physiological mechanisms linking fat and bone metabolism 
[15]. 
 
We believe that any estimation of an average direct effect of fat on bone that statistically 
discounts its weight component raises important validity concerns. Even if we use the 
unrealistic assumptions of no unmeasured confounding by common causes of adiposity 
and weight, and no collider bias due to conditioning on weight (Figure 1), the close 
biological dependence between weight and adiposity has clear potential for sparse data 
bias: it is very implausible, for instance, that we find empirical data from individuals with 
high fat mass but low body weight [16]. These common challenges illustrate the 
limitations of using epidemiology to disentangle physiological processes, which are not 
its object [17]. 
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Figure 1. Diagram depicting hypothesized causal relations between adiposity, body weight and 
bone mass in the implausible scenario of 1) no unmeasured confounding by common causes of 
adiposity and body weight, and 2) no collider bias due to conditioning on weight as an 
intermediate step. In this unlikely scenario, body weight adjustment would suffice to estimate 
the specific (weight-independent) effect of adiposity on bone mass. 
 
An alternative straightforward approach that seems more coherent with epidemiologic 
thinking is to use common causes as a benchmark. In most high-income countries, the 
distribution of adiposity is socially-patterned, whereas this effect is currently a lot less 
marked for other body size and composition traits, such as height and lean mass [18]. If 
adiposity is a specific determinant of bone mass beyond its contribution to body size, we 
expect that specific causes of adiposity (i.e. that are less relevant for other constitutional 
traits) are also indirect causes of bone mass, to a measurable extent. If this is the case, 
the associations between socioeconomic position (SEP) indicators and bone mass 
should mirror those between SEP indicators and fat mass. Evidence to the contrary may 
be interpreted as a lack of specificity of fat as a determinant of bone mass. 
 
Therefore, in this study we aimed to indirectly test the potential for adiposity to specifically 
influence bone physical properties in children, by assessing whether well-documented 
socioeconomic causes of fat mass are associated with bone mineral content in a birth 
cohort of 7-year-old children. 
  
Adiposity Body weight Bone mass
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Methods 
 
Study population and sample 
This study was conducted within Generation XXI, a birth cohort study with a 
geographically defined target population. All women who delivered live-born children with 
more than 23 weeks of gestation in one of the five public units providing level III 
obstetrical and neonatal care in the metropolitan area of Porto, Portugal, between April 
2005 and August 2006, and whose residence was in the units’ catchment area were 
eligible for recruitment. Of those invited, 91.4% accepted to participate. All 8647 children 
enrolled at birth were invited to attend follow-up assessments at ages four (2009-2011) 
and seven (2012-2014) years (86.3% and 79.7% participation, respectively). Children 
were typically invited for evaluations up to 8 weeks after their birthdays. Ethical approval 
was obtained from the Ethics Committee of the Hospital de São João and the University 
of Porto Medical School. The study protocol is registered with the Portuguese Data 
Protection Authority and conforms to the Helsinki Declaration and national legislation. At 
each evaluation, written informed consent was obtained from all legal guardians and oral 
assent was obtained from children. Detailed procedures have been published elsewhere 
[19,20]. Questionnaires in Portuguese are available online: 
http://www.geracao21.com/pt/projeto#avaliacoes. 
 
This study was conducted in a consecutive subsample of participants who attended the 
face-to-face interviews at age seven between December 1, 2012 and August 31, 2013 
and were invited to perform a whole-body dual-energy X-ray absorptiometry (DXA) scan. 
The selection of this subsample was due to funding schedule and equipment availability. 
Of the 3015 eligible participants, DXA scans were conducted successfully in 2408 
children (257 explicitly refused to undergo the scan, 335 did not show up to any of three 
different scheduled appointments or did not respond to at least five invitations, one did 
not cooperate, one had no working phone contacts, and 13 had images with 
unacceptable technical quality).  
 
Body size and composition 
Anthropometrics were obtained with children in underwear and barefoot. Height was 
measured to the nearest 0.1 cm using a wall stadiometer (SECA, Hamburg, Germany) 
and weight was measured with a digital scale (Xinyu Electronic Co., Limited, Zhongshan, 
China) to the nearest 0.1 kg. DXA scans were performed using a Hologic Discovery QDR 
4500W device (Hologic Inc., Bedford, Massachusetts), software version 13.3.0.1, while 
children were barefoot in light indoor clothing and without metal accessories. Total body 
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less head (subtotal) fat (kg), fat-free mass (kg) and bone mineral content (BMC, kg) were 
extracted. Lean mass (kg) was obtained by subtracting BMC from fat-free mass. 
 
Socioeconomic position 
As socioeconomic position indicators, we selected variables that were both described in 
the literature as well-documented causes of fat mass [21-23] and supported by empirical 
observation in our study population [24]. Information was self-reported and collected 
using face-to-face questionnaires applied to legal guardians in the 7 years of age follow-
up with the exception of maternal smoking during pregnancy, which was collected at 
recruitment. Educational level was recorded as the number of completed years of formal 
schooling and categorized as higher (>12 years) or less than higher education (≤12 
years). Occupation was recorded using the main current job and classified according to 
the International Standard Classification of Occupations (ISCO-08) [25]. Occupations 
were further grouped into upper white-collar (armed forces, managers, professionals, 
technicians and associate professionals), and lower white-collar or blue-collar (clerical 
support workers, services and sales workers, skilled agriculture, forestry and fishery 
workers, craft and related trades workers, plant and machine operators and elementary 
occupations). The main caregiver was classified as current smoker (including daily and 
occasional smokers) or non-smoker (including former smokers with at least six months 
abstinence and never smokers). Maternal smoking during pregnancy was considered 
present if mothers had smoked any amount in at least one trimester. Monthly household 
income was recorded in EUR 500 categories and grouped into two categories: less or 
equal to EUR 3000 and more than EUR 3000. The type of school that the child attended 
(public vs. private) was also recorded. Indicators of material living conditions included 
hiring a housekeeper full or part-time and taking holidays away from home at least once 
a year. 
 
Data analyses 
Figure 2 represents the simplest formulation of our main causal assumptions: if fat mass 
is a cause of bone mass and SEP is a cause of fat mass, we expect to find a statistical 
association between SEP and bone mass. We cannot exclude, however, that SEP 
influences bone mass through a different non-adiposity-mediated mechanism, which 
explains the direct edge from SEP to bone mass. 
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Figure 2. Diagram depicting the causal relations between socioeconomic position (SEP), fat 
mass and bone mass under the assumptions that: 1) SEP has an effect on fat mass, 2) fat 
mass has an effect on bone mass, and 3) there is a direct effect of SEP on bone mass not 
mediated by fat mass. According to the mechanostat theory, the potential direct effect of SEP 
on bone mass would most likely involve the remaining constitutional components as mediators, 
summarized in this paper as lean mass and height. When compared to adiposity, the evidence 
of the effect of SEP on either height or lean mass in younger cohorts is much weaker, even 
though both of them are documented determinants of bone mass. Therefore, assuming a weak 
direct (fat-independent) effect of SEP on bone mass, if the magnitude of the fat-mediated effect 
of SEP on bone is high, we expect that SEP will be statistically associated with bone mass, 
which would indirectly translate a specific role of adiposity on bone mass 
 
We started our data analysis by estimating the statistical associations between BMC and 
the remaining body composition and anthropometric variables using linear regression 
coefficients and their respective 95% confidence intervals (95% CI). This served to test 
the consistency of Generation XXI data with prior knowledge regarding the fundamental 
assumption that each body size or composition trait is associated with bone mass. To 
illustrate the reversal of estimate direction from a crude to a weight-adjusted model 
documented in previous studies, we calculated a regression coefficient for fat mass 
adjusted for total body weight. Also using linear regression, we then quantified the 
magnitude of the associations between each socioeconomic position indicator and 
height, weight, fat mass, lean mass, and BMC. We used the associations between SEP 
and fat mass as a positive control and the associations between SEP and height or lean 
mass as negative controls for our test set of associations, i.e. between SEP and BMC. 
The term “control” is used here in the laboratory and not the case-control sense, i.e. we 
expected to find stronger statistical associations between SEP indicators and fat mass 
than those between SEP and lean mass or, particularly, SEP and height [26]. All 
anthropometric variables were z-scored using the means and standard-deviations 
derived from the study sample and regression coefficients are presented crude and 
standardized to facilitate the comparison of the magnitude of effect estimates. 
 
Socioeconomic 
position
Fat mass Bone mass
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To estimate the effect on our findings of losses due to nonparticipation and attrition 
during follow-up, we conducted a sensitivity analysis based on the assumption of a 
continuous gradient of difficulty in recruitment and retention in cohort studies [27]. When 
compared to participants who were readily willing to participate in all follow-up waves 
after a single contact, we assumed that subjects whose participation required more effort 
on our part were more similar to those who did not participate at all. Therefore, among 
the children included in our study, we reran a set of analyses by excluding, in separate 
models, children who did not participate in the 4-years-old evaluation (n=249) and 
children who underwent the 7-year-old evaluation when they were 7.5 or more (n=158). 
We also used observed differences between subjects included and those lost to follow-
up as an additional marker of participation, and computed estimates after excluding 
participants who were likely more similar in terms of social background to those lost to 
follow-up: children whose mothers were younger than 25 years at delivery (n=337) and 
children whose household crowding index was above 1.5 (n=152). For conciseness we 
selected three SEP indicators (main caregiver educational level, child’s type of school 
and maternal smoking during pregnancy) and our three main outcomes (fat mass, BMC 
and height). Statistical analysis was performed with Stata, version 11.2, for Windows 
(Stata Corp LP). 
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Results 
 
Our sample of 2408 Generation XXI children (47.4% girls) had mean (SD) age 7.4 (0.4) 
years, height 124.6 (5.6) cm and weight 27.2 (5.5) kg. The proportions of overweight 
children were 39.3% and 36.0% according to the WHO and CDC cutoffs, respectively. 
Mean (SD) subtotal fat mass was 7.7 (3.4) kg and lean mass 14.7 (2.3) kg. Mean (SD) 
subtotal bone mineral content was 0.60 (0.08) kg. Table 1 reports linear regression 
coefficients for the associations between each of the body size and composition 
variables and BMC at 7 years of age. As expected, all variables were clearly associated 
with BMC and standardized coefficients were lowest for fat mass and highest for height 
and lean mass. After adjustment for weight, fat mass was negatively associated with 
BMC. 
 
Table 1. Associations between bone mineral content (g) and body size (weight and height) and 
body composition (fat mass and lean mass) at 7 years of age (linear regression analysis), 
Generation XXI, Porto, Portugal (n=2408) 
 Change per unit increase a Change per SD increase 
 Crude coefficient 
(β) 
95% CI Standardized coefficient 
(βst) 
95% CI 
Height  0.012 0.011, 0.013 0.069 0.067, 0.071 
Total body weight 0.012 0.011, 0.012 0.064 0.062, 0.066 
Lean mass 0.030 0.029, 0.031 0.069 0.067, 0.071 
Fat mass 0.014 0.013, 0.014 0.047 0.044, 0.050 
Fat mass adjusted for weight  -0.021 -0.022, -0.020 -0.072 -0.077, -0.067 
 
a Height in cm, total body weight, lean mass, fat mass and fat mass adjusted for weight in kg. 
Abbreviations: CI, confidence interval; SD, standard deviation  
 
In terms of socioeconomic position indicators (Table 2), more than one third of the main 
caregivers (the mother in 97.9% of children and the father in 1.4%) and almost half of 
the secondary caregivers (the father in 89.3% of children and a grandparent in 6.1%) 
had less than 9 years of formal schooling. Main caregivers were more likely to be white-
collar workers while secondary caregivers were frequently upper white-collar workers or 
skilled blue-collar workers. One fifth of the mothers in our sample had smoked during 
pregnancy. More than a quarter of children lived in a household with an average monthly 
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income lower than EUR 1000. Regarding material living conditions, less than one fifth of 
families hired a housekeeper and one quarter reported not taking holidays away from 
home. 
 
Table 2. Distribution of participants according to socioeconomic position indicators at 7 years of 
age, Generation XXI, Porto, Portugal 
 n (%) a 
Main caregiver educational level   
≤9 years 901 (37.5) 
10-12 years 749 (31.2) 
>12 years 753 (31.3) 
Missing 5 
Secondary caregiver educational level  
≤9 years 1131 (48.5) 
10-12 years 665 (28.5) 
>12 years 536 (23.0) 
No second caregiver 40 
Missing 36 
Main caregiver occupation  
Upper white-collar 864 (37.2) 
Lower white-collar 977 (42.0) 
Skilled blue-collar 247 (10.6) 
Unskilled blue-collar 237 (10.2) 
Student or Homemaker 4 + 77 
Missing 2 
Secondary caregiver occupation  
Upper white-collar 970 (41.9) 
Lower white-collar 476 (20.6) 
Skilled blue-collar 712 (30.8) 
Unskilled blue-collar 156 (6.7) 
Student or Homemaker 9 + 30 
No second caregiver 40 
Missing 15 
Main caregiver smoking status  
Non-smoker  1860 (77.4) 
Current smoker 543 (22.6) 
Missing 5 
Maternal smoking during pregnancy  
Never smoked 1897 (79.4) 
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Ever smoked 491 (20.6) 
Missing 20 
Monthly household income  
≤ EUR 1000 634 (26.8) 
EUR 1001– EUR 3000 1569 (66.4) 
> EUR 3000 160 (6.8) 
Not known or Undisclosed 42 + 2 
Missing 1 
Child’s type of school  
Public 2166 (90.2) 
Private 234 (9.8) 
Other 5 
Missing 3 
Hiring a housekeeper  
Full-time  403 (16.8) 
Part-time 33 (1.4) 
No 1968 (81.9) 
Missing 4 
Taking holidays away from home   
Yes  1835 (76.2) 
No  572 (23.8) 
Missing 1 
 
a Percentages sum 100% for participants included in the analysis of each SEP indicator (n=2403 for main 
caregiver educational level; n=2332 for secondary caregiver educational level; n=2325 for main caregiver 
occupation; n=2314 for secondary caregiver occupation; n=2403 for main caregiver smoking status; n=2388 
for maternal smoking during pregnancy; n=2363 for monthly household income; n=2400 for child’s type of 
school; n=2404 for hiring a housekeeper; n=2407 for taking holidays away from home). 
 
Figure 3 and supplemental tables 1 and 2 present the magnitudes of the associations 
between each socioeconomic position indicator and each body size or composition 
outcome. By design, all 10 SEP indicators selected were associated with fat mass. With 
the exceptions of monthly household income and child’s school type, associations of 
SEP indicators with total weight showed a very similar pattern to those with fat mass, 
namely with regard to the rank of magnitudes, with the strongest associations being 
observed for educational levels of the main caregiver (less than higher education vs. 
higher education: standardized coefficient (βst)=0.29, 95% CI: 0.20, 0.37 for fat mass and 
βst=0.25, 95% CI: 0.16, 0.33 for total weight) and secondary caregiver (βst=0.28, 95% CI: 
0.18, 0.38 for fat mass and βst=0.24, 95% CI: 0.14, 0.33 for total weight). These were 
followed by main and secondary caregivers’ occupations, hiring a housekeeper, 
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maternal smoking during pregnancy, main caregiver current smoking and taking holidays 
away from home. With the exception of a comparatively weak association with primary 
caregiver educational level, height – our negative control – showed negligible 
associations with all the SEP indicators selected. As for our main outcome, BMC, we 
found associations with main (βst=0.15, 95% CI: 0.07, 0.24) and secondary (βst=0.13, 
95% CI: 0.03, 0.22) caregivers’ educational levels and main (βst=0.12, 95% CI: 0.03, 
0.20) and secondary (βst=0.10, 95% CI: 0.01, 0.18) caregivers’ occupations. 
Associations were weaker or imprecise with monthly household income, child’s school 
type, hiring a housekeeper, maternal smoking during pregnancy, taking holidays away 
from home and main caregiver current smoking. A very similar pattern of associations 
with SEP indicators was found for lean mass, including the rank and magnitude of 
standardized measures of association. In addition, for both BMC and lean mass, the 
magnitudes of the strongest associations with SEP indicators were substantially lower 
than those found for fat mass and total weight. 
 
Figure 4 presents the results of our sensitivity analysis excluding, in four separate 
models, children who did not participate in the 4-years-old evaluation, children who 
underwent the 7-year-old evaluation when they were 7.5 of more, children whose 
mothers were younger than 25 years at delivery and children whose household crowding 
index was above 1.5. In each of these four subsamples we found similar associations 
between SEP indicators and fat mass, BMC and height to those found for the whole 
sample.  
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Figure 3. Standardized linear regression coefficients (βst) and 95% confidence intervals for the associations between socioeconomic position indicators and each of the body 
size and composition outcomes. Socioeconomic indicators ordered by decreasing strength of association with fat mass 
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Figure 4. Standardized linear regression coefficients (β) and 95% confidence intervals for the 
associations between socioeconomic position indicators (main caregiver educational level, 
child’s type of school and maternal smoking during pregnancy) and body size and composition 
outcomes - A) Fat mass, B) BMC and C) Height.  
 
Diamond: whole sample of children included in the analysis of each socioeconomic position indicator 
(n=2403 for main caregiver educational level; n=2388 for maternal smoking during pregnancy; n=2400 for 
child’s type of school). Square: excluding children who did not participate in the 4-years-old evaluation 
(n=2156 for main caregiver educational level; n=2142 for maternal smoking during pregnancy; n=2153 for 
child’s type of school). Circle: excluding children who underwent the 7-year-old evaluation when they were 
7.5 of more (n=2246 for main caregiver educational level; n=2232 for maternal smoking during pregnancy; 
n=2242 for child’s type of school). Triangle: excluding children whose mothers were younger than 25 years 
at delivery (n=2066 for main caregiver educational level; n=2056 for maternal smoking during pregnancy; 
n=2063 for child’s type of school). Cross: excluding children whose household crowding index was above 
1.5 (n=2252 for main caregiver educational level; n=2237 for maternal smoking during pregnancy; n=2248 
for child’s type of school). BMC, bone mineral content. 
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Discussion 
  
In this work our central assumption was that traits that are causally related share causes 
to a measurable extent. We found that socioeconomic predictors of fat mass at 7 years 
of age were in general weakly associated with bone mineral content at the same age. 
Our causal interpretation is that there is little evidence of a specific effect of adiposity on 
bone mass in 7-year-old children beyond its contribution to body size. 
 
We decided to address this issue due to the singularity of the relation between adiposity 
and bone resistance. The observation that fat mass has a crude positive association with 
bone mass is generalized, but a causal interpretation of those findings would have 
delicate implications in the face of the numerous harms of obesity. This is no reason to 
discredit a beneficial effect of fat on bone, but it is certainly a reason to assess its 
robustness. A number of papers have attempted to isolate the effect of fat by conditioning 
on the remaining body size and composition measures, and many found an inversion of 
adjusted estimates (also illustrated in our results) that would suggest a harmful effect of 
fat on bone [28]. However, this issue is particularly challenging to study using 
anthropometric and body composition traits alone, since the different measures are very 
closely related, physiologically and constitutionally, particularly during growth. In 
practice, it is very likely that any measure of body size or composition is statistically 
associated with bone mass simply because it is part of the same organ system or 
because it evolves together with the skeleton during growth. In fact, height velocity drives 
lean mass, fat mass, and bone mass velocities, all of which peak within a 10-month 
period [29]. In the present study, this is demonstrated in the strong associations of height, 
weight, fat mass and lean mass with bone mineral content. This analytical problem is 
also illustrated by the implausibility of directed acyclic graphs that attempt to represent 
relations between traits whose expression is largely regulated by physiological feedback. 
The common endocrine control of body composition during growth renders directional 
causal assumptions particularly challenging to formulate or test and may explain the 
inversion of adjusted estimates through collider and/or sparse data biases [16,30]. 
 
We believe that the population health perspective requires analytical approaches that 
address causation without overworking empirical data, while taking advantage of a 
special attention to different disease causation levels. Therefore, we chose a benchmark 
from outside the domain of physiology, but with documented specificity for fat, i.e. more 
strongly causally related with fat than with other body size or composition traits. We 
assumed that if there was a strong causal relation between fat mass and bone mineral 
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content then the causes of fat mass would also be indirect causes of bone mass, to an 
extent that we could estimate using statistical associations. In this framework, our main 
finding was the difference between fat mass and bone mass in terms of their associations 
with SEP indicators. It is well-known that social background is related with adiposity in 
high-income countries [18,22,31]. While this was replicated in our study, we now add 
that the same ten SEP indicators in the same cohort have much weaker or negligible 
associations with bone mineral content. However, we acknowledge that the observed 
association between SEP and bone mass may be the net result of two different 
components, only one of which mediated by fat (Figure 2). The present results may be 
due to the cancelling out of a fat-mediated effect by a direct effect of SEP on bone in the 
opposite direction. This has been suggested in another birth cohort, where authors 
concluded that social position seemed positively related to bone mass due to increased 
height but that this influence was counteracted by a positive effect of fat deposition on 
bone area [32]. Although we cannot exclude this possibility, a height-mediated effect of 
SEP on bone is not likely in our population, since little evidence of an effect of SEP on 
height was found in the whole cohort [26]. The explanation might be that Generation XXI 
children were born more recently (2005-2006) and socioeconomic disparities in height 
have narrowed substantially over the last decades in several contexts [18,33,34]. In fact, 
we took advantage of this absence of a measurable effect of SEP on height to use it as 
a negative control for our findings regarding adiposity. An additional relevant aspect that 
we did not address here is confounding by parental anthropometry: a large genetic study 
found that one’s height and BMI are likely to have an effect on one’s SEP, which implies 
that parental anthropometry could be a common cause of parental SEP and child 
anthropometry in our study [35]. However, if this was a major source of confounding in 
the younger generations, we would again expect to find an association between parental 
SEP and children’s height, which we did not. 
 
Interestingly, the pattern of associations with SEP was very similar between bone mineral 
content and lean mass, with caregivers’ educational level and occupation as the only 
potential causes. This is consistent with previous findings of high correlations between 
muscle and bone mass in children, which are typically stronger than those between fat 
and bone [36]. The interpretation might be that lean mass determines bone mass or, 
even more likely, both are a result of common environmental exposures, such as 
physical activity, that may modulate overall musculoskeletal development while being 
influenced by particular literacy-related features of SEP such as educational level. 
Nevertheless, we acknowledge that the similarity between bone and lean mass 
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outcomes might be inflated due to the fact that both were extracted from the same whole-
body DXA scan. 
 
Socioeconomic position is a complex construct and its measurement challenging. By 
design, we chose to test only SEP indicators that were associated with adiposity, leaving 
out other potential measures that were not predictive of fat mass in our target population. 
We recognize that this option may have disregarded important dimensions, although we 
believe we have captured the most relevant SEP indicators in our context [24]. In 
addition, SEP was used here to establish a positive benchmark due to its association 
with adiposity. The inclusion of indicators that are not associated with fat mass would not 
contribute useful information to test our main hypothesis. Also with regard to exposure 
assessment, we cannot exclude that SEP indicators collected using a face-to-face 
questionnaire were subject to social desirability or unwillingness to disclose, but it seems 
unlikely that this has had a large impact on our findings since they were robust to 10 
different SEP indicators and to different exposure categorization strategies (latter results 
not shown). Our use of dichotomous variables for SEP indicators also likely diluted the 
effect of misclassification between finer categories, which were not essential to test our 
hypothesis. 
 
Several voluntary and involuntary filters sequentially affected the composition of the final 
sample. We imposed a design filter on sample size by consecutively selecting a 
subsample of around 3000 children for DXA scans and used a technical quality criterion 
for scans. We believe these options had negligible effects on our estimates, since the 
former was solely based on equipment availability and funding schedule and the latter 
affected a small number of exams. More importantly, however, the results presented 
here were obtained in individuals whose families accepted to participate in the cohort 
study, to be followed up to age seven, to undergo DXA, and to report on SEP indicators. 
A number of different mechanisms may be hypothesized to explain nonparticipation, 
losses to follow-up or unwillingness to disclose particular information. To assess their 
impact on our findings, we opted to conduct a sensitivity analysis based on the 
assumption that participant-dependent filters (nonparticipation, attrition and 
nondisclosure of information) act probabilistically [27]. We considered that, among 
participants, there are individuals who are more similar to extreme nonparticipants and 
that this similarity may be assessed on the basis of their record of interactions with the 
research team and background characteristics. Our sensitivity analyses showed that 
exclusions had a minor impact on our main findings, suggesting that our results were not 
seriously biased in this regard. 
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It is possible that our findings are not generalizable to older birth cohorts, where the 
relations between socioeconomic background and body size seem at least quantitatively 
different. We can also hypothesize different causal structures in other populations where 
our results would not necessarily be applicable. However, as long as SEP is specific for 
adiposity when compared to other body size and composition traits, we believe that our 
findings may be replicable in other settings. An important external validation is that our 
results on the effect of SEP on bone quality generally agree with those of previous 
studies in high-income countries [32,37-40]. Finally, our study does not intend to provide 
estimates for children with established metabolic or hormonal disease, even though the 
present findings were obtained from a sample where more than one third of children 
were overweight at age seven, accurately reflecting the source population. 
 
In conclusion, in a setting where SEP is an undisputed cause of adiposity, we found little 
evidence of a social determination of bone mineral content at 7 years of age. Our 
interpretation is that either fat mass does not have a specific effect on bone beyond its 
contribution to body size or that it has a small comparative effect, positive or negative, 
not enough to overcome that of other constitutional traits. The main implication of our 
study is that adiposity is unlikely to be an important cause of bone mass in childhood at 
the population level. 
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Supplemental table 1. Linear regression coefficients (β) and 95% confidence intervals for the associations between socioeconomic position indicators and each of 
the body size and composition outcomes 
 
Fat mass 
(kg) 
Total body weight 
(kg) 
Bone mineral 
content (kg) 
Lean mass 
(kg) 
Height 
(cm) 
 β 95% CI β 95% CI β 95% CI β 95% CI β 95% CI 
Main caregiver educational level (less than higher 
education vs. higher education) 
0.99 0.69 1.28 1.37 0.90 1.84 0.01 0.01 0.02 0.33 0.13 0.53 0.55 0.07 1.03 
Secondary caregiver educational level (less than higher 
education vs. higher education) 
0.97 0.63 1.30 1.32 0.79 1.85 0.01 0.00 0.02 0.30 0.08 0.52 0.34 -0.20 0.88 
Child’s type of school (Public vs. Private) 0.75 0.28 1.21 0.65 -0.09 1.40 0.00 -0.02 0.01 -0.09 -0.41 0.22 -0.59 -1.34 0.16 
Main caregiver occupation (Lower white-collar and blue-
collar vs. Upper white-collar) 
0.72 0.43 1.01 1.11 0.64 1.57 0.01 0.00 0.02 0.33 0.13 0.52 0.39 -0.07 0.86 
Monthly household income (≤ EUR 3000 vs. > EUR 3000) 0.69 0.14 1.25 0.72 -0.16 1.61 0.00 -0.01 0.02 0.05 -0.32 0.42 -0.12 -1.01 0.78 
Secondary caregiver occupation (Lower white-collar and 
blue-collar vs. Upper white-collar) 
0.66 0.37 0.94 0.93 0.48 1.39 0.01 0.00 0.02 0.24 0.05 0.43 0.18 -0.28 0.64 
Hiring a housekeeper (No vs. Yes) 0.62 0.26 0.97 0.68 0.11 1.25 0.00 -0.01 0.01 0.05 -0.19 0.28 -0.16 -0.74 0.42 
Maternal smoking during pregnancy (Yes vs. No) 0.59 0.25 0.93 0.63 0.08 1.17 0.00 -0.01 0.01 0.03 -0.20 0.26 -0.23 -0.78 0.32 
Main caregiver current smoking status (Yes vs. No) 0.59 0.26 0.92 0.70 0.17 1.23 0.00 -0.01 0.01 0.09 -0.13 0.31 -0.24 -0.77 0.30 
Holidays away from home (No vs. Yes) 0.57 0.24 0.89 0.73 0.21 1.24 0.00 0.00 0.01 0.09 -0.12 0.31 0.23 -0.29 0.75 
Socioeconomic indicators ordered by decreasing strength of association with fat mass.  
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Supplemental table 2. Standardized linear regression coefficients (βst) and 95% confidence intervals for the associations between socioeconomic pos ition 
indicators and each of the body size and composition outcomes 
 
Fat mass 
(z-score) 
Total body weight 
(z-score) 
Bone mineral 
content (z-score) 
Lean mass 
(z-score) 
Height 
(z-score) 
 βst 95% CI βst 95% CI βst 95% CI βst 95% CI βst 95% CI 
Main caregiver educational level (less than higher 
education vs. higher education) 
0.29 0.20 0.37 0.25 0.16 0.33 0.15 0.07 0.24 0.14 0.06 0.23 0.10 0.01 0.18 
Secondary caregiver educational level (less than 
higher education vs. higher education) 
0.28 0.18 0.38 0.24 0.14 0.33 0.13 0.03 0.22 0.13 0.03 0.23 0.06 -0.04 0.16 
Child’s type of school (Public vs. Private) 0.22 0.08 0.35 0.12 -0.02 0.25 -0.06 -0.19 0.08 -0.04 -0.18 0.09 -0.11 -0.24 0.03 
Main caregiver occupation (Lower white-collar and 
blue-collar vs. Upper white-collar) 
0.21 0.12 0.29 0.20 0.12 0.28 0.12 0.03 0.20 0.14 0.06 0.23 0.07 -0.01 0.15 
Monthly household income (≤ EUR 3000 vs. > EUR 
3000) 
0.20 0.04 0.36 0.13 -0.03 0.29 0.05 -0.11 0.21 0.02 -0.14 0.18 -0.02 -0.18 0.14 
Secondary caregiver occupation (Lower white-collar 
and blue-collar vs. Upper white-collar) 
0.19 0.11 0.27 0.17 0.09 0.25 0.10 0.01 0.18 0.10 0.02 0.18 0.03 -0.05 0.11 
Hiring a housekeeper (No vs. Yes) 0.18 0.08 0.28 0.12 0.02 0.23 0.01 -0.09 0.12 0.02 -0.08 0.12 -0.03 -0.13 0.08 
Maternal smoking during pregnancy (Yes vs. No) 0.17 0.07 0.27 0.11 0.02 0.21 0.02 -0.08 0.11 0.01 -0.09 0.11 -0.04 -0.14 0.06 
Main caregiver current smoking status (Yes vs. No) 0.17 0.07 0.27 0.13 0.03 0.22 -0.01 -0.11 0.08 0.04 -0.06 0.14 -0.04 -0.14 0.05 
Holidays away from home (No vs. Yes) 0.16 0.07 0.26 0.13 0.04 0.23 0.05 -0.05 0.14 0.04 -0.05 0.13 0.04 -0.05 0.14 
Socioeconomic indicators ordered by decreasing strength of association with fat mass.
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5. Overall discussion 
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5.1. Main findings 
In a large population-based prospective cohort study of children and their mothers, we 
explored the effects of growth during different stages of the life course on bone 
mineralization at 7 years of age.   
Beginning in the intrauterine life, our results were indicative of heterogeneous 
associations between weight gain by mothers during pregnancy and offspring bone 
mineralization, according to maternal body mass index in early pregnancy. Among 
women who were under/normal weight at the beginning of pregnancy, gestational weight 
gain was slightly associated with increased offspring bone mineralization at 7 years, 
while in overweight/obese mothers increased gestational weight gain had no effect on 
childhood bone measures. When we analyzed gestational weight gain by using Institute 
of Medicine recommended categories for healthy weight gain during pregnancy, we 
found that excessive weight during pregnancy had no overall advantageous effect on 
childhood bone mineralization in both under/normal weight and overweight/obese 
mothers. 
As for the role of children’s growth in their bone mineralization at 7 years of age our 
findings suggested that both height and weight velocities in the first 6 years of life were 
clearly associated with increased childhood bone mass. Growth between 1 and 3 years 
had the strongest positive associations with childhood bone mineral mass, a finding 
possibly attributable to the adoption of the upright position and the development of 
walking abilities. Despite a strong statistical dependence on body size, this finding held 
for both height and weight growth. In addition to the identification of early childhood as a 
particularly sensitive period for the effect of growth on bone development, we found that 
differences in the overall shape of growth since birth up to the age of six, particularly with 
regard to the trajectory of weight gain, were also relevant for childhood bone mass and 
density. Specifically, children who followed trajectories of increased weight gain since 
birth, reflecting greater and longer exposure to loading, had clearly increased bone 
mineralization at the age of seven. Adjustment for concurrent body size uncovered the 
strong biological and statistical dependence between growth and the final weight 
attained, while suggesting a beneficial effect of a trajectory of later weight gain in 
comparison to an average (normal) trajectory. However, these important effects of early 
life growth on bone mineralization were not observable when we analyzed measures of 
bone turnover. In fact, in contrast to what happens in the clinical pediatric setting, bone 
formation and resorption markers seem to have limited utility in generally healthy 
children, specifically for describing overall anthropometric growth and bone 
mineralization status.  
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With respect to the relative contribution of components of weight, our results suggested 
that lean mass was a more important determinant of childhood bone mineralization than 
fat mass. We further explored the potential of fat mass for specifically affecting childhood 
bone mass through a singular approach that used common causes as a benchmark, i.e. 
assuming that traits that are causally related share causes to a measurable extent. In 
view of the absence of social determination of bone mass, in a context where fat mass 
is clearly determined by socioeconomic position, we suggest that fat mass may not have 
a specific effect on bone mass, beyond its contribution to childhood body size, or it effect 
is small in comparison to other body size and composition traits.  
 
In this thesis, despite different underlying research questions in the two studies 
assessing the role of infancy and childhood growth on bone mineralization, the results 
from both studies showed consistent strong positive associations between growth and 
bone. The fact that there was a broad agreement in the results between these 
approaches, despite different underlying assumptions, further reinforces our conclusion 
that growth is an important determinant of bone mineral accrual. Even though results 
from studies using distinct statistical approaches to model growth are not always 
straightforwardly comparable, the different methods of analysis are complementary and 
it is recommended to use more than one approach to describe growth associations [138].  
 
Additionally, although we recognize that maternal gestational weight gain reflects 
increases in several traits other than fetal growth, our findings of gestational weight gain 
and bone associations also contribute to show the relevance of growth, from as early as 
the intrauterine life, as a determining factor of childhood bone mineralization [119].  
 
An additional issue in our results is that we steadily found more consistent and strong 
associations of growth with bone mineral content (the most size-dependent measure) 
and much less marked associations with bone density. These findings are not surprising 
as they reflect the clear interdependency between the size of the overall skeleton and 
whole body growth, both in height and in weight.  
 
5.2. Implications for clinical practice and policy 
Throughout the thesis, potential implications of our findings at the policy and clinical 
practice levels are presented. However, we must recognize that etiological research 
does not aim to test the effectiveness of recommendations and other policy changes, 
and may not be directly applicable to the clinical and policy settings. If implications are 
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to be extracted, however, at the individual level, our findings support the inclusion of 
children’s skeletal health as a goal for weight counseling during pregnancy. Women 
should be informed that adherence to weight gain recommendations during pregnancy 
will also contribute to optimize their child’s skeletal health. Additionally, our results point 
to the importance of identifying disturbances in normal growth, particularly during early 
childhood, that may impact bone mineralization. Regarding the serum measurement of 
bone metabolism markers, our results do not support the general implementation of 
these measurements as part of standard clinical care of healthy children to monitor the 
status of bone mineral accrual. At the policy level, our findings reinforce the application 
of the Institute of Medicine guidelines for weight gain during pregnancy in order to also 
promote child skeletal health [122]. Furthermore, this thesis provided some evidence to 
highlight that strategies to optimize childhood growth before puberty are likely to have 
beneficial effects on bone mineralization. Specifically, interventions aiming to optimize 
childhood bone health might be more successful in early childhood. Additionally, 
preventive strategies or interventions aiming at reducing childhood adiposity might not 
be particularly relevant to promote childhood bone mineral accrual. 
 
5.3. Methodological considerations 
5.3.1. Selection bias 
In the present work, we analyzed data from a cohort of children followed prospectively 
since birth, and evaluated at 4 and 7 years of age. Selection bias at recruitment is 
possible, since only women giving birth in public maternities were invited to participate, 
therefore excluding women delivering in private facilities. Although it was estimated that, 
at the time of recruitment, births occurring in public hospitals corresponded to 91.6% of 
the total number of deliveries occurring in the whole catchment population, an 
overrepresentation of women from lower socioeconomic background and of those with 
complicated pregnancies is expected. In the Porto region, in accordance with national 
practice, level III public maternity units with differentiated pre and perinatal support are 
the preferential referral centers for high risk pregnancy cases which are also at greater 
risk of obstetric complications. This may mean that women with complicated pregnancies 
or who were not willing or capable to pay for private health care will be overrepresented 
in public maternities. An additional methodological decision, and potential source of 
selection bias, was the fact that not all eligible mothers were invited to participate in the 
cohort study because of logistic constraints, namely availability of human resources. In 
these circumstances, 70% of the eligible mothers were invited on a first come first served 
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basis [187]. To understand the impact of these selection options on potential selection 
bias, comparisons regarding main demographic and delivery characteristics between 
cohort participants and all women delivering in the catchment area and in Portugal were 
previously conducted using official statistics published by Statistics Portugal [188]. In 
comparison to women from the catchment area who gave birth between 2005 and 2006, 
mothers that integrate the cohort were slightly younger although similar in what regards 
to marital status. The prevalence of caesarean section in the cohort was slightly higher 
than the prevalence estimated for Portugal in the year 2004. Regarding delivery 
characteristics, a similar sex distribution was observed between babies included in the 
cohort and all babies born in Portugal in the corresponding period.  However, a higher 
proportion of multiple fetuses was found in the cohort participants compared to national 
estimates. Also, in comparison to deliveries in Portugal between 2005 and 2006, the 
cohort was characterized by a higher proportion of preterm and low birth weight 
newborns, which might be reflecting the overrepresentation of complicated pregnancies 
in public maternities with differentiated perinatal support. It is difficult to speculate 
whether these differences may have biased our effect estimates. However, since the 
selection of public maternities was not related to the objectives of this thesis, we expect 
that these selection criteria have not largely biased our associations. An additional 
selection strategy that needs to be discussed as potential source of selection bias is that 
related to the subset of participants included in our analyses. These participants 
represented a consecutive sample of all children evaluated in-person at 7 years of age, 
who were invited to perform a DXA scan. These participants corresponded to 27.8% of 
the entire cohort who differed from the remaining cohort participants in anthropometric 
and sociodemographic characteristics. In view of the minor magnitude of these 
differences and, again, of the independence of sample selection criteria from the 
objectives of this study, we expect minor selection bias. 
 
5.3.2. Participation bias 
An additional issue that needs to be assessed in cohort studies is the extension of 
potential participation bias, which may occur due to nonparticipation at baseline or 
attrition throughout follow-up. In the Generation XXI study, 91.4% of the invited mothers 
accepted to participate. Mothers who refused to participate are likely to be systematically 
different from those who accepted to take part in the evaluations. However, owing to 
ethical issues it was not possible to collect information on eligible individuals who refused 
to participate and therefore to estimate the scope of such differences. Nevertheless, the 
high participation proportion at baseline may decrease the impact of that potential 
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limitation [180]. We also believe, as previously demonstrated in another cohort study, 
that our results were not strongly biased by nonparticipation at baseline [189]. Regarding 
losses to follow-up, our analyses used data collected at the 4 and 7-years-old 
reevaluations, in which 69.2% and 67.6% of the entire cohort, respectively, participated 
in the in-person evaluation. These attrition rates of around 30% may not have been an 
important source of bias in the results of this thesis, particularly in results from regression 
analyses, since a previous study suggested that, even when subjects who stay differ 
from those who drop out of a study, estimates of associations tend to remain robust to 
such differences [190]. In each of the present studies, comparisons between children 
and mothers who were and were not included in the analyses revealed differences in 
sociodemographic and anthropometric characteristics collected at recruitment and 
during follow-ups. The magnitude of those differences was however generally small. This 
observation supports our belief that our effect estimates were not largely biased due to 
selective loss to follow-up. Additionally, whenever possible, our analyses were adjusted 
to factors that were presumed to affect censoring and outcomes simultaneously [141]. 
Specifically in paper I, bearing in mind that in our setting, the most important 
determinants of nonparticipation at baseline and attrition throughout follow-up were in 
fact determinants of misclassification of pregnancy weights, our sensitivity analyses, 
which revealed a minor impact of weight misclassification, also suggests that our 
estimates are not substantially biased by attrition and nonparticipation. In each study, we 
opted for complete case analysis, which assumes that the probability of being a complete 
case is independent of the outcome variable, i.e. the bone mineral properties attained, 
after adjustment for all the important covariates [191]. Overall, although differential 
losses to follow-up are a major concern for the generalizability of findings from birth 
cohorts, these studies remain the most valuable approach to assess associations 
between risk or protective factors and later health outcomes [191]. Cohort studies are 
particularly useful to understand the temporal sequence between exposure and 
outcome, to estimate effects in a comparatively long-term, and to study trajectories of 
growth during infancy unaffected by cohort or period effects [192]. 
 
5.3.3. Misclassification 
Regarding potential misclassification, we believe that differential misclassification of 
exposures was not a significant problem in our studies. Data on exposures was collected 
longitudinally, before the assessment of bone outcomes, and the team of technicians 
that performed DXA scans to obtain bone measurements was blinded to the exposure 
status. Both interviewers and parents or legal guardians were unaware of the specific 
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research questions under study. Nevertheless, non-differential misclassification, a 
source of random error, might have reduced our statistical power and/or induced biased 
results. Information on prepregnancy and predelivery maternal weight was self-reported 
and an underreporting of weight associated to pregnancy has been previously described 
[193]. However, misreporting weight might not be a significant source of bias in 
associations between gestational weight gain and childhood bone outcomes as 
previously demonstrated for other offspring outcomes [194]. We must also acknowledge 
that anthropometric measurements used in growth modeling were obtained from health 
care records, which included the contribution of several health professionals with 
different measurement equipment. Height/length and weight data routinely collected 
from child health records has previously shown to have little systematic error [195] but 
we cannot rule out the possibility of random error.  
Regarding the possible misclassification of bone outcomes, it is important to recognize 
some limitations of DXA. The main disadvantage of DXA is its two-dimensional 
methodology of a 3D structure that results in an estimate of BMD that is not a true 
material volumetric density but an areal measure easily influenced by bone size [61]. The 
impossibility of DXA to account for the third dimension leads to an erroneous estimation 
of aBMD i.e., considering two bones with the same volumetric density, the large bone 
will be assigned a higher value of areal density than the smaller one. This makes BMD 
assessment in growing children particularly challenging. Many statistical procedures 
have been proposed to decrease the influence of bone size on bone mass and density 
measures and these go from the inclusion of bone area, weight and height as 
independent variables in multiple regression models to height adjustment equations 
[61,182]. In the present thesis, we opted to compute a measure of size-corrected BMC 
(scBMC) to account for bone size effects. This measure was derived by linear regression 
of BMC on bone area and addition of the resulting residuals to the mean sample’s BMC 
[182]. This was postulated as an adequate correction of BMC for skeletal size differences 
and as an approximate measure of volumetric BMD [196]. Alternatively, in order to clarify 
the size dependency of bone mass, we used as height at age 7, as a measure of linear 
growth, and BMC adjusted to height, as a measure of bone mass relative to body size, 
as outcomes. The latter outcome aimed to provide an estimate of skeletal growth relative 
to height up to that point, more closely related to cumulative bone growth than to the 
physical properties of bone tissue. Additionally, we also performed analysis using BMC 
and areal BMD without size adjustment. We acknowledge that these outcomes are 
biased by current body size, and are not accurate measures of the material properties of 
bone tissue. However, taking into account that both material density and bone size 
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contribute to overall bone strength, BMC and areal BMD also reflect overall bone 
strength [197]. This is also supported by the accuracy of BMC to predict the risk of 
fracture in children, which is ultimately a key clinical validation [61].  
Another important limitation of DXA is that it cannot distinguish trabecular from cortical 
bone. In our work, this distinction could have helped to clarify the relationships between 
bone metabolism markers and bone mineral properties, since trabecular bone is 
considerably more available for metabolic processes than cortical bone [145]. To 
overcome this limitation we analyzed bone outcomes at the lumbar spine as a proxy of 
trabecular bone, since this anatomical site is mostly composed of this type of bone.  
Overall, we opted to use DXA to estimate bone strength because this is the 
recommended method for assessing BMC and BMD in children due to safety, rapid scan 
times and low radiation, which are especially important features in studies conducted in 
children [61,198]. Additionally, the fact that DXA is the most widely used method for bone 
assessment allows for comparisons between settings and populations. We followed the 
recommendations for research in pediatric populations of the International Society for 
Clinical Densitometry and we analyzed total body less head (subtotal) bone measures 
[61]. The exclusion of the head is recommended because skull mineralization is not 
responsive to physical or environmental stimuli, it accounts for a large percentage of the 
skeleton, and skull fractures do not represent fragility fractures. To avoid additional 
exposure to radiation, we did not collect data on reproducibility using repeated 
measurements for each subject, which would have been essential to quantify in vivo 
precision. However, reproducibility of the DXA device was tested using the spine 
phantom with and without repositioning, in two distinct moments, and the estimated 
coefficient of variation was below 1%.   
 
5.3.4. Confounding  
To account for confounding, all analyses were adjusted for potential common causes of 
exposures and outcomes. We selected covariates based on the literature or on their 
associations with the exposures and outcomes of interest. In general, results remained 
practically unchanged after adjustment for potential confounders, which advocates in 
favor of the robustness of our findings. Although information about many potential 
confounders was available in the studies included in this thesis, residual confounding 
might still be present. Additionally, the self-reported nature of several confounders might 
have contributed to residual confounding.  
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An important concern regarding our findings, is whether associations of maternal weight 
gain during pregnancy with childhood outcomes reflect direct intrauterine mechanisms, 
i.e. programming, or confounding by shared environmental, lifestyle or genetic 
characteristics as previously suggested for other outcomes such as childhood obesity 
[199] or, more likely, a cumulative effect of these two. Likewise, relationships between 
longitudinal growth and later bone mineralization might be, at least partially, explained 
by the overlapping genetic determination of these traits or the common endocrine control 
of body composition during growth, which is also, to a large extent, genetically 
determined [88]. Nevertheless, the identification of genetic or hormonal determinants of 
growth and bone associations are outside the scope of this work. A key consideration is 
the observational nature of our studies that raises important challenges to infer effects 
of gestational weight gain, growth or body composition traits on bone mineralization. 
These influences should be seen in the context of homeostatic feedback mechanisms 
rather than as a set of unidirectional effects, which has particularly challenging 
implications regarding the control for confounding. 
 
5.4. Interpretation of main findings 
Although the results of this thesis provided some evidence that early life growth impacts 
subsequent bone development in childhood, the extent to which such an influence could 
persist up to peak bone mass and beyond to decrease the risk of fragility fracture in 
adulthood is unclear [200,201]. Evidence of bone mass tracking in longitudinal studies is 
relatively short-term and its implications are contingent on the assumption of the peak 
bone mass model. It is undeniable that childhood is an important period for the 
attainment of bone strength because of the great amount of bone mineral acquired during 
this stage (Figure 18, A). Therefore, it is widely assumed that interventions aiming at 
increasing bone mass acquisition in childhood will optimize PBM and may have a 
persistent effect on bone mass throughout life and ultimately decrease fragility fracture 
risk (Figure 18, B) [83]. However, one of the main limitations of the concept of optimizing 
PBM is that it is unidimensional and may oversimplify the complex dynamics of bone 
development during growth [201]. If bone mass is governed by a homeostatic system 
acting in the short-term with any perturbation tending to be corrected over time (as 
defended by the mechanostat theory), bone mass may depend primarily on recent 
conditions rather than on the distant past [124]. This would mean that the effect of an 
intervention could disappear over time as bone mass tends to revert to a homeostatic 
set point (Figure 18, C, D, F). In view of this, optimizing PBM may not have a relevant 
benefit on fracture occurrence. Indeed, laboratory findings and clinical trials have raised 
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doubts regarding the effectiveness of interventions of increasing PBM (Figure 18, C) and 
of increasing PBM to maintain higher bone strength throughout adulthood (Figure 18, D). 
 
Figure 18. Proposed models for the effect of interventions to increase peak bone mass. The 
dashed curves represent the bone mass resulting from the intervention; the solid curves 
represent bone mass in the absence of intervention (reproduced from Gafni & Baron [200]) 
 
However, even if optimizing bone mineral accrual by intervening on modifiable factors 
does not improve PBM or if PBM optimization by itself does not decrease fracture risk, it 
is very likely that modifiable determinants of bone properties, such as body size and 
composition, are similar since intrauterine life until adulthood. Additionally, pregnancy 
and childhood are critical for establishing health-related behaviors affecting maternal 
gestational weight gain and childhood growth. These behaviors, particularly related with 
nutrition and physical activity are likely to be shared by mothers and children, and persist 
throughout the life course [202-204]. As such, even if there are no direct long-term effects 
on adult bone from interventions on modifiable determinants of healthy maternal weight 
gain and childhood growth, early intervention on these life-long causes of bone fragility 
may have indirect persistent effects, if such exposures keep their relevance throughout 
the life course. As such, the search for the etiology of bone fragility from early life and 
the intervention upon its modifiable causes seems to remain relevant as a life course 
approach, which could result in an early initiation of sustained beneficial health related-
behaviors rather than a “one-time investment” in bone quality with long-term effects. 
We also acknowledge that, from a biomechanical point of view, bone mass changes 
have limitation in describing peak bone strength attainment. Indeed, bone growth cannot 
strictly be described as an increase in the material density of existing tissue [205], but 
rather as a redistribution of bone tissue that causes an increase in mass in areas where 
it optimizes bone strength for the least possible mass [201]. This is the prevailing view 
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during the reproductive period, where no adaptive advantage of overmineralized bones 
is likely. However, it is possible that in the generally healthy pediatric population the full 
genetic potential is defined as the most efficiently adapted skeleton in terms of amount 
and distribution of bone mass. Differences in bone mass between children of similar body 
size may be seen as a measure of the attainment of that genetic potential, which, 
although arguable, is one of the main premises of the present thesis.  
 
The Generation XXI birth cohort has allowed for the collection and analysis of a wide 
spectrum of data related to several dimensions of childhood health since intrauterine life. 
Specifically regarding bone health, the Generation XXI has provided a valuable 
framework to measure and characterize physical and biochemical measures of bone 
quality, as well to test potential effects of prenatal determinants and longitudinal growth 
on childhood bone health.  
The fact that all children were born in a short period of 17 months, between 2005 and 
2006, and were reevaluated at the same age minimized possible confounding by age, 
cohort or period effects. However, as a representation of the Portuguese context, the 
Generation XXI population is comparatively homogeneous in terms of geographical 
origin, which may limit the generalizability of our results to other settings. Nevertheless, 
the population-based design of the Generation XXI cohort optimizes the generalizability 
of findings, potentially extending their applicability within the public health framework, 
namely to design population-targeted interventions that are potentially more effective 
and efficient in the general population. 
Regarding the timing of bone measures, we should note that Generation XXI is a multi-
purpose cohort designed to identify effects of numerous exposures on several 
dimensions of health. We decided to perform bone densitometry close to the 7 years-old 
follow-up evaluation because this age represents a biological milestone before the onset 
of puberty, when sexual development becomes a major driving force for growth and 
development, particularly regarding micro and macroarchitectural changes to the 
skeleton. In a life course approach to the study of the etiology of suboptimal bone 
strength, the prepubertal years represent an important milestone to identify and intervene 
in environmental determinants of bone mass.  
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5.5. Future research 
A number of major issues remain to be addressed in future studies. In terms of etiology, 
it will be relevant to assess whether these findings have long-lasting repercussions on 
the children’s bone mass as they go through adolescence and enter adulthood. In a more 
distant future, it will be important to find out whether maternal pregnancy weight gain, 
and early life growth and body composition influence the most relevant long-term clinical 
outcome, i.e. fragility fracture risk in older ages. As for policy, we still have a long way to 
go in terms of knowing the real-world effectiveness of specific interventions namely to 
improve adherence to weight gain recommendations. Both pregnancy and childhood 
may be a critical opportunity in humans’ lives to build up or reinforce health promotion 
skills and literacy, but pragmatic evidence from public health research is still needed. 
Given the inherent limitations of observational studies, particularly regarding the study of 
physiological mechanisms, evidence obtained from basic molecular biology, genetic 
epidemiology, instrumental variable approaches, natural experiments and randomized 
controlled trials may be relevant to complement our findings [82]. 
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6. Conclusions 
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In the present thesis, we found no beneficial effect of excessive maternal gestational 
weight gain on childhood bone mineralization, in both normal weight and overweight 
women prior to pregnancy, from which we concluded that adherence to the current 
recommendations for weight gain during pregnancy will contribute to optimize child’s 
skeletal health. 
With regard to effects of postnatal growth on bone development, weight and height 
velocities in the second and third years of life had the largest impact on childhood bone 
measures suggesting that early childhood represents a sensitive period for the effect of 
growth on childhood bone mineralization. Additionally, the overall trajectory of weight 
since birth may shape the development of childhood bone mineralization. The overall 
growth trajectory was not, however, particularly associated with childhood bone 
metabolism markers, which may represent more dynamic measures of bone turnover. 
Those markers were also negligibly associated with bone mineralization outcomes 
suggesting a limited ability to describe overall growth and bone mass in generally healthy 
children. 
Regarding cross sectional effects of childhood body composition on bone mineralization, 
we found that adiposity is likely to have a small specific effect on bone mass beyond its 
contribution to body size in childhood. 
Overall, these findings emphasize the importance of a life course approach to explore 
the effects of body size and composition on childhood bone mineralization. 
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